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A bstract
A t the m olecular level, K atp is an octam eric protein com plex composed o f an inwardly  
rectifying K + channel subunit (Kir6..r) which forms the channel pore and a regulatory  
sulphonylurea receptor subunit (SU R ). B y sensing intracellular nucleotide  
concentrations, K atp channels couple the membrane potassium  conductance o f a cell to  
its m etabolic state.
T o understand the m olecular basis o f m etabolic regulation o f  the K atp/K ndp channel 
K ir6.1/SU R 2B , the cell-based Rubidium -86 (86R b+) efflux assay was em ployed, using  
H E K 293 cells as the expression system . 86Rb+ efflux was activated  on the addition o f  
lOpM levcrom akilim  and m etabolic poisoning (induced by 20mM 2-deoxyglucose and 
2.5mM  sodium  cyanide), and inhibited by lOpM glibenclam ide. The subsequent 86R b + 
distribution between intracellular and extracellular space was determ ined via the 
m easurem ent o f Cherenkov radiation, the relative am ount o f 86R b+ in the cell 
supernatant being a direct m easure o f channel activ ity . The functionality  o f selected  
m utants was also investigated  under physiological conditions by the perforated patch- 
clam p m ethod, w hereby currents were evoked via voltage clam p recordings over 
1000m s voltage steps between -150mV and +50m V  from a holding potential o f -80mV.
AN-Kir6.1-AC truncations were made in an attem pt to understand the role o f  the pore- 
form ing subunit pharm acologically in channel gating, as has previously been shown for 
Kir6.2AC26. M utants for which the R X R  m otif was removed were surface expressed  
(as show n via irnmunofluorescent staining using an anti-H A-fluorescein conjugated  
antibody), and showed increased basal efflux in the absence o f SU R 2B  which was 
reduced by inhibitors which bind to the pore-forming subunit (ImM  BaCb or 100pM  
P N U -37883A ). H ow ever, these m utants did not display intrinsic A TP sensitiv ity , as 
for AN-Kir6.2-AC, and for Kir6.1AC48/AN13 this was confirmed by perforated patch  
clam ping.
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W hen Kir6.1 AC48/AN13 was expressed w ith SU R 2B , glibenclam ide was able to reverse 
efflux induced on m etabolic inhibition, but it was suspected that under this condition  
the sterical conform ation o f the channel changed which prevented Kir6.x-speciflc  
inhibitors from binding (since they were not able to reverse m etabolically induced  
efflux). In contrast, application o f either ImM BaCb or lOOpM PN U -37883A  was able 
to reverse m etabolically induced efflux for Kir6.2AC26/SUR2B. On the introduction o f  
m utations into NBD1 or N B D 2 (K 708A  and K1349M respectively) o f SU R 2B , 
K ir6.1/SU R 2B  K 708A/K 1349M  was shown to be non-functional, whereas 
K ir6.2/SU R 2B  K 708A/K 1349M  displayed normal pharm acology on the addition o f  
KCOs and m etabolic inhibitors.
In conclusion, K ir6.1/SU R 2B  is sensitive to m etabolic poisoning in an analogous 
fashion to  K ir6.2/SU R 2B , but the Kir6.1 pore-forming subunit does not display  
intrinsic m etabolic sensitiv ity , unlike Kir6.2. M etabolic sensitiv ity  o f K ir6.1/SU R 2B  is 
determ ined by both nucleotide binding dom ains o f SU R 2B , and finally the  
pharm acology o f  m etabolically attenuated  currents is different from those activated  by 
a K atp channel opener.
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Com m only used A bbreviations
AN N-term inal deletion
AC C-terminal deletion
[ATP]i intracellular A T P
2-DG  2-deoxy-glucose
86R b+ 86-rubidium
ABC A T P-binding cassette
AM PK  5 ’-A M P-activated protein kinase
A T P adenosine triphosphate
A D P  adenosine diphosphate
BaCb barium  chloride
CHO Chinese ham ster ovary cells
cD N A  com plem entary D N A
DMSO dim ethylsu lphoxide
D N A  deoxyribonucleic acid
E.coli Escherichia coli
E k equilibrium  potential for K+ ions
G F P  green fluorescent protein
H B S H E P E S  (4-(2-hydroxyethyl) piperazine-1 -
acid Buffered Saline 
H E K 293 H um an Em bryonic K idney 293 cell line
IC50 ha lf m axim al inhibitory concentration
K + potassium  ion
K atp potassium -A TP ion channel
KCB potassium  channel blocker
KCO potassium  channel opener
kbp kilo base pairs
Kir inwardly rectifying K + channel subunit
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K ndp  potassium -N D P  ion channel
M gAD P m agnesium  adenosine diphosphate
MI m etabolic inhibition
NaCN sodium  cyanide
N B D s nucleotide binding dom ains
PCR polym erase chain reaction
PK A  protein kinase A
PKC protein kinase C
PN U -37883A  4-m orpholinecarboxim idine-N -l-adam antyl-N '-
cyclohexylhydrochloride  
SEM standard error o f the m ean
SU R  sulphonylurea receptor
VSM vascular sm ooth muscle
W a w alker A m otif
W b w alker B m otif
CL cytoso lic  loop
TM transm em brane dom ain
Am ino acids are abbreviated according to the standard one and three letter code
5
Acknow ledgem ents
I would like to give my thanks to the following:
My primary supervisor, Professor Andrew Tinker, for his guidance, enthusiasm  and 
optim ism  throughout m y studies.
To Professors Lucie Clapp and Gordon Stewart for their critical appraisal o f m y work.
To Drs Philippe Behe, Jatinder A hluw alia and Brian Tennant and for their valuable  
expertise and help with the patch-clam ping.
To m em bers o f the Tinker L aboratory, past & present: Drs Alison Thom as, Sean  
Brown, K athryn Quinn, Jon G iblin, Morris M uzyamba, Muriel N obles, Steve Harmer, 
and Dr K eat-Eng Ng for their friendship and advise.
My Ph.D . was sponsored by the B ritish Heart Foundation, w ithout whom  this work 
would not have been possible.
Special thanks to my parents, M ansour and Christine Farzaneh, and to m y sisters 
Taraneh and Afsaneh Farzaneh for their support and encouragem ent.
6
Contents
A bstract 2
List o f A bbreviations 4
Acknow ledgem ents 6
List o f Tables 8
List o f Figures 9
Chapter One: Introduction 13
1.1 Importance o f  Potassium Channels and the existence o f  Superfamilies  14
1.2 General features o f  A TP-sensitive K + channels 23
1.3 Regulation o f  the A TP-sensitive K + channel by nucleotides 30
1.4  A TP-sensitive K *  channel structure 40
1.5 Vascular Smooth muscle A TP-sensitive K + channels 45
1.6 Regulation o f  the A TP-sensitive K + channels via metabolically active proteins 51
1.7 Physiological roles o f  the vascular smooth muscle K a t p  channel 62
1.8 A im s  and Hypotheses 66
Chapter Two: Materials and Methods 67
2.1 General Molecular Biology  68
2 .2  Cell culture 84
2.3 Immunohistochemistry and Immunofluorescence microscopy 90
2.4 Procedure for Rubidium -86 ( 86Rb+) efflux in cultured cells 93
2.5 The Patch Clamp technique 96
2.6  General data analysis  107
7
Chapter Three: Results
Characterization o f  K a t p  channel current in response to metabolic inhibition and  
signalling pathways  109
Chapter Four: Results
Determination o f  the functionality  and surface expression o f  K ir6 .1 /S U R 2 B  after
truncation o f  the N- and C-terminus o f  the pore-forming subunit 142
Chapter Five: Results
The application o f  K a t p  channel inhibitors to infer the role o f  the pore-forming
subunit in channel regulation under metabolic inhibition 167
Chapter Six: Results
The role o f  the Sulphonylurea receptor in K a t p  channel regulation 189
Chapter Seven: Discussion 205
Bibliography 220
List o f  Tables
1.1 The clinically relevant and atypical A B C  proteins in humans with their 21 
corresponding ligands/functions and associated diseases
1.2 Subunit composition o f  K a t p  channels in various tissues 24
4.1 Sum m ary o f  the functionality  &  surface expression o f  A C -K ir6 .x -A N  truncation 166 
mutants
5.1 Sum m ary o f  the response o f  AC- K ir6 .x-A N  truncation mutants to KCOs and M is  186
8
»List o f Figures
Chapter One
1.1 The evolutionary tree o f  the inward rectifying K +-channel fa m ily  17
1.2 Time-course o f  whole-cell currents generated for K a t p  and K ir  18
1.3 Hypothetical structures o f  a pore-forming subunit o f  an a-subunit o f  K v  and K ir  19 
Channels
1.4 A model for the N B D  dimer o f  S U R  23
1.5 Transmembrane topology o f  a single S  UR and K ir6 .x  subunit o f  a K a t p  channel 26
1.6 Nucleotide regulation o f  K a t p  activity  34
1 .7 Hypothetical coordination o f  the A T P  molecule with S U R  35
1.8 Model for  nucleotide regulation 39
1.9 Location o f  molecular models within the 3D K ir6 .2 -S U R 1  structure 43
1.10 Traverse sectional view o f  the E M  density o f  a model o f  K ir6 .2  44
1.11 Model to propose how S U R 1  and K ir6 .2  might assemble to for the K a t p  channel 44
1.12 A K ph os pho tra ns fe r  c o m m u n i c a t e s  mitochondr ia-generated  s i gna ls  to 52 
K a t p  channels
1.13 Factors that regulate vascular K a t p  channels 58
1.14 Energy levels are regulated by A  M P K  60
Chapter Two
2.1 The main features o f  p c D N A 3 .1  69
2 .2  The principles o f  site-directed mutagenesis 82
2.3  Measurement o f 86R b+ efflux o f  transfected H E K 2 9 3  cells 95
2.4  The Jive configurations o f  the patch-clamp technique 99
2.5 Configuration o f  patch-clamp recording setup 101
2.6  Perfusion o f  the patch-clamp recording setup 103
9
Chapter Three
3.1 ^Rb* efflux time course assay on H E K 2 9 3  cells transfected with K ir6 .1 /S U R 2 B  113
3 .2  Sum m ary o f  the effects o f  variation in pharmacology on the K a t p  channel after 115 
the application o f  the K a t p  channel opener/closer.
3 .3  The effect o f  Metabolic Inhibitiors on the K a t p  channels K ir6 .2 /S U R 2 B  117 
and K ir6 .1 /S  UR2B
3.4 Measurement o f 86Rb+ efflux o f  native potassium channels in aortic and  119 
cardiac smooth muscle cell lines
3 .5  Measurement o f 86Rb+ efflux o f  native potassium channels in HL-1  120 
and C2C12 cell systems
3 .6  Examples o f  K ir6 .1 /S U R 2 B  currents in stably transfected H E K 2 9 3  cells 123 
as recorded by the whole-cell patch clamp configuration
3 .7  Examples o f  K ir6 .1 /S U R 2 B  currents in transiently transfected H E K 2 9 3  cells 125 
as recorded by the whole-cell patch clamp configuration
3 .8  The effect o f  metabolic inhibition on the K a t p  channel K ir6 .1 /S U R 2 B  current 128 
as demonstrated by the perforated patch-clamp method
3.9  Effect o f  metabolic inhibition on the K a t p  channel K ir 6 .2 /S U R 2 B  current as 130 
demonstrated by the perforated patch-clamp method
3.10  The ability o f  P K A  inhibitors adenosine receptor antagonists to reverse 133 
86Rb+ efflux in response to metabolic inhibitors or increased cA M P  levels
3.11 The effect o f  point mutations on the P K A  consensus sites T234 and S385 in 135 
Kir6 .1  on the functionality  o f  K ir6 .1 /S U R 2 B  as shown b y 86Rb+ efflux
3 .12  The effect o f  point mutations on the P K A  consensus sites T633 and S1465  137 
in S U R 2 B  on the functionality  o f  K ir6 .1 /S U R 2 B  as shown b y 86Rb+ efflux
3.13 The effect o f  A M P K  activators and inhibitors on the response o f  the K a t p  139 
channel to metabolic inhibition as shown by 86Rb+ efflux
10
Chapter Four
4.1 Generation o f  the A N -K ir6 .1 -eH A -A C  truncation mutants via conventional P C R  145
4 .2  Truncation o f  K ir 6 .1: Sequence o f  K ir 6 .I A N 33 obtained using T 7prim er  146
4.3  Surface staining o f  K ir6 .1 -H A  N- or C-terminal deletion mutants 148
4 .4  Surface staining o f  K ir6 .1 -H A  N- or C-terminal deletion mutants 150
4 .5  Surface staining o f  wild-type and mutant K ir6 .2 /S U R 1 K a t p  channel complexes 154
4.6  Surface staining o f  wild-type and mutant K ir6 .2 /S U R 1 K a t p  channel complexes 156
4 .7  The effect o f  truncation o f  the N /C  terminus o f  Kir6.1 on the function o f  the 158 
K ir6 .1 /S  U R 2B  as shown b y 86Rb+ efflux
4 .8  The effect o f  truncation o f  both the C & N  terminus o f  K ir6 .1  on the function o f  the 160 
K ir6 .1 /S  U R 2B  as shown b y 86Rb+ efflux
4 .9  Deduction o f  the functionality  o f  K ir 6 .1AC48!AN13 and K ir6 .1AC 48  162 
expressed in H E K 2 9 3  minus the sulphonylurea receptor
4 .10  Patch clamp recordings obtained from H E K 2 9 3  cells transiently transfected with  165 
K ir6 .1A C 48/A N 13/S  U R 2B , K ir6 .1A C 48/SU R 2B  and K ir6 .1 A N 3 3 /S U R 2 B
Chapter Five
5.1 Dose response curve to determine concentration at which the potassium channel 169 
inhibitor, P N U -3 7 8 8 3 A , results in maximal inhibition o f  Kir6 .1  conductance
5 .2  The effect o f  potassium  channel pore blockers on H E  K 293 cells transfected with  171 
Kir6.1  truncated mutants
5 .3  The effect o f  potassium  channel blockers on A N -K ir6 .1 -A C  truncation 174 
mutants expressed with S U R 2 B
5.4  The effect o f  potassium  channel inhibitors specific to K ir6 .x  on the K ir6 .1 /S U R 2 B  
stable cell line 175
5 .5  The effect o f  the K a t p  channel inhibitor P N  U-37883A on the reconstituted 178 
channel K ir6 .1A C 48/A N 13/S U R 2B
11
5.6  The effect o f  the K a t p  channel inhibitor P N  U -37883A on the reconstituted 181 
channel K ir6 .1AC 48/A N 13
5 .7  The effect o f  potassium channel Kir6.x-specific inhibitors on H E K 2 9 3  cells transfected 
with K ir6 .2AC 26  183
5 .8  The effect o f  a K C O  and metabolic inhibitors on H E K 2 9 3  cells transiently 185 
expressing K ir6 .2A C 26 both with and without S U R 2 B
Chapter Six
6.1 The effect o f  mutating the W a m otif  lysine o f  N B D s  1 and 2 o f  the sulphonylurea 191 
receptor on the functionality  o f  the K a t p  channel K ir6 .1 /S U R 2 B
6.2  Comparison o f  the functionality o f  K ir6 .1 /S U R 2 B  and K ir6 .2 /S U R 2 B , whereby 193 
SU R2Bcontains mutations in both the W a m otif  lysines o f  both N B D 1 and N B D 2
6.3 The effect o f  introducing a single mutation into the linker domains o f  the 195 
sulphonylurea receptor on the functionality o f  the K a t p  channel K ir6 .1 /S U R 2 B  and 
K ir6 .2 /S  U R 2B
6.4 The effect o f  mutating both the W a motifs o f  the K a t p  channel K ir6 .2 /S U R 2 B  on 198 
channel functionality  ( i.e . K ir6 .2  &  S U R 2 B  K 1 3 4 9 M /K 7 0 8 A ) as demonstrated by the 
perforated patch-clamp method
6.5 The effect o f  mutating both the W a motifs o f  the K a t p  channel K ir6 .1 /S U R 2 B  199 
(i.e . K ir6 .1  &  S U R 2 B  K 1 3 4 9 M /K 7 0 8 A )  on channel functionality as demonstrated by the 
perforated patch-clamp method
6 .6  The effect o f  mutating Arg 816 , Thr 1345 and Lys 1349 o f  the sulphonylurea 202 
receptor on the functionality  o f  the K a t p  channel K ir6 .1 /S U R 2 B
6. 7 Diagram depicting the sulphonylurea receptor to indicate the mutations that were 203
introduced into N B D 1  and N B D 2
12
Chapter One
Introduction
13
Chapter One: Introduction
1.1 Importance o f Potassium Channels and the existence o f Superfamilies 
A typical excitable cell contains an intracellular potassium  concentration o f  
approxim ately 150mM, while the extracellular concentration lies in the range o f  3-5mM  
(H ille 1992). This dis-equilibrium  ex ists because o f the differences that occur between  
the plasm alem m al perm eabilities o f  N a+, K +, Ca2+ and C l\ and together with the 
activ ities o f electrogenic pumps (principally the N a+/K + A TPase), the activ ity  o f co- 
transporters (such as the N a+/Ca2+ exchanger) and the synthesis o f large, non-diffusable 
ions, a resting or basal membrane potential in the region o f -60m V is generated. This 
varies according to the tissue concerned. The membrane potential (EK) at which  
[K +]i:[K+]0 would be in equilibrium is around -90mV, and the m odulation o f K-channel 
gating offers the cell a m ethod o f altering its excitability  status. W hen K + channels are 
opened, the m em brane is hyperpolarised towards EK, and its excitability  decreases. 
Conversely, there is a significant K +-conductance at resting membrane potentials, and 
K +-channel closure results in m em brane depolarisation and an increase in its 
excitab ility  (H ille 1992).
K + channels p lay a crucial role in basic cellular functions such as excitab ility , secretion, 
proliferation and volum e regulation. T hey occur in virtually  every eukaryotic and 
prokaryotic cell, and with enorm ous advances made in the elucidation o f their 
architecture and function, they  are undoubtedly one o f the best understood ion 
channels. The growing number o f m utations in potassium  channel genes that have been 
linked w ith disease illustrates the fundam ental im portance o f K+ channels to an 
organism: B artter’s syndrom e (a rare disorder m anifested by primary inherited renal 
tubular hypokalaem ic m etabolic alkalosis) long-QT syndrom e (a heart disease in which  
is there is an abnorm ally long delay between depolarisation and repolarisation o f the 
ventricles o f the heart) and fam ilial persistent hyperinsulinaem ic hypoglycaem ia o f  
infancy (whereby the secretion o f insulin is unregulated resulting in profound
14
h y p °g ly cem ia), are exam ples o f  diseases arising from m utations in K+ channels or via  
altered K + channel function (Cohen 2003; K leta and Bockenhauer 2006; W eese-M ayer, 
Ackerman et al. 2007).
The com bination o f electrophysiological and structural inform ation has enabled the 
classification o f K+ channels into three superfamilies: (1) Kv channels (activated by a 
change in transm em brane voltage), (2) inward rectifier channels (Kirs) and (3) twin- 
pore inward rectifier channels.
Superfamily 1: Kv, Ka, and BKc*
The first K + channel subunit cloned was the Shaker Drosophila K+ channel, and is 
thought to be related to this superfam ily (Butler, W ei et al. 1989). Here the K+ 
channels include the delayed rectifier (K v), the ‘A ’-channel (Ka) and the large 
conductance, Ca2+ sensitive channel (B K ca)- The Of-subunits o f the Kv channels consist 
o f six transm em brane segm ents (SI to S6), and one potential pore-forming region (H5) 
between S5 and S6 (Figure 1.4). T he S4 region is positively charged, and is thought to 
act as a voltage sensor, and the am ino (N-) and carboxy (C-) termini are located  
intracellularly. T his structure is thought to be similar to that o f the voltage-dependent 
N a2+ and Ca2+ channels, although the latter are formed by a single m olecule, whereas 
Kv channels are formed of an aggregate o f 4 subunits. The gating properties o f the a -  
subunits can also be m odulated by P-subunits (Isom oto, Kondo et al. 1997). 
Electrophysiologically, they are activated upon depolarisation, with typically  
outw ardly-rectifying current-voltage relationships when measured under w hole cell 
voltage-clam p conditions. They exh ib it a wide range o f tim e-dependent inactivation  
properties, ranging from very rapid (Ka) to essentially none (BKca) (Isom oto, Kondo et 
al. 1997).
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Superfamily 2: Kir and K atp
In 1993, the expression cloning o f cD N A s encoding distinct inwardly rectifying K+ 
channels (Kir) was reported (H o, N ichols et al. 1993; Kubo, Baldwin et al. 1993), which  
led to the identification o f the structure and function o f the Kir subfam ily. A variety o f  
cells possess Kir channels, which stabilize the resting potential near the K+ equilibrium  
potential, controlling cellular excitab ility . Their nam e is derived from the fact that 
inward currents evoked by hyperpolarisation are greater than currents elicited by 
depolarisation o f the sam e am plitude. They also play a role in the m aintenance o f  
resting m em brane potential, the regulation o f action potential duration, in the secretion  
and absorption o f K + ions across the m em brane and in receptor-dependent inhibition o f  
cellular excitab ility . Cells expressing a sufficient quantity o f Kir channels are expected  
to have a resting potential near to E K and m ay not excite autom atically , but when 
stim ulated exhib it action potentials w ith a long-lasting plateau when the abundance o f  
voltage-gated outward K + channels is less frequent.
The inwardly rectifying K + channel proteins so far identified vary from ~  360 to 500 
am ino acids long, and the am ino acid hom ology is ~40%  between members belonging to 
different subfam ilies and ~60%  between individual members w ithin each subfam ily  
(N ichols and Lopatin 1997). Figure 1.1 details the seven subfam ilies have now been 
identified, designated Kir 1.0-7.0.
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Kir3.2a-d/GIRK2a-d
Kir3.4/GIRK4
-Kir3.3/GIRK3
Kir3.1/GIRK1
Kir6.1/uKATP'1
Kir6.2/BIR
Kir5.1/BIR9
Kir1.3/Kir4.2
Kir1.2/Kir4.1/KAB'2
Kir4.3
Kir1.1a-f/ROMK1-6
Kir7.1
Kir2.1/IRK1
Kir2.2/IRK2
Kir2.4/IRK4
Kir2.3/IRK3
G-protein
activated
UKir3.*)
A T P-sensitive  y (Kir6.x)
K+ transport 
(Kir1.0/Kir4.x)
>
>
C lassical
inward
rectifier
(Kir2.x)
Figure 1.1: The evolutionary tree of the inward rectifying K+-channel family with two- 
membrane-spanning domains (adapted from Fujita & Kurachi; 2000).
In contrast to the K\ superfam ily, they comprise only tw o hydrophobic  
transm em brane-spanning segm ents separated by the conserved H5 region that 
determ ines K+ se lectiv ity  (Figure 1.3). The classic Kir channels such as Kir2.:c conduct 
modest currents at physiological potentials, but exhibit a m arkedly-enhanced current 
flow negative to Kk- This inw ardly-rectifying behaviour, illustrated in Figure 1.2. is a 
function o f  the m em brane potential and |K ^]o. The Kir6.x fam ily m embers are unique 
in that they form a heterom ultim eric K+ channel/receptor com plex together w ith  
sulphonyl urea receptor subunits to exert K* channel function, i.e. form the K a tp
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channel (Inagaki and Seino 1998; Aguilar-Bryan and Bryan 1999). K a tp  channels are 
‘‘w eak” inward rectifiers; they are m odulated by changes in intracellular A T P , [ATP]i, 
and as the [ATP]i increases, K a tp  closes, while channel opening is associated w ith a 
lowering o f [A TP]i. Ik(ATP) currents show no tim e-dependent activation , and I-V  
relationships show som e evidence o f inward rectification, but this effect is small 
compared w ith Kir channels (Ashcroft and Ashcroft 1990).
(A) (B)
Figure 1 .2 : A theoretical current/voltage relationship for (A) a strong and (B) a w eak inward  
rectifier (such as Katp) generated during a ramp protocol.
Superfamily 3: Twin-Pored Inward Rectifier Channels
A novel yeast K + channel subunit (TOK1), structurally equivalent to a Kir subunit in 
tandem  with a six-transm em brane dom ain Kv subunit and which expressed outwardly  
rectifying K+ currents in Xenopus  oocytes has been described (K etchum , Joiner et al. 
1995), as has the cloning and expression o f a m am m alian channel (TW IK -1), which  
consists o f tw o transm em brane domain channels in tandem  (Lesage, R eyes et al. 1996). 
Since the expressed currents through TW IK -1 channels appear to be weakly inwardly  
rectifying, sim ilar to those expressed by K ir l.l  channels, it is possible that a generation  
o f novel Kir channels arose from a gene duplication (Lesage, R eyes et al. 1996). They  
play an im portant role in the background potassium  conductance o f a wide range of  
tissues with poor pharm acology.
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(A) (B)
H5
COO-
Extra
84 88 88
Intra
COO-
Figure 1.3: Structures o f  a pore-form ing subunit o f  an a -su b u n it o f  K\ channels (A) and Kir 
channels (B). P u ta tive  transm em brane segm ents are num bered. H5 and P are pore-form ing  
regions. S4 is the vo ltage-sen sitive  segm ent.
The ATP-binding cassette (ABC) Superfamily
The ABC transporter superfam ily is one o f the largest groups o f proteins involved in 
active transport across cell membranes, their characteristic feature being the highly  
conserved A T P-binding cassette in the m olecules (H yde. Em sley et al. 1990). E xisting  
in all species, w ith 29 members known in yeast. 69 in E.coli (accounting for 5% o f  its 
genom ic coding capacity) and 48 in hum an, they couple the transport o f various 
com pounds to A T P-binding and hydrolysis (D ean. H am on et al. 2001). M any have  
great clinical significance: MDR1 confers cancer resistance to chem otherapeutic drugs 
(G ottesm an 1988). and m utations o f ABCR. CFTR and cMOAT cause Stargardt 
m acular dystrophy o f eyes (Allikm ets. Gerrard et al. 1996). cystic fibrosis (Riordan. 
Rom m ens et al. 1989) and D ubin-Johnson (Paulusina. Bosnia et al. 1996) syndrom e  
respectively all o f  which are caused by the failure to export a specific ligand across a 
lipid bilayer. ABC proteins can be regarded as active transporters, using the energy o f  
ATP hydrolysis: m any regulate ion channels. CETR is a Cl'channel itself and regulates 
the outw ardly rectifying Cf channel (ORCC) and the epithelial sodium channel (ENaC) 
(S tu tts, Canessa et al. 1995). MDR1 has been considered to be a regulator o f the
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volum e-sensitive chloride channel (Miwa, Ueda et al. 1997). The clinically relevant and 
atypical ABC proteins in hum an are shown in Table 1.1.
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ABC Protein Ligand(s)/Function Associated D isease(s)
ABC1 Cholesterol Tangier disease
ABCR Retinal Various eye diseases (Stargardt)
T A P I/2 Peptides Bare lym phocyte syndrom e
ABC7 Iron Anemia and X L SA
M RP6 9 Pseudoxanthom a elasticum
ALD vlcFA Adrenoleukodystrophy
Sterolin Vz Sterols Sitosterolem ia
PG Y 3/M D R 3 Phosphatidylcholine Liver disease: PFIC 3, OC
B SE P /SP G P Bile acids Liver disease: PFIC2
M RP2 Conjugated bilirubin Liver disease: D -J syndrom e
MDR1 H ydrophobic drugs Failure o f chem otherapy
BC R P/M X R H ydrophobic drugs
M RP1 Conjugated drugs
M R P4 Conjugated nucleosides
Atypical ABC proteins (Nontransporter)
CFTR Chloride ion channel Cystic fibrosis
SU R Regulation o f K ir channel PH H I
SMC1-6 Chromosome m aintenance
Rad50 D N A , telomere repair
MutS D N A  m ism atch repair
M SH2/6 D N A  m ism atch repair
E lflp m RNA trafficking
Abbreviations: X L SA , X-linked sideroblastom ic anemia; PFIC, progressive familial 
intrahepatic cholestasis; OC, obstetric cholestasis; D -J , D ubin-Johnson syndrome; 
P H H I, persistent hyperinsulinem ic hypoglycem ia o f infancy
Table 1.1: The clinically relevant and atyp ical ABC proteins in hum ans w ith  their  
corresponding ligands/functions and associated diseases (adapted from Linton; 2007 &  H iggins 
&  Linton; 2004).
In bacteria, both com plete and partial structures o f ABC transporters have been 
determ ined (Oswald, Holland et al. 2006), revealing that they are dimeric and consist o f  
two transinem brane dom ains (TM Ds), which form the ligand binding sites and provide 
specificity, and two nucleotide binding dom ains (N B D s) which bind and hydrolyse ATP  
to drive the translocation of the bound ligand. The N B D s are well conserved in both
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sequence and structure throughout the fam ily, and have several characteristic m otifs, 
including the W a and W b m otifs an intervening linker m otif (LSGGQ) which is unique  
to all ABC proteins and is thus known as the ABC signature, and stacking arom atic D , 
H , and Q loops. The W a and W b m otifs are specifically involved in nucleotide binding  
and hydrolysis, but the function o f the signature sequence is less clear, and is thought 
that the linker serines are involved in transducing nucleotide binding into channel 
activation . Via these conserved regions, A T P binding and hydrolysis is often coupled to 
changes in protein activ ity  in all ABC proteins. The transm embrane dom ain sequences, 
on the other hand, are poorly preserved. The exact order o f the TM Ds and N B D s varies 
and can be encoded on different polypeptides or fused together in any com bination. 
These dom ains are often  separate subunits that co-assem ble to produce a functional 
ABC protein in prokaryotes, whereas in eukaryotes a single gene usually encodes both  
N B D s and TM Ds (L inton and H iggins 1998; Campbell, Sansom et al. 2003).
Functional studies involving both bacterial and eukaryotic ABC proteins have  
indicated that the tw o N B D s o f ABC proteins interact and operate as a functional unit 
(Kerr 2002). It would appear that the N B D s dimerize in a nucleotide-sandwich  
conform ation, w ith  the signature sequence (linker) o f one N B D  m onomer located close 
to the W a m otif o f the other. Crystallographic and functional studies o f ABC proteins 
have provided experim ental evidence in favour o f this conform ation (Locher, Lee et al. 
2002).
A model o f the SU R  1-N B D  dimer with bound A T P is shown in Figure 1.4. A T P lies in 
the binding pocket formed by the W a and W b m otifs o f one N B D  and the linker m otif  
o f the other. An aspartate in the W b m otif co-ordinates the Mg2+ ion o f M g-ATP and is 
required for nucleotide binding. A lysine in the W a m otif interacts with the y and P 
phosphate groups o f A T P, and is essential for A T P hydrolysis (H iggins 1992). Aside 
from the established role o f each o f the N B D s in nucleotide hydrolysis, the signature  
linker sequence is thought to be critical for transduction (Kerr 2002). The model 
depicts that the W a and W b o f N B D 1 associate with the linker sequence o f N B D 2, and
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v ic e  versa. T h e n u cleo tid e-b in d in g  p ock ets are referred to  as 's ite  1* (W alker m o tifs  o f  
N B D 1 , linker N B D 2 ) and 's ite  2 ’ (W alker m otifs  o f  \ B D 2 .  linker N B D 1 ). T he  
stru ctu ra l d e ta ils  o f  th e  A T P a se  cy c le  and th e  in teraction  b etw een  th e  tw o  N B D s  o f  
ABC transporters are s t ill con troversia l h ow ever (M atsuo. D abrow sk i et al. 2002).
Site 1
Site 2
Figure 1.4: A model of the N BD s o f  SU R 1, showing the nucleotide-sandwich dimer and the 
conserved motifs. The W \ m otif (yellow ). Wb m otif (orange) and the signature sequence (green) 
are shown. N BD1 is blue, and N B D 2 is purple, and sites 1 and 2 are indicated. The binding 
pocket thought to be formed by the MgATP molecule (red) is also depicted (taken from 
Campbell et al., 2003).
T h e stron g  con servation  o f  seq u en ce  and structure in th e  N B D  o f  A BC  p rote in s w ith  
d iverse  fu n ctio n s  su ggests th a t th is  dom ain  m ay  be th e  s ite  at w h ich  a com m on  
m ech an ism  occurs to power a v a r ie ty  o f  cellu lar processes in  a sim ilar fash ion .
1.2 General features o f  A  TP-sensitive  K + channels
A T P -se n s it iv e  K + (K atp) ch an n els w ere orig in ally  d iscovered  in th e heart (N o m a  1983). 
and are w id ely  d istributed  in  m a n y  cells and tissu es in clu d in g  p an crea tic  B-cells 
(A sh cro ft, H arrison et al. 1984: Cook and H ales 1984: R orsm an  and T rube 1985) brain  
(A sh ford . S tu rgess et al. 1988: A m oroso , S ch in id -A n tom arch i et al. 1990), sk eleta l 
(Spruce, S ta n d en  et al. 1985), sm o o th  m uscles (S tan d en , Q u ayle  et al. 1989) and k id n ey  
(H u n ter  and G ieb isch  1988). T h e y  are in h ib ited  by in tracellu lar A T P  and a c tiv a te d  by  
M g A D P  (N o m a  1983: A shcroft 1988). and b y  sen sin g  ch an ges in in tracellu lar  a d en in e  
n u cleo tid e  co n cen tra tio n , cou p le  th e  altered m etab olic  s ta te  o f  th e  cell, for ex a m p le
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w ith hyperglycem ia, hypoglycaem ia, ischem ia and hypoxia, to membrane potential 
(Yokoshiki, Sunagawa et al. 1998). K atp channels exhibit characteristic 
pharm acological properties. A ntidiabetic sulfonylurea derivatives, e.g. glibenclam ide  
and tolbutam ide, selectively inhibit them , whereas agents such as pinacidil, 
levcrom akalim  and nicorandil activate  them . Table 1.2  shows that heterologous 
expression o f  two types o f Kir6.jr subunit and three main SU R subunits in differing 
com binations reconstitutes different types o f K atp channel w ith distinct 
electrophysiological properties and nucleotide and pharm acological sensitivities, 
reflecting the various K atp channels in native tissues.
Subunit composition Type
Kir6.2/SUR1 Pancreatic B-cell (Inagaki et al., 1995; Sakura et al., 1995)
Kir6.2/SUR2A Cardiomyocyte {Inagaki et al., 1996)
Kir6.2/SUR2B Non-vascular smooth muscle? (Isomoto et al., 1996)
Kir6.1/SUR2B Vascular smooth muscle ( Yamada et al., 1997)
Table 1.2: Subunit composition of K a t p  channels in various tissues
The physiological role o f  K atp channels has been best characterised in insulin-secreting  
pancreatic B-cells (Cook, Satin et al. 1988; Ashcroft and Rorsman 1989), whereby an 
increase in glucose m etabolism  leads to an increase in A TP concentration which closes 
the K atp channels. This closure results in depolarization o f the B-cell m em brane, leading  
to opening o f  the voltage-dependent calcium  channels (VDCCs) allowing calcium  influx. 
The subsequent rise in intracellular calcium  concentration in the B-cell triggers 
exocytosis o f insulin-containing granules. It is therefore apparent that K atp channels in 
B-cells are critical in the regulation o f glucose-induced insulin secretion.
The K atp channel is a hetero-octam eric com plex comprising either Kir6.1 or Kir6.2 and 
a regulatory Sulphonylurea Receptor (SU R ) subunit, so named because it binds 
sulphonylureas (that are used for the treatm ent o f type 2 diabetes m ellitus) w ith high
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affin ity (Ashcroft and Gribble 1998; Aguilar-Bryan and Bryan 1999; Seino 1999). There 
is roughly 70% am ino acid identity  between Kir6.1 and Kir6.2 (Inagaki, Tsuura et al. 
1995). In inwardly rectifying K + channels there is a highly conserved G ly-Tyr-G ly m otif  
in the H5 region, critical for ion selectiv ity . H owever, in Kir6.* members this is Gly- 
Phe-G ly. Sulphonylurea receptors belong to members o f the ABC protein superfam ily  
(H iggins 1992) and two isoforms, SUR1 and SU R 2, exist. The partial am ino acid 
sequence o f [125I]-iodoglibenclam ide binding to purified protein was used to obtain the 
first clone o f SUR1 from the pancreatic fl-cell cD N A  libraries (Aguilar-Bryan, N ichols 
et al. 1995). SU R 2, now renamed SU R 2A , was subsequently cloned by hom ology  
screening using SUR1 as a probe (Inagaki, Gonoi et al. 1996). There is a major variant 
o f  SU R 2A , SU R 2B , resulting from alternative splicing (Chutkow, Simon et al. 1996; 
Isom oto, Kondo et al. 1996; Chutkow, Makielski et al. 1999). These splice variants differ 
by 42 am ino acids in the C-terminus, and consequently the C-terminus o f SU R 2B  is 
sim ilar to SU R 1. A further splice variant o f SU R 2A , SUR2C, which has a deletion o f 35 
am ino acids in the intracellular loop between the 11th and 12th membrane spanning 
dom ains has also been cloned, but its function is not clear (Chutkow, Simon et al. 1996; 
Ashcroft and Gribble 1998). Further alternative splicing events have also been observed 
for SU R 2, and a total o f  six splice variants o f SUR1 have been identified to-date (Shi, 
Y e et al. 2005). Studies w ith  m em brane-im permeable b iotinylating reagents (Conti, 
Radeke et al. 2001) have confirm ed that the sulfonylurea receptor is com posed o f three 
transm em brane dom ains, TM D 0, TMD1 and TM D2, each o f which consists o f five, six 
and six m em brane spanning regions respectively. This topographical arrangement is 
illustrated in Figure 1.5. SU R s also have two nucleotide binding folds (N B D 1 and 
N B D 2) with W a and W b m otifs on the cytoplasm ic side o f the cell. They are located in 
the loop between TMD1 and TM D2 and in the C-terminus respectively (Conti, Radeke 
et al. 2001). The W alker m otifs are crucial for stim ulation of K a tp  gating by ATP and 
N D P s in the presence o f  Mg2+. Biochem ical studies have indicated that the molecular 
m ass o f the glycosylated com plex o f K ir6.2/SUR1 to be 950kD a (Clement, K unjilwar et 
al. 1997), indicating that the K a tp  channel is likely to be a hetero-octam eric com plex o f
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Kir6.2 and SLR1 in a 4:4 stoichiom etry (Clement, Kunjilwar et al. 1997: Inagaki, 
Gonoi et al. 1997; Shyng. Ferrigni et al. 1997).
TMDO TMD1 TMD2
Inhibit: Glibenclamide
(CL3 and CL8) (Mikhailov et al., 2001)
Activate: Pinacidil
(TMs 13-16) (Ashcroft & Gribble; 2000)
Activate: Levromakalim 
(TM 17) (Moreau et al.,2000)
PORE SUBUNIT
(Kir6.1/Kir6.2)
I M H
NBD2
Inhibit: ATP & ADP 
(Tucker et al., 1997)
Activate: PIP2 
(Shyng et al., 2000)
Block: BaCI2&
PNU-37883A 
(Cui et al., 2003)
Figure 1.5: Transm em brane topology o f a single SL R (left) and Kir6.x (right) subunit o f a K a t p  
channel. The sites o f channel activators and inhibitors, including the suspected sites o f  action  
o f  the KCOs and KCBs used in this thesis, are shown.
Co-expression o f Kir6.* and SL R is necessary to generate significant plasmalemmal 
currents, and aside from functional regulation, both subunits are required for cell 
surface expression of the channel. There is a wealth o f evidence to suggest that Kir6.2 
and SLR1 contain small tripeptide Arg-Lys-Arg motifs (RK R) that act as a quality  
control mechanism, ensuring surface expression of only properly assembled octameric 
proteins (Zerangue, Schwappach et al. 1999). In smooth m uscle-type K atp channels, it 
remains elusive as to which of the m any factor(s) modify the expression of K atp 
channel com ponents in the cell plasma membrane, although the RK R m otif is
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considered to play an im portant role here too (Zerangue, Schwappach et al. 1999). It 
has been proposed that in partially and preassembled channel proteins, the R K R  m otif 
is exposed and that this either prevents export o f  the protein from the ER  and/or 
retrieves it from the golgi. U pon com plete assem bly o f the channel com plex, the R K R  
m otifs becom e shielded to allow the channel to traffic to the plasma m em brane as they  
are able to pass the E R  quality control checkpoint. The sugar m oiety on SUR1 is 
modified before translocation to the plasma membrane (Raab-Graham , Cirilo et al. 
1999; Conti, Radeke et al. 2001). Deletion o f the R K R  m otif allows each protein to 
express independently, and m utation  to AAA leads to unregulated surface expression of  
the individual subunits and partially assembled channel com plexes (Bryan and Aguilar- 
Bryan 1999; Sharma, Crane et al. 1999; Giblin, Quinn et al. 2002; Chan, Zhang et al. 
2003; Y an, Lin et al. 2004).
Pharm acology o f  K atp channels
A T P -sensitive K + (K atp) channels are the targets for several clinically im portant 
groups o f drugs including the sulphonylureas, a type o f K atp channel blocker (KCB) 
which are used in the treatm ent o f  type 2 diabetes, and the K atp channel openers 
(KCOs), which are used to treat angina and hypertension. As well as containing  
binding sites for sulphonylureas, the SU R subunit confers sensitiv ity  to KCOs. In 
general, channel activation  by  KCOs leads to hyperpolarisation o f the cell membrane, 
w ith the functional consequences obviously depending on the tissue involved.
A chimaeric approach has been used to localize the binding sites for KCOs within  
SU R 2, based on the fact that openers such as pinacidil, cromakilim and P1075 are 
highly effective on SU R 2 but not SU R 1-containing K atp channels. TM D2 was 
im plicated as critical for KCO action. A ctivation by pinacidil was conferred by the 
transfer o f TMs 13-16 from SU R 2A  into SU R 1, whereas the reverse swap impaired 
pinacidil sensitiv ity  (Ashcroft and Gribble 2000).
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Chimerical studies in which regions w ithin TM D2 were swapped between SUR1 and 
SU R 2, have shown that part o f  CL7 and TMs 16-17 are im portant for both P1075  
binding and channel activation by openers, although there are differences depending on 
the KCO used (Reim ann, Proks et al. 2001). Using a cromakilim analogue, it was 
shown that transfer o f  TM17 from SU R 2A  was sufficient to confer opener sensitiv ity  to 
SU R 1, and th at am ino acids L1249 and T1253 o f TM17 o f SU R 2 are critical for opener 
action (Moreau, Jacquet et al. 2000). D iazoxide activates K ir6.2/SUR1 and 
K ir6.2/SU R 2B  channels when M gATP is present and K ir6.2/SU R 2A  channels when  
M gAD P is present. Transfer o f  TMs 6-11 together w ith N B D 1 from SUR1 conferred 
diazoxide sensitiv ity  on SU R 2A , suggesting that these regions are involved in diazoxide  
action. It has been suggested that diazoxide m ay occupy the same binding site as other 
KCOs, but th a t TM s 6-11 and N B D 1 couple diazoxide to the gating m echanism  for 
Kir6.2 (Babenko, Gonzalez et al. 2000).
Nucleotides are also important for the action o f KCOs. It has been proposed that 
nucleotide binding or hydrolysis at the N B D s act allosterically to increase the affinity  
o f the KCO binding site, and allosteric effects can act in the opposite direction to alter 
channel-nucleotide interactions in response to KCOs. Pinacidil, for exam ple, can  
stabilize M gA D P binding to K ir6.1/SU R 2B (Satoh, Yam ada et al. 1998). Pinacidil also 
increases A T P hydrolysis by N B D 2, and contributes to channel activation via  
stabilization o f  the M g-nucleotide bound sta te  (Zingman, Alekseev et al. 2001).
The sulphonylurea and glinide drugs bind to SUR1 o f the P-cell K atp channel to cause 
channel closure and in itiate insulin secretion. Chimeric and m utagenesis studies have  
im plicated TM D2 as a high affinity binding site in SU R 1. In particular the serine 
residue S I 237 w ithin  cytoplasm ic loop CL8 is critical for high affinity drug binding  
(Ashfield, Gribble et al. 1999). The L0 linker (CL3) has also been im plicated, and it has 
been suggested that native SUR1 L0 and CL8 lie in close proxim ity, leading to the 
form ation o f the sulphonylurea binding site (M ikhailov, M ikhailova et al. 2001).
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N on-selective com pounds such as glibenclam ide, show high affinity block o f SU R 2 and 
SUR1 channels. SU R  1-selective agents such as tolbutam ide, do not show high affinity  
block o f SU R 2 channels and in structural terms contain a non-sulphonylurea region. 
Aside from the critical Serine 1237 residue found in SUR1 alone, there is a site that 
binds m eglitinide-like structures and which is com m on to SUR1 and SU R 2 (Gribble and 
Reim ann 2003). The effect that M gADP has on channel inhibition by sulphonylureas 
also differs between SUR1 and SU R 2-containing channels. M gA D P impairs 
sulphonylurea inhibition o f SU R 2-containing K atp channels, yet enhances inhibition  
o f SU R 1-containing K atp channels (Gribble, Tucker et al. 1998). In the latter, 
sulphonylurea binding prevents M gADP activation , but weak inhibition at the 
inhibitory site o f Kir6.2 remains, giving an apparent increase in block o f the drug 
(Gribble and Reim ann 2003). The regions responsible for this differential effect have  
been identified as TMs 8-11 o f TMD1 and the first part o f N B D 1 (Reim ann, Dabrowski 
et al. 2003).
There are tw o novel K atp channel inhibitors: PN U -37883A  and PN U -99963. Both  
com pounds inhibit relaxation o f blood vessels and hypotension induced by KCOs. 
PN U -99963 has dem onstrated little selectivity between different K atp channels and 
appears to act primarily through the SUR subunit. PN U -37883A  blocks K atp channels 
o f the sm ooth muscle and appears to act w ith the pore-forming subunit, w ith selectiv ity  
for Kir6.1 over Kir6.2 (Surah-Narwal, X u et al. 1999). Chimerical experim ents have  
lead to the suggestion th at PN U -37883A  sensitiv ity  resides in an 81 am ino-acid section  
o f the C-terminus o f Kir6.1 (K ovalev, Quayle et al. 2004). Conversely, another study  
has reported sensitiv ity  for PN U -37883A  for SU R 2B -containing channels, but little  
discrim ination between K ir6.1/SU R 2B  and K ir6.2/SU R 2B (Cui, Tinker et al. 2003).
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1.3 Regulation o f the A TP-sensitive K + channel by nucleotides 
The unusual m olecular architecture o f  K a tp  channels is related to their com plex gating  
behaviour. In a nutshell, intracellular A T P, [ATP]i, inhibits K a tp  channels by directly  
binding to the Kir6.a: subunits, whereas M gADP increases channel activ ity  upon the  
hydrolysis o f A TP to A D P  at N B D 2 o f SU R . The membrane phospholipid  
phosphoinositol 4,5-bisphosphate, P IP 2, also interacts with the Kir to increase channel 
open probability and gating. This A T P /A D P  dependence allows K a tp  channels to link 
m etabolism  to membrane excitability; im portant for m any physiological functions, 
such as insulin secretion.
[ATP]i is the m ain regulator o f classical K atp channels and has the dual function o f  
closing the channel and m aintaining channel activ ity  in the presence o f Mg2+ (Trube 
and H escheler 1984; Findlay and Dunne 1986; O hno-Shosaku, Zunkler et al. 1987; 
Takano, Qin et al. 1990). [ATP]i dem onstrates ligand action and hydrolysis dependent 
action. [ATP]i binding to the K atp channel is assumed to be required for activ ity , which  
persists as long as [ATP]i is hound to the channel. H ydrolysis o f [ATP]i in the presence 
o f Mg2+ is also required, whereby when the channel is operative, [ATP]i inhibits channel 
opening, and when channels are not operative, treatm ent with M gATP restores channel 
opening. N D P s are also major regulators o f K atp channel activ ity , having two distinct 
actions: (1) attenuating  ATP-induced channel inhibition via com petition with the 
binding o f [ATPji to the K atp channels and (2) perm itting K atp channel opening even  
after channel rundown (Faivre and Findlay 1989; Dunne and Petersen 1991; Tung and 
Kurachi 1991; Beech, Zhang et al. 1993; Terzic, Tung et al. 1994). H owever, the 
absolute concentrations o f ATP and A D P  are critical in channel regulation. Patch  
clam ping studies have dem onstrated very clearly that for the same A T P /A D P  ratio, 
high concentrations o f ATP and A D P  result in channel inhibition, whereas low  
concentrations support channel activ ity , i.e. that nucleotides exert both stim ulatory  
and inhibitory actions on channel activ ity , and the inhibitory action o f A D P  dom inates 
at concentrations that are greater than 1 mmol/1 (Tarasov, Dusonchet et al. 2004).
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B y varying their open probability in accordance with changes in the [ATP]/[ADP] ratio 
inside the cell, A T P-sensitive potassium  channels link cellular m etabolism  to membrane 
excitab ility  (Ashcroft 2006). K atp channels sense changes in energy m etabolism  in 
several ways: (1) via direct interactions between the channel and cell m etabolites 
(producing interm ediate and sequential effects on channel activ ity), (2) via the 
physiological effects o f adenosine and (3) via regulation o f K atp gene expression by 
energy m etabolism  (producing a delayed, but more profound affect on channel 
quantity) (Zhuo, H uang et al. 2005). They m ay also exert trafficking effects (Zerangue, 
Schw appach et al. 1999). The underlying question, where K atp regulation is concerned, 
has alw ays been which properties o f the K atp channel are intrinsic to Kir and which are 
endowed by SU R . The primary site at which intracellular free ATP acts to cause K atp 
channel inhibition appears to lie on Kir6.2 (N ichols and Lederer 1991; Ashcroft and 
Gribble 1998; R ibalet, John et al. 2003), whereas the SU R  subunit is the primary site 
for pharm acological agents (Aguilar-Bryan, Nichols et al. 1995; Inagaki, Gonoi et al. 
1996). The SU R  subunit also m ediates the stim ulatory effects o f intracellular M gADP  
and enhances channel open probability (N ichols, Shyng et al. 1996; Proks and Ashcroft 
1997; Trapp, Tucker et al. 1997; Tucker, Gribble et al. 1997).
Studies involving Kir6.2
D espite the fact that Kir6.2 contains no obvious consensus sequences for nucleotide  
binding, a single m utation in the subunit (K185Q) significantly reduces the ability o f  
A T P to inhibit channel activ ity  (Tucker, Gribble et al. 1997). This inform ation  
suggested that the site  at which ATP m ediates channel inhibition resides on Kir6.2. The 
ability  o f A T P in the absence o f Mg2+, or non-hydrolysable analogues o f A T P to inhibit 
channel a ctiv ity , suggests that A T P hydrolysis is not required for channel inhibition, 
and that binding o f  the m olecule is sufficient for channel closure (Ashcroft and 
Rorsman 1989). The inhibitory effects o f  A T P were analysed using Kir6.2AC26 and 
Kir6.2AC36 isoforms expressed in the absence o f SU R , since this overcom es the problem  
o f the dual ability  o f nucleotides to both stim ulate and inhibit w ild-type K atp channels 
(Tucker, Gribble et al., 1997). The C-terminal dom ain o f Kir6.2 expressed in E.coli
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binds the A T P analogue, 2’3,-0-(2,4,6-trin itrophenylcyclo-hexadienylidene), and it  
therefore becam e apparent that both the B-phosphate and m oieties w ithin the adenine 
ring were critical for K atp channel inhibition by A TP (Tanabe, Tucker et al., 1999). 
Site-directed m utagenesis studies and changes in single channel patch clam ping kinetics 
identified that regions in the N-term inus im m ediately preceding TM1 and the C- 
term inus im m ediately following TM2 are equally im portant. Various other m utations 
at the cytosolic end o f TM2 were sim ilarly identified, and found to significantly reduce 
the frequency o f the long closed channel state, suggesting that they impair the ability  o f  
the channel to close, and that they  form part o f  an intracellular gate that governs access 
to the channel pore (Proks, Gribble et al., 1999; Tanabe, Tucker et al., 1999).
Other m utations did not affect single channel kinetics, and m ay reduce A T P inhibition  
via interfering w ith A T P binding or the link between A T P binding and channel closure 
(Tucker, Gribble et al. 1998). Aside from the K185 m utant, m utations in R50, 1182, 
R201 and G334 reduce the channel A T P sensitiv ity  independently o f ATP-binding  
affin ity, by altering the intrinsic stability  o f the open state. These residues are all close 
to each other at the inter-subunit interface in the model, but are well separated in the  
primary sequence (Tucker, Gribble et al. 1997; Drain, Li et al. 1998; Proks, Gribble et 
al. 1999; Li, W ang et al. 2000; Shyng, Cukras et al. 2000). It has also been suggested  
that the N and C term inal dom ains o f Kir6.2 are involved in the ATP binding pocket, 
since both the R50G and K185Q m utations reduced photoaffin ity labelling o f Kir6.2 by  
8-azido-A T P (Tanabe, Tucker et al. 1999). A thiol m odification and cysteine  
substitution study also suggest that R50 interacts w ith the y-phosphate and K185 
interacts w ith the B-phosphate o f ATP (Trapp, Haider et al. 2003).
K atp channel inhibition by A T P and activation by P IP 2 are interrelated because P IP 2 
decreases A T P sensitiv ity . K inetic analysis indicates that unliganded Kir6.2 subunits 
are relatively unstable, and therefore will be predom inantly bound to either A T P or 
P IP 2 at any tim e. In the absence o f A T P, w ild-type subunits are bound to membrane 
P IP 2, and are in the ‘open’ state. B inding o f A T P to the unliganded subunit will trap it
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in the non-perm issive, ‘closed’, state. Trapping o f any one subunit in the closed 
conform ation is sufficient to close the channel (Enkvetchakul, Loussouarn et al. 2000; 
M arkworth, Schwanstecher et al. 2000), yet all four subunits need to be in the ‘open’ 
state for the channel to be active; for m ost cells the expected open probability is 
negligible w ithout the stim ulatory effects o f M g-nucleotides acting at SU R  (Nichols 
2006).
It has been suggested that com petition between A TP and P IP 2 for binding to K atp 
channels m ay account for the decrease in the A T P sensitivity evoked via P IP 2 (Shyng, 
Cukras et al. 2000; MacGregor, Dong et al. 2002). P otential P IP 2-interacting residues 
(R 54, R 176, R177 and R206) are near the A T P binding-site, and appropriately located  
to interact w ith  P IP 2 headgroups. It has been proposed that ‘negative heterotrophic’ 
interaction o f these two ligands in channel regulation exists (Shyng and Nichols 1998; 
E nkvetchakul and N ichols 2003), and overlapping ATP- and P IP 2-binding sites, and 
biochem ical com petition  o f the two ligands for the non-ligand bound state (MacGregor, 
Dong et al. 2002) would be consistent with this theory. H owever, other data have  
suggested that the tw o ligand binding sites have no com m on residues (R ibalet, John et 
al. 2003), therefore would not com pete for binding. There are another group o f residues, 
R314 and E229, that are too far away from the m em brane to interact w ith  P IP 2 
directly, but which m ay alter protein conform ation and allosterically affect the  
interaction o f P IP 2 w ith the other group o f residues. These residues are thought to form 
inter-subunit interactions between the C-tails o f the Kir tetramer. A model has been 
proposed whereby these subunit interactions stabilise the tetramer, which in turn 
facilitates channel interaction with P IP 2 in order to achieve a high channel open 
probability (Lin, Jia et al. 2003). In line w ith this model, P IP 2 has previously been 
shown to affect the interaction of SUR1 with Kir6.2, causing functional uncoupling  
between the two subunits, as m anifested by loss o f channel inhibition to glibenclam ide 
and reactivation by M gAD P (R ibalet, John et al. 2000). The proposed nucleotide 
regulation o f K atp channel activ ity  and the proposed involvem ent o f P IP 2 activ ity  is 
depicted in Figure 1.6.
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Figure 1.6: N ucleotide regulation o f  K a t p  activ ity . The cytoplasm ic end o f the inner channel 
cavity  is where the m etabolically controlled gate is located. P IP 2 serves to open the channels 
and ATP binding serves to close the ligand-operated gate, possibly by the physical link 
provided by the side helix (red). At the interface between NBD1 and N B D 2 o f  SU B  are ATP- 
binding sites to which MgATP binds. ATP hydrolysis at N B D 2 results in a conform ational 
‘activated" state that overrides ATP inhibition at the Kir6.2 subunit. M gADP dissociation  
m aintains this activated  state, and can be m aintained by MgADP rebinding (adapted from 
M chols C; 2006).
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Studies involving SUR subunits
M u ta tio n s 011  e ith er  or b o th  o f  th e  tw o  con served  ly s in e  residues in  th e  W a  m o t if  in  th e  
first (K 7 1 9 A ) or secon d  (K 1384M ) N B I)  o f  S U R 1  did not m od ify  th e  [A T P], s e n s it iv ity  
o f  K ir6 .2  (G ribb le , T u ck er et a l. 1997). H o w ev er . S U R 1  has a lso  been  sh o w n  to  p ossess
W a m o tif  or th e  a sp a rta te  residue in  th e  W b m o tif  in  N B D 2  did not a ffect [A TP]i 
s e n s it iv ity , b u t th e  corresp on d in g  m u ta tio n s  in  N B D 1  ab olish ed  th e  h ig h  a ffin ity  
b in d in g  (L e d a . In agak i et al. 1997). M g A T P  a lso  a c tiv a te d  S L R 1 /K ir 6 .2  c h a n n e ls  b y  
in tera ctio n  w ith  !NBDs o f  S L R 1 . w h en  S U R 1  w as coexp ressed  w ith  K ir6 .2 -R 5 0 G  (an  
A T P  in se n s it iv e  m u ta n t). H o w ev er , r eco n stitu ted  ch a n n e ls  com p osed  o f  K ir6 .2 -R 50G  
and a W a ly s in e  m u ta n t o f  SL  R1 w as not a c tiv a te d  b y  M gA T P  (G ribble, T u ck er  et al.
1998). T h is  is a lso  su g g estiv e  th a t b o th  M gA T P  and M gA D P  can  s tim u la te  ch a n n e l 
a c t iv ity  v ia  N B D s  o f  th e  S U R  su b u n it. S t im u la tio n  b y  th e  la tter  is fu rth er  ev id en ce  
th a t S L  R fu n c tio n s  as a regu lator o f  K ir6 .x  rather th a n  an a c tiv e  tran sp orter , and th a t  
[A T P ], b in d in g  un d erlies the sen sitiza tio n  o f  K ir6.2 to [A TP]i by S L R 1 .
tw o  d istin ct [A T P ]i-b in d in g  s ite s  w ith  h igh  and low a ffin ities. T h e  form er w as sa tu ra ted  
w ith  [A TP]i in th e  ab sen ce o f  Mg2+. S u b stitu tio n  o f  con served  ly s in e  m u ta tio n s  in  the
W67e| Y 1 3 1 8  
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Figure 1.7: H ypothetical coordination o f the ATP molecule with SL R . The first binding 
pocket formed by the W \ motif, Q-loop. W b  m otif. H-loop o f N BD 2 and the linker region o f  
N BD 1 is represented by the internal circle o f  coloured elem ents. The second binding pocket is 
represented by the external circle (clear elem ents) and is composed o f the counterparts o f NBD1  
and N B D 2 (taken from Matsuo et al., 2005).
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[ATP]i inhibits K ir6.2/SU R 2A  and Kir6.2AC26 (expressed w ith the sulphonylurea  
receptor) w ith similar potencies (Inagaki, Gonoi et al. 1996; Tucker, Gribble et al. 1997; 
O kuyam a, Yam ada et al. 1998). Therefore, SU R 2A  m ay not significantly increase 
[ATP]i sensitiv ity  to Kir6.2. K ir6.2/SU R 2A  channel is equally sensitive to free M gATP  
and Mg2+-bound [ATP]i, while K ir6.2/SU R 2B channel is more sensitive to free Mg2+. 
This m ay be due to the difference in am ino acid sequence o f the C-terminus between  
SU R 2A  and SU R 2B  (Isom oto, Kondo et al. 1996). The last 42 am ino acids in the C 
term inal o f SU R 2B  is more similar to SUR1 than SU R 2A , and m ay be involved in the 
discrim ination o f  Mg2+-bound rather than Mg2+-free [ATPJi by K atp channels. The 
second N B D  is known to play a crucial role in [NDPJi-induced activation  o f K atp 
channels (N ichols, Shyng et al. 1996), and in SUR1 the binding o f [ADPJi to the second 
N B D  potentially  antagonises [ATP]i binding to the first N B D  in the presence o f Mg2+ 
(Ueda, Inagaki et al. 1997).
The depicted hypothetical coordination o f the sulphonylurea receptor w ith an ATP  
m olecule is illustrated in Figure 1.7. In SU R 1, it has been reported that N B D 2 is 
generally a more efficient A T Pase than N B D 1, which in turn is similar in its properties 
to both SU R 2A  N B D 1 and N B D 2 (Masia, Enkvetchakul et al. 2005). A T P hydrolysis 
at the N B D s is a requirem ent for M gADP stim ulation o f K atp channels. M utations that 
abolish, or are expected , to abolish A T P hydrolysis, abolish M gADP stim ulation  
(Gribble, Tucker et al. 1997; Shyng, Ferrigni et al. 1997), and it has been speculated  
that it is not the intrinsic ATPase activ ity , but rather the stab ility  o f the A D P-bound  
configuration o f the N B D s that underlies SU R -dependent M gADP stim ulation o f K atp 
channels (Masia, E nkvetchakul et al. 2005). Azido-nucleotide labelling studies have also 
shown that SU R1 N B D 1 is a site o f tight ATP binding and potentially low hydrolysis 
rates, whereby N B D 2 is a site o f rapid ATP hydrolysis (Ueda, Inagaki et al. 1997; 
Ueda, Kom ine et al. 1999; M atsuo, Tanabe et al. 2000). SUR1 N B D 2 has also been 
shown to exhibit higher Mg2+-dependence o f ATP-binding than SU R 2A  N B D 2  
(M atsuo, Tanabe et al. 2000). H owever, the transduction pathw ay o f SU R -m ediated  
activation o f K atp channels is thought to be too com plicated to reduce to isolated
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N B D s, and m ay lie in inter-N B D  interactions, since conflicting evidence exists. For 
exam ple, replacing N B D 2 o f SU R 2A  with N B D 2 o f SUR1 is w ithout effect on M gADP  
stim ulation (Reim ann, Dabrowski et al. 2003). SU R  photoaffinity labelled w ith 8- 
azido-A TP was also digested w ith trypsin to exam ine the N B D s in more detail, and the  
tryptic fragm ents im m unoprecipitated with antibodies against NBD1 or N B D 2. The 
results indicated that NBD 1 o f SU R  binds 8-azido-ATP in a Mg2+-independent manner, 
and that N B D 2 binds in a Mg2+-dependent manner, suggesting that N B D 2 is 
responsible for channel activation  by M gADP (M atsuo, Tanabe et al. 2000). The m ost 
recent 8-azido-[Of-32P]A T P experim ents performed suggest that M gAD P, either via  
direct binding to N B D 2 or hydrolysis o f bound M gATP, is likely to induce a 
conform ational change in N B D 2 which transduces another conform ational change in 
N B D 1 to stabilize nucleotide binding at N B D 1 (Ueda, Kom ine et al. 1999). Since the C- 
term inal tail o f SU R s is very close to the first N B D  in primary structure it was 
speculated that the C-terminal serves to regulate either [ATP]i hydrolysis or [ADP]i 
binding to the second N B D  in the presence o f Mg2+. It m ay interact w ith the N B D 2  
W a m otif (M atsushita, Kinoshita et al. 2002), or m ay be part o f the N B D 1-N B D 2  
dimer interface (Y am ada and Kurachi 2004).
The effects o f nucleotide binding and Mg2+-nucleotide stim ulation o f K atp channel 
activ ity , o f  m utating the invariant serine linker m otif o f N BD 1 (SR I) or N B D 2 (SR2) 
to arginine was exam ined (the linker m otif o f NBD 1 o f SU R x being LSGGQ, and that  
or N B D 2 being LSQGQ in SUR1 and LSVGQ in SU R 2). Neither M gATP nor M gADP  
binding was altered by m utation o f the linker serine in either N BD 1 or N B D 2 o f SU R 1, 
nor was M gATP hydrolysis abolished. H owever, SR I reduced and SR2 abolished  
activation o f K ir6.2/SUR1 and K ir6.2/SU R 2B channels by M gATP and M gADP, 
whereas no effect o f  m utating SR 2 was observed for K ir6.2-SUR 2A channels (Matsuo, 
Dabrowski et al. 2002). This indicates that the linker serines play a critical role in 
transducing nucleotide binding into channel opening, but how this occurs remains 
unclear. It is possible that the linker residue interacts w ith the TM Ds o f SU R 1, 
inducing a conform ational change in the TM Ds that would be transm itted to the TM Ds
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in Kir6.2. It is also possible that the linker either interacts directly/indirectly w ith the 
cytosolic dom ains o f Kir6.2. Because the SR2 m utation did not impair transduction in 
K ir6.2/SU R 2A  channels, this suggests that the ‘ta il’ o f SU R 2 m ay interact with the 
linker o f N B D 2 in the transduction process, and that this interaction differs for SU R 2A  
and SU R 2B . The C-terminus and the N B D 2 linker m ay co-operate in transducing 
nucleotide binding into channel stim ulation, and the C-terminus o f SU R 2A  is able to 
com pensate for the effect o f the linker m utation, either directly or allosterically. It 
m ight influence the local structure o f N B D 2 such that it is able to tolerate the effect o f  
the serine to arginine m utation at residue 1446. Another possibility is that the SR2 
m utation abolishes function in SU R1 and SU R 2B , but not SU R 2A  (M atsuo, Dabrowski 
et al. 2002).
Differences between the SUR subunits on the interaction with adenine nucleotides
The nucleotide-binding properties that are similar am ong all SU R  subtypes are that: (1) 
N B D 1 is a Mg2+-independent nucleotide binding site; (2) N B D 2 is a Mg2+-dependent 
nucleotide binding site; (3) 8-azido-ATP binds to NBD 1 stably; (4) M gATP or M gADP  
binding to N B D 2 stabilizes 8-azido-ATP binding at NBD1; (5) N B D 2 has ATPase  
activ ity , whereas N B D 1 has little or no ATPase activ ity . H owever, the affinities o f  
N B D s o f SU R  for M gATP and M gADP differ am ong subtypes, and are probably 
related to the differential regulation of K atp channels and their different physiological 
roles. The affinities o f NBD 1 o f SUR1 for A D P , and especially A T P, are significantly  
higher than those o f SU R 2A  and SU R 2B . The affinity o f N B D 1 o f SU R 2B  for A T P, 
and N B D 2 o f SU R 2B  for ATP and A D P are significantly higher than those o f SU R 2A  
(M atsuo, Kimura et al. 2005).
SUR as an intracellular ADP sensor and the role of ATP hydrolysis
A model, as sum marised in Figure 1.8 , has recently been proposed for the nucleotide  
activation o f the K atp channels by SU R  subunits. The [ATP]i concentration is 
presumed to be several mM, approxim ately 10 tim es higher than the [ADP]i 
concentration, suggesting that N B D 1 o f SU R  binds M gATP rather than M gA D P, since
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N B D 1 has low  A T P a se  a c t iv ity . Irresp ectiv e  o f  ch a n n el op en  and c lo sed  s ta te s , N B D 1  
o f  SL  R b in d s M gA T P . S U R  is in an a c t iv e  s ta te  w h en  b in d in g  M gA T P  at N B D 1  and  
M gA D P  at N B D 2  to  o p en  th e  pore o f  th e  K ir6.2 su b u n it. S in ce  N B D 2  o f  S U R  has  
A T P a se  a c t iv ity , bound M gA T P  is h y d ro ly sed  to  M gA D P  a t N B D 2 . W h en  M g A D P  
d isso c ia te s  from  N B D 2  fo llow ed  b y  b in d in g  o f  M gA T P , th e  three s ta te s  o f  S U R  form  a 
c y c le  (M atsu o , K im ura et al. 2005).
SUR
Channel activation
M gA TP y M g A D P
ATP hydrolysis
N BD IBD2
M g
A D P
A D P
M gA T P
M g A T P M g A T P  V M g A T PII
M gA T P
Figure 1.8: Model for nucleotide regulation: State I is the 'active’ state in which SU R  stim ulates 
channel activ ity . S tate II is transient, and states II & III are ‘inactive’ states in which SU R  
cannot stim ulate channel activity (adapted from Matsuo et al., 2005)
Can changes in adenine nucleotides solely regulate Katp channel activity?
T h e p r in cip le  arg u m en ts aga in st A T P  b e in g  th e  sole regu lator  o f  K atp ch a n n e l a c t iv ity ,  
is th e  o b v io u s  d ifferen ce  b etw een  A T P  se n s it iv ity  o f  ch an n el m easured  in  th e  in sid e-o u t  
p a tch  (IC5o= 10-30p m ol/l) and th at in th e  in ta c t cell (IC5o= 0 .8 m m o l/l) . A lso , in  B-cells 
ex p o sed  to  g lu co se-free  so lu tio n s, s ign ifican t ch an n el a c t iv ity  can  be recorded  from  on - 
cell p a tch es, d esp ite  th e  fact that w h en  [A T P], is m easured  under sim ilar  c o n d it io n s  th is  
su g g ests  th at th e  ch a n n e ls  shou ld  be co m p le te ly  closed  (G h osh , R on n er et al. 1991). 
P I P 2 , (p h o sp h a tid y lin o s ito l-4 ,5 -b isp h o sp h a te ), related  p h o sp h o in o sitid es  (P P I s ) . lon g-  
ch a in  acyl-C oA  esters (LC -C oA s) and M g A D P  all d ecrease th e  a b ility  o f  A T P  to  c lose  
th e  ch a n n el. It is not k n ow n  w h eth er  th ese  a g en ts  ch a n g e  th e  se n s it iv ity  o f  th e  ch a n n e l 
to  p h y sio lo g ica l ch a n g es o f  [A T P]i, by sh ift in g  th e  A T P  co n c e n tr a tio n -in h ib itio n  cu rve
39
to the right, or whether m etabolically generated changes in P IP 2, LC-CoA or M gADP  
serve to couple m etabolism  to K atp channel activation.
1.4 AT P-sensitive K+ channel structure
Cryoelectron m icroscopy has recently revealed insight as to the three-dim ensional 
structure o f  the K a tp  channel com plex (M ikhailov, Campbell et al. 2005), which is 
com pact in structure, roughly 18 nm in cross-section and 13 nm in height. The EM 
(electron m icroscopy) density map accom m odates molecular m odels o f Kir6.2 and 
SUR1 (Figure 1.9), w ith a central pore composed of four Kir6.2 subunits that is 
surrounded by four SUR1 subunits. U sing this model, one can make novel predictions 
about the w ay in which the com plex is organised (despite the low resolution o f the 
structure; 18 A). In the ligand-free state the N B D  and adjacent SUR1 subunits come 
into close physical opposition, suggesting that N B D s o f adjacent SUR1 subunits m ay  
interact functionally . This supports evidence obtained from other crystal structures o f 
isolated N B D s from bacterial ABC proteins. In alm ost every case, the N B D s crystallise  
as ‘head-to-taiP dimers, and each nucleotide-binding pocket formed at the dimer 
interface contains elem ents from both N B D s (H ung, W ang et al. 1998; Hopfner, 
Karcher et al. 2000; Locher, Lee et al. 2002). E xtensive intersubunit interactions 
between SU R1 and Kir6.2 with both the transm embrane and cytosolic dom ains as 
suggested by various studies (Giblin, Leaney et al. 1999; M ikhailov, M ikhailova et al. 
2000; Schw appach, Zerangue et al. 2000; Babenko and Bryan 2002; Chan, Zhang et al. 
2003; Bryan, Vila-Carriles et al. 2004; Rainbow , Jam es et al. 2004) is also accounted for 
by the close juxtap osition  o f Kir6.2 and SUR1 subunits in these regions (M ikhailov, 
Campbell et al. 2005). It further suggests that nucleotide binding/hydrolysis causing 
m ovem ent o f  the N B D s o f SUR1 (H iggins and Linton 2004; Vergani, Lockless et al. 
2005) m ay influence the opening and closing o f the pore via the TM Ds and via the 
cytosolic dom ains o f Kir6.2. ATP m ay access its binding site on Kir6.2 through a cleft 
running between adjacent SUR1 subunits just below the membrane, and this may 
explain how the sulphonylurea receptor enhances the affinity o f Kir6.2 for ATP  
(Tucker, Gribble et al. 1997). W ith reference to Figures 1.9-1.11 , a com bination o f
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m olecular m odelling and site-directed m utagenesis has led to speculation that the ATP  
binding site on Kir6.2 is approxim ately 2nm below the membrane and at the interface 
between adjacent Kir6.2 subunits (Antcliff, Haider et al. 2005). It is not yet certain  
how A T P binding to the Kir6.2 tetram er is translated into pore closure.
There have been various speculations as to the location o f TMDO o f SU R1 in the K atp 
channel com plex. Initially it was thought to be outside the com plex (Zerangue, 
Schwappach et al. 1999; Schwappach, Zerangue et al. 2000). It was then suggested that 
TMDO was sandwiched between Kir6.2 and TM Ds 1 & 2 o f SUR1 (Bryan, Vila-Carriles 
et al. 2004) when subsequent studies showed that Kir6.2 and TMDO interact both  
physically and functionally (Babenko and Bryan 2002; Chan, Zhang et al. 2003). 
H owever, recent insertion of the hom ology m odels into the EM density map indicates 
that the five TMDO helices are more likely to lay between adjacent SU R  subunits, and 
interface w ith TM1 o f Kir6.2. In this position residues 76-78 in TM1 o f Kir6.2 which  
specify physical assem bly with SUR1 (Schwappach, Zerangue et al. 2000) are well 
placed to interact w ith  TMDO (M ikhailov, Campbell et al. 2005), and is consistent with  
functional studies show ing that the N-term inus o f Kir6.2 lies in close proxim ity to the 
cytosolic loop (L0) between TM Ds 0 and 1 o f SUR1 (Babenko and Bryan 2002; Chan, 
Zhang et al. 2003).
M utations th at abolish A TP hydrolysis w ithout affecting M gATP or M gADP binding 
would be an invaluable tool to test that idea that M gATP does not activate the channel 
directly, but m ust first be hydrolysed to M gADP (Zingman, Alekseev et al. 2001). 
U nfortunately, none have been identified to date, but current evidence suggests that 
m ost A T P hydrolysis occurs at Site 2 (Zingman, Alekseev et al. 2001; Masia, 
Enkvetchakul et al. 2005) which is formed largely from N B D 2 with contributions from  
the linker region o f  N B D 1 (Campbell, Sansom et al. 2003). A lthough the ATPase- 
activ ity  o f the K ir6.2/SUR1 tetramer has not been determined previously, it has been 
determined for isolated N B D s by fusing them to m altose-binding protein (Masia, 
Enkvetchakul et al. 2005). Since the rate o f A TP hydrolysis and affinity for ATP were
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significantly higher for the K atp channel com plex (M ikhailov, Campbell et al. 2005) 
than for isolated N B D s (Masia, Enkvetchakul et al. 2005), this m ay be reflective o f the 
fact that there is a requirement for heterodim erization of the N B D s for concerted  
nucleotide binding (Chan, Zhang et al. 2003; Vergani, Lockless et al. 2005). 
A dditionally, it m ay be due to Kir6.2 influencing the ATPase activ ity  o f the N B D s o f  
SU R 1, or due to cooperative interactions between SUR1 subunits o f the same tetramer 
(Ashcroft 2006). We can be confident in concluding th at at A resolution, cardiac, 
skeletal, and vascular sm ooth m uscle K atp channels will share structural features 
similar to the (3-cell SU R 1-K ir6.2 channel, due to the extensive sequence sim ilarity  
between Kir6.x and SU R x fam ilies (Seino and Miki 2003).
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Figure 1.9: Location o f molecular models within the 3D Kir6.2-SUR1 structure. (A-D) 
respective top and side views o f the EM density with models o f Kir6.2 (blue), SUR1 minus the 
first five transm em brane domains TMDO (red), and TMDO (yellow) inserted sequentially from 
(B) to (D). ATP molecules are shown in green (taken from M ikhailov et a l 2005).
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Figure 1.10: Traverse sectional view o f  the EM density o f  a model o f Kir6.2 (dark blue) showing  
clefts (as indicated by arrow) through which ATP (green) could access its binding site on Kir6.2 
(taken from Ashcroft; 2006).
Kir6.2
EXTRACELLULAR
SUR1
INTRACELLULAR
Figure 1.11: Another model o f  how SUR1 and Kir6.2 might assemble to for the K a t p  channel. 
This model illustrates that the channel com plex contains 4 ATP-binding sites on Kir6.2 and 8 
Mg nucleotide-binding sites on SLR1 (taken from Ashcroft; 2005).
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1.5 Vascular Smooth muscle A TP-sensitive K + channels
It is generally accepted that K + channel activation prevents the developm ent o f action  
potentials in vascular sm ooth m uscles, allowing graded changes in m em brane potential 
to regulate their tone. As such they play a role in total peripheral resistance, the 
distribution o f blood flow between and within tissues and organs, and m icrovascular 
exchange. Several K+ channels, w ith different molecular bases, contribute to the  
regulatory basal K+ conductance in sm ooth m uscle cells: Kv, B K ca, small conductance  
Ca2+-activated K+ channels (SK ca), two-pore dom ain K + channels (TASK ), stretch- 
dependent K+ channels, Kir and K atp channels (Jackson 2005; Thorneloe and Nelson  
2 0 0 5 ).
The predom inant Kir channel isoform expressed in sm ooth m uscle is Kir2.1 (Bradley, 
Jaggar et al. 1999). These channels are blocked by B a2+ ions at micromolar 
concentrations and are activated by increases in extracellular K+, acting as sensors for 
increases in K +, leading to m em brane hyperpolarisation and vasodilation when  
extracellular K + is elevated from 5-15mM  (Quayle, Nelson et al. 1997).
In sym m etric KC1 recording conditions, the predom inant K atp channel subtype  
expressed in sm ooth muscle cells has a relatively low unitary conductance (20-50pS), 
and is activated  by N D Ps. The nucleotide sensitiv ity  differs considerably from that o f  
‘classic’ K atp channels o f pancreatic 6-cells, for exam ple, hence they have been 
classified as a functionally distinct N D P -sensitive, K ndp subtype o f K atp channel 
(Ashcroft and Ashcroft 1990; Zhang and B olton 1996). In contrast to ‘classic’ K atp, 
channel gating is observed in the presence o f N D P s and Mg2+, whereas the classical 
K atp channels open spontaneously when [ATP]i is removed from the internal surface o f  
the membrane. M gATP can substitute for M gND Ps and m aintain channel activ ity  
(Zhang and B olton 1996; Teram oto, McMurray et al. 1997). K ndp  channels are also 
inhibited by A T P and glibenclam ide, but inhibition by A TP occurs at much higher, and 
more variable concentrations compared to pancreatic 6-cell or cardiac K atp channels 
(Babenko, Aguilar-Bryan et al. 1998). A dditionally, inhibition is bell shaped, and
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m axim al activ ity  occurs between 0.1 and ImM . Inhibition occurs in the absence and 
> lm M  [ATP]i. In other words, the K ndp channel is activated rather than inhibited by 
[ATPJi (Yam ada and Kurachi 2005).
Medium conductance (50-70 pS) K atp channels also exist in vascular sm ooth muscle 
(VSM), although they have a more lim ited distribution, an exam ple being the cardiac- 
like LK channel o f rat portal vein m yocytes. These channels exhibit spontaneous 
activ ity  in inside-out patches in the absence o f nucleotides, are activated by m etabolic 
inhibition and are inhibited by glibenclam ide and also A T P in the micromolar range 
(with an approxim ate IC50 o f 20pM). They partially m im ic classic K atp channels in 
terms o f their unitary conductance, activ ity  in the absence o f nucleotides and a lack of  
sensitiv ity  to KCOs, when applied at concentrations that increase K nd p  gating (Zhang 
and B olton 1996; Cole, Malcolm et al. 2000). Large-conductance (> 100 pS) channels 
that d isplay sensitiv ity  to A TP, KCOs and glibenclam ide also exist in vascular  
m yocytes, but it is debatable whether these channels should be categorised as a distinct 
K atp channel subtype (Standen, Q uayle et al. 1989; Zhang and Bolton 1995).
Evidence that Kir6.1/SUR2B Represent K n d p  of VSM
The K ir6.1/SU R 2B  channel is similar to the K atp channel in VSM cells (i.e. the K ndp 
channel), especially in terms o f single channel conductance and A TP sensitiv ity , and is 
sim ilarly responsive to M gADP. The relatively small conductance ~35pS and the bell­
shaped relation for the ATP action on the channel are closely related to those o f VSM  
(20-40pS conductance). H owever, channels containing Kir6.2 have a 70-80pS  
conductance in sym m etrical 140mM K+ conditions (Teram oto, Tomoda et al. 2006). 
W hereas the single-channel conductance o f heteromeric Kir6.1-Kir6.2 channels 
containing one or two Kir6.2 subunits is within the range o f values reported for K nd p , 
they are dissim ilar in that the latter are activated by PKC, and exhibit spontaneous 
activ ity  in the absence o f nucleotides (Babenko and Bryan 2001; Cole and Clement- 
Chomienne 2003). P ig urethral K atp channels have a conductance o f 43 pS (an 
interm ediate conductance betw een that o f Kir6.1 and Kir6.2 subunits) (Teram oto,
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Creed et al. 1997), suggesting that the nature o f the pore region o f urethral channels 
differs from that o f vascular K atp channels. Even though different experim ental 
recording conditions could be responsible for the different channel conductances 
observed, the latter provides evidence for a heteromeric channel structure, with the 
channel pore composed o f Kir6.1 and Kir6.2 subunits (Teram oto 2003). The difference 
in conductance between Kir6.1 and Kir6.2 is determined by a chain o f am ino acids in 
the M 1-H5 extra-cellular link and a single am ino acid in the H5-M2 link (N123-V124- 
R125 and M148 in Kir6.1 and S113-I114-H 115 and V138 in Kir6.2) (Repunte, 
Nakam ura et al. 1999). Steric effects at Kir6.1 M148 or Kir6.2 V138 m ay directly  
influence K + diffusion, and structural constraints between Kir6.1 N123 and R146 or 
Kir6.2 SI 13 and R136 m ay influence the configuration o f the perm eation pathw ay  
(R epunte, Nakam ura et al. 1999).
The K atp channel K ir6.1/SUR 2B is dose dependently stim ulated by 0.1-100pM  ATP  
and inhibited by l-3m M  ATP in the presence o f pinacidil, w ith m axim al activ ity  at 
~ lm M  A T P. Spontaneous activ ity  o f this channel is not observed on patch excision to 
the inside-out configuration unless nucleoside diphosphates or triphosphates and Mg2+ 
are present, as was described for K ndp channels (Zhang and Bolton 1996). This 
requirement for N D P s is not observed for heteromeric K ir6.1-Kir6.2/SUR1 channels, or 
channels containing Kir6.2 subunits expressed with SU R 1, SU R 2A  or SU R 2B . Since 
there is evidence to suggest that the presence o f  only one Kir6.2 subunit in heteromeric 
K ir6.1-K ir6.2/SU R1 channels permits gating in the absence o f Mg2+ and nucleotides 
(Babenko, Gonzalez et al. 2000), this indicates that only homomeric Kir6.1 channels 
mimic the nucleotide regulation characteristic o f VSM K n d p*
K ir6.1/SU R 2B channels exhibit a SU R  and KCO pharm acology consistent with that o f  
VSM K ndp channels, i.e. are activated by pinacidil and diazoxide, whereas SU R 1- 
containing channels are not affected by pinacidil and SU R 2A -containing channels 
exhibit a low sensitiv ity  to diazoxide in the absence o f intracellular M gADP (D'Hahan, 
Moreau et al. 1999). K ir6.1/SU R 2B channels exhibit around four-fold higher
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glibenclam ide sensitiv ity  than K ir6.2/SU R 2B channels (Ham brock, Loffler-W alz et al.
1999) and this difference in sensitiv ity  is comparable to the high glibenclam ide  
sensitiv ity  ascribed to the low-conductance K ndp channel compared to the medium- 
conductance cardiac-like K atp channel subtype o f rat portal vein (Zhang and Bolton  
1996). The similar reciprocal allosteric coupling o f KCO, glibenclam ide and nucleotide  
action reported for K ir6.1/SU R 2B has also been reported for K ndp  channels (Zhang and 
B olton 1996). In a recent study it was shown that isoflurane (a volatile anaesthetic) 
activates K ir6.1/SU R 2B channels but not K ir6.2/SUR 2A channels expressed in 
H E K 293 cells, which was consistent w ith experim ents using m ouse perfused heart and 
vascular sm ooth muscle cells whereby coronary vasodilation was achieved (Fujita, 
Ogura et al. 2006).
The regulation by PKC dem onstrated for native VSM K ndp and whole-cell K atp 
currents is m im icked by K ir6.1/SUR 2B (purified PKC applied to inside-out patches in 
the presence o f A T P and M gADP inhibits K ir6.1/SU R 2B channel gating, as does 
activation o f PKC due to exposure to a phorbol ester or angiotensin II). The presence o f  
a single Kir6.2 subunit in heteromeric K ir6.1-K ir6.2/SU R 2B channels abolishes 
inhibition o f gating by PKC observed for K ndp  (Thorneloe, Maruyama et al. 2002; 
Quinn, Cui et al. 2003).
Studies using a gene knockout strategy also provide strong evidence that Kir6.1, but 
not Kir6.2, is essential for the form ation o f VSM K atp channels. Kirh.l'^ mice 
(generated via disruption of the gene K C N J 8 )  exhibit sudden death as the result o f  
m yocardial ischem ia due to abnormal regulation o f coronary arteriolar vascular tone 
and presence o f coronary vasospasm  (Miki, Suzuki et al. 2002), indicated by 
spontaneous elevation o f  ST segm ents followed by AV blocks o f various degrees on the 
electrocardiogram. Kir6.2 knockout mice, however, were unaffected (Suzuki, Sasaki et 
al. 2002).
In another knockout study em ploying aortic sm ooth muscle cells, pinacidil was shown  
to stim ulate significant K+ currents that were blocked by glibenclamide in wild type
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and Kir6.2 knockout mice, but not in Kir6.1'/_ mice, indicating that Kir6.1 is an 
essential com ponent o f K atp in vascular sm ooth muscles (Miki, Suzuki et al. 2002; 
Suzuki, Sasaki et al. 2002).. The lack o f vasodilatation response to pinacidil was 
confirmed in vitro by m easuring the isometric tension o f aortic rings isolated from  
Kir6.1_/' mice. M ethylergom etrine, a diagnostic compound for vasospastic angina (also 
known as Prinzm etal angina in humans) was used to induce vasospasm s in Kir6.1'A 
mice both in vivo and in vitro. D isruption o f SU R 2 also produces the phenotype o f 
Prinzm etal angina (Chutkow, Pu et al. 2002) and SU R 2-null mice dem onstrate ST 
elevation , coronary vasospasm  and sudden cardiac death, as well as narrowing of the 
coronary arteries and elevated blood pressure (Chutkow, Pu et al. 2002). The 
cum ulative evidence therefore suggests that the K ir6.1/SU R 2B channel is critical in the  
regulation o f vascular sm ooth muscle, especially in the coronary arteries.
RT-PCR was used to dem onstrate the presence o f Kir6.1 transcript in rat pulm onary  
artery (Cui, Tran et al. 2002), Kir6.1 was detected in the mouse aorta using the 
Northern blot technique (Suzuki, Li et al. 2001), and transcripts o f Kir6.1 in rat aorta, 
tail artery, pulm onary artery and mesenteric artery tissues have been identified (Cao, 
Tang et al. 2002). The use o f an anti-Kir6.1 antibody (generated using G ST-tagged  
Kir6.1C fusion protein) has also identified Kir6.1 proteins in four rat vascular sm ooth  
muscle tissues, including mesenteric artery, tail artery, pulm onary artery and aorta 
(Sun, Cao et al. 2004). The differential expression o f Kir6.1 and SU R 2B  subunits has 
becom e apparent due to in situ hybridization studies, which have shown that both  
subunits are expressed in the sm ooth m uscle layer o f arterioles as well as small and 
interm ediate arteries. Since these blood vessels are known to determine blood pressure 
and circulation resistance (W ilson 1989), this is suggestive that the K ir6.1/SU R 2B  
channel is the m ediator o f vascular diameter in accordance with the change o f  
physiological and pathophysiological conditions. Such experim ents are also suggestive  
that the ion channel believed to be responsible for the fast endothelial response to Ca2+ 
signals and m ediate the release o f endothelium -derived relaxing factor is
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K ir6.1/SU R 2B, since the m R N A  o f each subunit are abundantly expressed in the  
capillaries o f the skeletal muscle and renal glomerulus (Li, Wu et al. 2003).
Recent experim ents using sensitive quantitative LightCycler technology in com bination  
with SY B R  Green D ye chem istry have allowed for accurate quantification o f K atp 
channel m R N A  subunits in rat basilar and middle cerebral artery R N A  preparations 
(Ploug, Edvinsson et al. 2006). In agreem ent with the in situ hybridisation experim ents 
performed in the rat by Li and colleagues, it was found that Kir6.1 and SU R 2B  were 
the predom inant transcripts in both rat basilar and middle cerebral artery. H owever, 
this data indicated that Kir6.1 m R N A  levels were higher than SU R 2B  m R N A  levels, 
especially in the cerebral arteries. Since this is not in accordance w ith the known 4:4 
K ir6.*/SU R  stoichiom etry, it was suggested that a minor population of K ir6.1/SUR1  
octam ers m ay exist, based on the available evidence from such studies (Li, Wu et al. 
2003; P loug, Edvinsson et al. 2006). It is a valid assum ption that not all proteins 
forming K atp channels are expressed at the same concentration, and that the protein  
least expressed is the one that determines the number o f K atp channels, and it has been 
shown that the level o f Kir6.2 protein in anti-SU R 2 im m unoprecipitate accurately  
reflects the num ber o f  K atp channels (Ranki, Crawford et al. 2002). W ith this in mind, 
a recent study using real-tim e RT PCR revealed that SU R 2A  m R N A  levels are lower 
than the concentration o f m R N A  of any other K atp channel-forming protein in the 
heart; overexpression o f the SU R 2A  protein generated a cardiac phenotype w ith more 
sarcolemmal K atp channels (composed o f pore-forming Kir6.2 and regulatory SU R 2A  
subunits) with increased resistance to hypoxia and ischemia-reperfusion (D u, Jovanovic  
et al. 2006).
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It is therefore apparent that the K ndp  channel represents the K atp channel 
K ir6.1/SU R 2B. This vascular K atp channel is readily activated during m etabolic stress 
such as hypoxia , ischemia and hypoglycaem ia. Channel activation results in 
hyperpolarization and a decrease in cellular excitability . In turn, the voltage-activated  
Ca2+ channels are inhibited w ith hyperpolarization, lowering intracellular Ca2+ 
concentration. As a result VSM contractility  decreases. In principle, this vasodilation  
allows a better perfusion within local tissues and reverses hypoxic ischemia.
1.6 Regulation o f the A  TP-sensitive K + channels via metabolically active 
proteins
The K a t p  channel complex as a component o f the cellular energetic network
Som e accessory proteins such as adenylate kinase (AK) and creatine kinase (CK), 
physically associate with the K atp channel and regulate its activ ity , and m ay be acting  
as integral parts o f the K atp channel com plex in vivo (Bienengraeber, A lekseev et al. 
2000; Carrasco, Dzeja et al. 2001; Crawford, Budas et al. 2002; Crawford, Ranki et al. 
2002; Selivanov, Alekseev et al. 2004). Mitochondria are responsible for the production  
o f the m ajority o f cellular A T P, and respond rapidly to m etabolic stress by the release 
o f signaling m olecules. They contribute to m etabolic oscillations that drive fluctuations  
o f m em brane current, and via the regulation of K atp channels, help set membrane 
excitab ility . W ith  high intracellular A T P levels however, K atp channels m ay not sense 
bulk cytosolic , but rather local submembrane nucleotide concentrations set by 
m em brane A T Pases and phosphotransfer enzymes. As such, cells w ith high and 
fluctuating energy demands, such as cardiom yocytes, possess well-defined  
phosphotransfer system s to facilitate energetic signaling between sites o f ATP  
production and A T P utilization and sensing, thus coupling channel behavior with  
cellular energetic state (Selivanov, Alekseev et al. 2004). There is a wide distribution o f  
adenylate kinase (AK: 2A D P <-> A T P + AMP) and creatine kinase (CK: A D P  + CrP <-» 
ATP + Cr) in cell membranes and com partm ents, and a known physical association  
with the K atp channel subunits which ensures their functional and structural 
interactions w ith the channel (Carrasco, Dzeja et al. 2001; Crawford, Ranki et al. 2002).
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In  kn ock ou t m ice  lack in g  th e  crea tin e  k in ase  gene M -CK, th e  ob served  A T P -in d u ced  
K a t p  ch an n el closure is lo st (A b rah am , S e liv a n o v  et al. 2002), and  in  ca rd io m y o c y te s  
la ck in g  th e  a d en y la te  k in ase A K 1 g en e, A T P -in d u ced  K a t p  ch an n el c losu re  is lost 
(C arrasco, D zeja  et al. 2001: S e liv a n o v , A lek seev  et al. 2004). T h e in v o lv e m e n t  o f  A K  
p h o sp h o tra n sfer  in lin k in g  m ito ch o n d ria l e v e n ts  w ith  K a t p  ch a n n e ls  h as been  
d em o n stra ted , w h ereb y p h arm aco log ica l in h ib itio n  o f  A K  p h osp h otran sfer  h as been  
sh o w n  to  im p ed e delivery' o f  m itoch on d ria l s ig n a ls  to  th e  K a t p  ch a n n el s ite . T h e  A K  
sy ste m  is a lso  cap ab le  o f  m o d u la tin g  ch an ges in th e  A T P /A D P  ratio . F igu re  1 .1 2  
illu stra te s  th a t under severe  m eta b o lic  ch a llen ge , p rov id ed  th a t g ly c o ly s is  m a in ta in s  
su b m em b ra n e  A T P  lev e ls , A K  ca ta ly s is  m a y  fa c ilita te  K a t p  ch a n n el o p en in g  b y  
e le v a tin g  A M P  flu x  in to  th e  su b m em b ran e co m p a rtm en t, and p ro m o tin g  g en era tio n  o f  
su b m em b ra n e  A D P  lev e ls  (A T P  +  A M P  —> 2 A D P ) (C arrasco, D zeja  et al. 2001; 
S e liv a n o v , A lek seev  et al. 2004).
CELL EXTERIOR CELL INTERIOR MITOCHONDRIA
ADP ADP ADP
SUR
AK AK
AMP ATP AMP ATP
K ir6 .2
ATI
Figure 1.12: AK phosphotransfer com m unicates mitochondria-generated signals to K a t p  
channels. A phosphorelay network of AK molecules is formed, and connects m itochondria 
w ith the cell membrane. Mitochondrial F|-Fo-ATPase consumes cellular ATP generating  
A D P under hypoxic stress, and this is delivered to the K a t p  channel through the chain of 
sequential AK -catalysed phosphotransfer reactions (adapted from Carrasco et a l., 2001).
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In the heart, the observation th at elevating extracellular glucose concentration to 
supraphysiologic levels reversed shortening o f the action potential during hypoxia  
suggested that g lycolytic A T P m ay be preferentially used to preserve membrane 
function (M cDonald and MacLeod 1973). G lycolysis has been shown to be a 
preferential source o f A T P for cardiac A T P-sensitive K+ channels, and has been shown  
to be related to the close physical proxim ity o f key glycolytic enzym es to the channels 
(W eiss and Lamp 1989). The preferential dependence o f the channels on A T P derived 
from anaerobic glycolysis is an attractive m echanism  linking the m etabolism  o f glucose 
directly to the activ ity  o f K atp channels. G lycolytic flux is composed of both  
exogenous glucose utilization and glycogenolysis. It has long since been reported that 
glycolytic  flux increases during early ischem ia (R ovetto  1979). Even though it is 
unlikely that K atp channels would be activated as a consequence, it m ay be necessary 
for both glycogenolytic and glycolytic enzym es to be associated with K atp channels for 
their activation during ischemia once ATP production from exogenous glucose 
utilization falls below a critical level.
Potential energetic regulation of the channel is also provided via integration w ith other 
cellular system s, including physical interaction between the actin cytoskeleton and the  
K atp channel, and via physical association w ith other m etabolic system s such as lactate  
dehydrogenase (LD H ) (Carrasco, Dzeja et al. 2001; Crawford, Budas et al. 2002;  
Crawford, Ranki et al. 2 0 0 2 ). The reaction N A D H  + Pyruvate <-> lactate + N A D  is 
catalysed by L D H , whereby lactate accum ulates in the vicin ity  o f LDH  and m odulates 
the sensitiv ity  o f K atp channels. The m uscle form o f lactate dehydrogenase (M -LDH) 
in the sarcolem m al K atp channel com plex appears to be required for early opening o f  
K atp channels during ischemia and cellular resistance against m etabolic stress 
(Crawford, Budas et al. 2 0 0 2 ). The integrity o f the m icroenvironm ent surrounding 
K atp channel proteins, in particular the actin filam ent network, may play an im portant 
role in m odulating the channel activ ity  o f K atp channels (Van W agoner and Lamorgese 
1 994). In cardiom yocytes, the actin  m icrofilam ent disrupter D N ase I has been shown  
to stim ulate the activ ity  o f K atp channels (Terzic and Kurachi 1 996). Sim ilarly, the
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activ ity  o f native K atp channels in sm ooth muscle was enhanced by cytochalasin B 
(Teramoto, Tom oda et al. 2002). The actin filam ent network and its related proteins 
m ight be involved in signal transduction between the inhibitory regulatory proteins and 
K atp channels. Regulation by the signaling pathw ays discussed below, direct channel 
effects o f G protein subunits (Terzic, Tung et al. 1994), pH effects via protonation o f  
channel proteins (Vivaudou and Forestier 1995), and changes in membrane 
phospholipids that interact w ith Kir6.2 to m odulate pore function (Baukrowitz, Schulte 
et al. 1998) are other system s that synchronize K atp channel function with changes in 
cellular energetic state.
K atp channels involved in insulin release from the pancreatic P-cell associate w ith Rim , 
Piccolo, Epacs and Ca2+ channel subunits, which confer regulation o f insulin release by 
cytosolic A T P, Ca2+ and cAM P (Shibasaki, Sunaga et al. 2004). The coordination o f  
exocytosis and ionic events leading to secretion m ay also occur via interaction o f the 
K atp channel with the vesicle docking protein, syntaxin-1 (Pasyk, Kang et al. 2004). It 
has also been dem onstrated that key glycolytic enzym es such as glyceraldehyde-3- 
phosphate (G A PD H ), triose phosphate isomerase (TP), and phosphoglycerate kinase 
(PK ) can associate w ith Kir6.2 subunits o f cardiac sarcolemmal A T P-sensitive K atp 
channels, that they are com ponents o f the K atp channel com plex and that their 
activ ity  regulates K atp channel opening by allowing fast-sensing o f glucose levels 
(Dhar-Chowdhury, Harrell et al. 2005; Jovanovic, Du et al. 2005).
Regulation by Cellular signalling pathways
Aside from the role o f  nucleotides in K atp channel regulation, K atp channels in vascular  
sm ooth muscle are also regulated by a wide range o f vasoconstrictors and vasodilators, 
which are thought to form an im portant part o f their control under physiological 
conditions. Small arteries play a major role in the control o f luminal flow, intravascular 
pressure, and responsiveness to local m etabolites. As such, they have a high density o f 
K atp channels.
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The vasodilators known to activate K ir6.1/SU R 2B include calcitonin gene-related 
peptide (CGRP), prostacyclin, adenosine, and 6-adrenoreceptor agonists. There is 
evidence to suggest that they act through the classical adenyl cyclase-protein kinase A 
pathw ay, i.e. activate PK A  through the form ation o f cyclic AM P. Intracellular 
application o f either cyclic AM P or the catalytic subunit o f PK A also activates the 
channel, whereby low intracellular A T P suppresses tonic activation (i.e. activation that 
does not require the presence o f receptor agonists), which is reversed by increasing ATP  
towards physiological levels. This m ay be im portant for the tonic contribution o f the 
channels to resting blood flow. The m olecular m echanism  via which PK A  activates the 
channel m ay be via a conserved consensus site in Kir6.1 at T234 (Brayden 2002; 
Standen 2003). B y em ploying the cloned equivalent o f vascular K atp, K ir6.1/SU R 2B, 
evidence was provided that PK A  activation involves phosphorylation o f both subunits; 
at S385 in Kir6.1 and T633 and S1465 in SU R 2B  (Quinn, Giblin et al. 2004). For 
substantial channel activation  to occur, it was deduced that a large number o f these  
sites need to be phosphorylated.
Adenosine is a mediator o f m etabolic distress. It is ubiquitously released, being formed 
in the extracellular space by the breakdown o f A T P, and in hypoxic tissues it 
accum ulates to high levels. Adenosine acts physiologically on specific cell surface G- 
protein coupled receptors, four o f which (A i, A 2A, A 2B and A3) have been cloned and 
described pharm acologically. Collectively, their expression is widespread, such that 
adenosine controls the function o f virtually every organ and tissue. Ai and A 3 receptors 
interact w ith pertussis toxin-sensitive G proteins o f the Gi and Go fam ily, whereas A2A 
and A 2B receptors stim ulate adenylyl cyclase via Gs. In addition, A 2B receptors can 
activate phospholipase C, and this is thought to be m ediated via activation o f Gq 
(Klinger, Freissm uth et al. 2002). Since they are able to couple to Gi and Go proteins, 
they m ediate a broad range o f signalling responses, and aside from adenylate cyclase  
and phospholipase C, regulate several other membrane and intracellular proteins upon  
activation, including Ca2+ channels and K+ channels (Fredholm, A P et al. 2001; 
Klinger, Freissm uth et al. 2002).
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There is a high expression o f A 2B receptors in sm ooth muscle cells, w ith high levels in 
the cecum, colon, bladder and blood vessels. Through A 2B receptors, adenosine also 
regulates the growth o f sm ooth m uscle cell populations in blood vessels, cell growth, 
intestinal function, inhibition o f Tumour Necrosis Factor (T N F -a), vascular tone and 
inflam m atory processes (Baraldi, Rom agnoli et al. 2006). It has been shown that 
agonists specific for the Ai receptor increase the activ ity  o f the high-affinity N a+- 
dependent adenosine transporter (CNT2) by a m echanism  which is com pletely  
dependent on K a t p  channel function, since the K a t p  channel m ediates the link between  
adenosine retrieval and uptake into the cell, where it m ay contribute to replenishing the  
nucleotide pool (D uflot, Riera et al. 2004). It has also been shown that under brief 
ischem ic conditions, adenosine receptors are activated, which in turn activate PKC and 
which phosphorylates the K a t p  channel. The phosphorylation alters the sensitiv ity  of  
K a t p  channels in such a way that these channels open earlier and/or more intensely  
during prolonged ischem ia (Liu, Gao et al. 1997).
Vasoconstrictors that inhibit the channel include angiotensin II, endothelin I, 
vasopressin, serotonin, phenylephrine, neuropeptide Y and histam ine and several o f  
these have been shown to inhibit the channel via PKC (Kubo, Quayle et al. 1997) 
resulting in depolarisation and contraction (Quayle, Nelson et al. 1997; Cole, Malcolm et 
al. 2000). PKC has been shown to directly inhibit recom binant channels comprising 
K ir6.1/SU R 2B , and this inhibition is consistent w ith the inhibition o f whole-cell 
vascular K a t p  currents by vasoactive agonists. H owever, the phosphorylation sites 
have not been identified (Thorneloe, Maruyama et al. 2002). In m any tissues, including  
vascular sm ooth muscle, A n g ll receptors (ATi and AT 2) have been shown to couple 
several cellular signalling pathw ays. The binding of Ang II to pertussis toxin- 
insensitive G protein (Gq/ll)-cou p led  Ang II receptors activates the phospholipase C 
(PLC) cascade, initiating the conversion o f phosphatidylinositol bisphosphate to 
inositol trisphosphate, which evokes Ca2+ release from intracellular stores, and 1,2- 
diacylglycerol, which activates PKC (Park, Kim et al. 2006). PKC has been shown to 
inhibit nucleotide diphosphate-sensitive K a t p  channels when applied to inside-out
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membrane patches excised from rabbit or rat pulm onary vein, and it was suggested  
that molecular m odulation o f activ ity  m ay occur via the conserved threonine (T190) in 
Kir6.1. This was shown to be the case for the corresponding residue on Kir6.2 (Light, 
Bladen et al. 2000). It was recently shown that in small-diam eter coronary arterial 
sm ooth m uscle cells, Ang II inhibits the Kir channel through activation o f PLC and 
Ca2+-dependent PK C a by acting at the ATi receptor (H ayabuchi, Standen et al. 2001; 
Park, Kim et al. 2006). Ang II receptors also cause inhibition o f cyclic AM P-dependent 
protein kinase (PK A ) through the inhibition o f adenylyl cyclase and reduction in cyclic 
AM P (Unger, Chung et al. 1996). Interestingly, when the intracellular concentration o f  
A T P is high, steady state K a t p  channel activation  by PK A  is observed (H ayabuchi, 
Standen et al. 2001), whereby Ang II acts via the ATi receptor to inhibit PK A  (to 
reduce this steady-state activation) and through the activation o f PKC. It was 
suggested that the PKCe isoform m ediates this effect (H ayabuchi, Standen et al. 2001). 
Therefore, the background activ ity  o f K a t p  channels m ay be set by steady-state  
activation o f PK A , and an additional pathw ay for the actions o f some vasodilators to 
act through PKC m ay be due to reduction in this PK A  activation by inhibition o f  
adenylyl cyclase.
Work in aortic sm ooth muscle has also indicated that calcium -sensitive protein 
phosphatase 2B (calcineurin) affects K a t p  channel activ ity  via regulation of  
intracellular Ca2+ concentration. Calcineurin m ay regulate the degree o f  
phosphorylation o f a site that causes channel activation, either on the channel itse lf or 
on an accessory regulatory protein, which m ay be the sam e site at which PK A  activates  
the channel (W ilson, Jabr et al. 2000).
There is also strong evidence for a key role o f an A-kinase anchoring protein (AK A P) in 
P K A - K a tp  channel signalling. Som e types o f A K A P can also bind PKC and P P 2B , and 
essentially form m ulti-enzym e com plexes that act synergistically to regulate the  
phosphorylation state o f cellular substrates. Since PK A , PKC and P P 2B  are all 
involved in K a tp  channel regulation, it has been proposed that all o f these enzym es
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m ig h t be loca lised  b y  th e  sam e A K A P , and th a t by an ch orin g  in to  a s ig n a llin g  co m p lex  
th eir  fu n ctio n s  in  reg u la tin g  th e  K a t p  ch a n n el m igh t be in teg ra ted . F igu re  1 .1 3  is  a  
h y p o th e tic a l sch em e o f  factors th at regu la te  v ascu lar  K a t p  ch a n n els  (S ta n d en  2003).
VASODILATORS
VASOCONSTRICTORS K a t p  CHANNEL
PL C A C
G s
G q
PKC
DAG
cA M P
P P 2B
A K A P  = A - k i n a s ? a n c h o r i n g
A C = A d e n y ly l c y c l a s e  
PL C  = P h o s p h o l i p a s e  C
PK A  = P r o te in  k in a s e  A 
P P 2 B  = P r o te in  P h o s p h a t a s e  2B  
DAG = D ia c y ly g ly c e ro l
Figure 1.13: Factors that regulate vascular K a t p  channels. Black arrows represent activation  
pathways, and blue arrows represent inhibitory pathways. A K A P is thought to be im portant in 
localising key regulatory enzymes close to the channel to form a regulatory com plex. Many 
vasodilators act through AC and PKA to cause channel activation. Vasoconstrictors act 
through PLC and inhibit the channel through PKC, and may further do so via activation  o f 
PP 2B  or via inhibition o f AC (adapted from Standen; 2003).
T h e  A T P -se n s it iv ity  o f  K a t p  ch a n n e ls  is a lso  m o d u la ted  b y  m em b ran e  in o sito l  
p h osp h o lip id s; an increase in P I P 2 or P I P 3 co n cen tra tio n  sh iftin g  th e  A T P -in h ib it io n  
cu rv e  to  h igh er  A T P  co n cen tra tio n s , and so in creasin g  th e  op en  p ro b a b ility  (H ilg em a n n  
and B all 1996; B a u k ro w itz , S ch u lte  et al. 1998; S h y n g  and N ich o ls  1998; B a u k ro w itz  
and F ak ler 2 000). P I P 2 b reak d ow n  b y  p h o sp h o lip a se  h as a lso  been  sh o w n  to  reduce
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K a t p  channel activ ity  in recom binant system s. It is not clear whether changes in 
phospholipid concentration serve to regulate the activ ity  o f native channels, or to 
provide a background reduction in A T P-sensitivity. It is possible that PK A  m ay  
increase the P IP 2 affinity for Kir6.2 resulting in channel activation, however Kir6.1 
already has a very high affinity for anionic phospholipids and the same m echanism  is 
unlikely to apply (Quinn, Cui et al. 2003).
AMP activated protein kinase
5’-A M P-activated protein kinase (AM PK ), a highly conserved heterotrimeric enzym e  
that is often described as an energy gauge, participates in the regulation o f fuel supply  
in response to  the m etabolic needs o f organ system s (K ahn, Alquier et al. 2005; Hardie, 
H aw ley et al. 2006). Upon its activation during m etabolic stress in response to elevated  
intracellular A M P/ATP ratios, a number o f energy producing m etabolic pathw ays are 
turned on, and energy consuming pathw ays inhibited (Hardie and Carling 1997). It 
does this via phosphorylation o f key enzym es in m etabolic pathw ays, such as acetyl- 
enzym e A (acetyl-CoA) and carboxylase (ACC), by m odulating their activ ities and by 
regulating the activ ity  o f transcription factors and transcriptional cofactors. A lthough  
specific m echanism s remain obscure, further upstream m ediators and pathw ays are 
likely to be im portant for nucleotide-independent activation o f AM PK (Carling 2004).
R ecent studies suggest that AM PK  plays an im portant role in regulating insulin release 
from P-cells o f  the pancreas, and this m ay occur via activation of K a t p  channels. B oth  
the Kir6.2 and the SUR1 subunits o f the K a t p  channel, along with the voltage-sensitive  
Ca2+ channel isoform expressed in p-cells, contain potential consensus AM PK- 
phosphorylation sites (Rutter, Da Silva Xavier et al. 2003). The potential role o f  
AM PK in m odulating this response needs to be further investigated, despite 
characterization o f the direct activating and inhibitory effects o f A D P and A T P on the  
channel respectively (Ashcroft and Gribble 1998).
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In  w ild  ty p e  ce lls, p reco n d itio n in g  in creases sa rco lem m a l/cy to so lic  K ir6 .2  ra tio , 
con firm in g  p rev iou s fin d in gs th a t  p reco n d itio n in g  stim u la te s  th e  recru itm en t o f  
sarco lem m al K a t p  ch an n els (B u d a s , J o v a n o v ic  et al. 2004; S u k h o d u b . J o v a n o v ic  et al. 
2007). A d o m in a n t n eg a tiv e  form  o f  th e  a2 A M P K  su b u n it (an a  su b u n it isoform  
sp ec ifica lly  expressed  in th e  liver , card iac  and sk e le ta l m u scle) w as overex p ressed  in  
c a r d io m y o c y te s  to  a n a ly se  th e  role th a t A M P K  p la y s  in p reco n d itio n in g  in  th e  h eart, 
y et ch a n n e l recru itm en t w as n o t o b serv ed , su g g estin g  th at a2 A M P K  c a ta ly t ic  a c t iv ity  
is e ssen tia l for p recon d ition in g -in d u ced  s tim u la tio n  o f  K a t p  ch a n n el tra ffick in g  to  th e  
sarco lem m a (S u k h od u b , J o v a n o v ic  et al. 2007).
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D e c r e a s e  e n e r g y  
d e m a n d I n c r e a s e  e n e r g y  s u p p ly
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Figure 1.14: Energy levels are regulated by AM PK. AMPK is activated by a rise in the 
AM P:ATP ratio. When threonine 172 (T172) o f the a  subunit is phosphorylated (catalysed by 
serine-threonine tumor-suppressor kinase, LKB1) AM PK is activated. ATP generating  
pathw ays are as such switched-on, and ATP utilizing pathways are switched-off. The combined  
roles o f AMPK ensure that the energy status o f the cell is finely balanced (adapted from 
Carling; 2005).
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Cell energy metabolism regulates Katp gene expression
As well as the described interaction o f K a t p  channels with nucleotides and cell 
m etabolites, K a t p  gene expression is also regulated by energy m etabolism , whereby  
alterations in m etabolism  will lead to changes o f K a t p  channel number. In rat 
pancreatic islets, a decrease o f Kir6.2 m R N A  level was induced by high glucose, which  
was reversed by exposure to low glucose (Moritz, Leech et al. 2001), and Kir6.1 m R N A  
was specifically upregulated in both ischem ic and non-iscbem ic regions o f the rat heart 
after ischem ia followed by reperfusion (Akao, Otani et al. 1997). Conversely, K a t p  
channel num ber was increased, and resistance conferred against Ca2+ loading in heart 
cells following the induction o f acute hypoxia (Crawford, Jovanovic et al. 2003). It was 
recently reported for the first tim e that hypoxia results in changes in the m R N A  level 
in the expression o f Kir6.1 and Kir6.2 genes in vivo , w ith up-regulation o f Kir6.1 and 
down-regulation o f Kir6.2 resulting in a significant change in channel com position. 
This m eant that Kir6.1 was the first ion channel gene to be identified as a member of  
the hypoxia-inducible gene fam ily, and implies that different regulatory m echanism s 
are responsible for gene transcription or m R N A  stability  o f the two pore sub-units 
(M elamed-Frank, Terzic et al. 2001). H owever, the mechanism o f energy m etabolism  
regulation over K a t p  gene expression is still unknown. It was suggested that the ratio 
o f  N A D /N A D H  is changed during mild hypoxia, which in turn activates  
phosphotidylinositol(PI)3-kinase and extra-cellular signal-regulated kinases (E R K s), 
which upregulates the c-jun protein to target the sur2 promoter and increase gene 
transcription (Crawford, Jovanovic et al. 2003). Kir6.1 expression is increased through 
activation o f the p42/p44 m itogen-activated protein kinase pathw ay (M APK) via  
urocortin (Lawrence, Chanalaris et al. 2002), and hyperglycem ia decreases Kir6.2 
m R N A  levels via inhibition o f m R N A  stab ility  (Moritz, Leech et al. 2001). The control 
of K a t p  channel number via genetic regulation has a significant im pact on channel 
function. There is a direct link between the levels o f cell resistance to oxidative stress 
and channel number (Crawford, Jovanovic et al. 2003), and enhanced sensitiv ity  to 
hypoxia or ischem ia o f cardiac cells is induced by inhibition o f K a t p  gene expression in 
diabetes (Ren, X u et al. 2003).
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1.7 Physiological and pathophysiological roles o f the vascular smooth muscle 
A  TP-sensitive K + channel
Resting membrane potential and basal tone
Various in vitro studies have shown that glibenclamide causes depolarisation and 
increases muscle tone in the vascular sm ooth muscle o f rabbit mesenteric artery and 
canine saphenous vein (Nelson, H uang et al. 1990; Nakashim a and V anhoutte 1995) 
and in guinea-pig trachea, dog bronchial and pig urethra non-vascular sm ooth muscle 
(K am ei, Y oshida et al. 1994; Teram oto, Creed et al. 1997). In vivo studies have also 
shown that glibenclamide significantly increases vascular resistance and decreases 
arterial diam eter (Quayle, Nelson et al. 1997). Presum ably there is a low density, or a 
low open probability o f native K a t p  channels, since direct recordings o f channel activ ity  
showed that they opened briefly in the absence o f channel openers (Teramoto, 
McMurray et al. 1997). Therefore the resting membrane potential o f sm ooth muscle 
m ay be regulated by K a t p  channels with a low level o f channel activ ity .
Endotoxins and Septic Shock
Since K + channel blockers reduce vasodilation (Clapp and Tinker 1998), it follows that 
activation  o f potassium  channels in the peripheral circulation m ight be im portant in 
the refractory vasodilation of shock, the characteristics o f which are vascular 
hyporesponsiveness to vasoconstrictors, inadequate tissue perfusion, low system ic  
resistance and hypotension. The first evidence for a role o f K a t p  channels in the  
vasodilatation induced by shock showed that the blood pressure in dogs w ith endotoxic  
hypotension could be restored via the vasoconstrictive action o f glibenclam ide (Landry 
and Oliver 2001). Since then, a wealth o f evidence has accumulated to suggest that the 
activ ity  o f K a t p  channels is increased in circulatory shock. Studies in rat and pig models 
in which shock is induced by bacterial endotoxins (lipopolysaccharides) have shown  
that glibenclam ide can partially restore arterial pressure (Salzm an, Vromen et al. 1997; 
Sorrentino, d'Em manuele di Villa Bianca et al. 1999). There is substantial evidence that 
increased synthesis o f nitric oxide (NO) contributes to the hyporeactivity o f shock and
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vascular hypotension (Garland and M cPherson 1992; M iyoshi, N akaya et al. 1994; 
Murphy and Brayden 1995; W u, Thiem erm ann et al. 1995), and it has been suggested  
that endotoxaem ia can reduce K a t p  channel sensitivity to glibenclam ide, m aybe  
through the action o f NO (O’Brien 2002). The requirement o f  Kir6.1 in securing 
coronary vasoreactivity has been dem onstrated in a model o f severe sepsis w ith acute 
endotoxic shock. K nockout o f the K C N J 8  gene (encoding for Kir6.1) interrupted a 
vital vasodilatory adaptive m echanism  in LPS-induced endotoxem ia, resulting in 
premature death and producing deficits in ischemic cardiac dysfunction and coronary 
flow (K ane, Lam et al. 2006).
Vasodilator Responses to Metabolic Demand and Exercise
Blood flow is closely correlated to m etabolic demand in m any vascular beds. 
M etabolically active tissue releases local vasodilator signals, such as prostacyclin and 
adenosine, in response to a fall in oxygen tension and pH. Blood vessel diameter and 
thus blood flow is subsequently altered. In the coronary circulation and several other 
vascular beds, K a t p  channel activation is im portant in hypoxic vasodilation. It has 
been suggested that K a t p  channels play an im portant role in post-ischaem ic  
vasodilation from studies o f reactive hyperaemia in both human forearm and guinea- 
pig (Bank, Sih et al. 2000; K ingsbury, Robinson et al. 2001). Endogenous substances 
that hyperpolarize and relax cerebral vascular sm ooth muscle such as endothelium - 
derived hyperpolarizing factor (E D H F ), prostacyclin, opioids and adenosine, appear to 
do this via K a t p  channels, which in turn m ay contribute to cerebral vasodilation in 
response to hypoxia and to cerebral vascular autoregulation (Lee, Kwon et al. 1993; 
Reid, Paterson et al. 1993; Faraci and Sobey 1998).
K a t p  channels m ay be involved in circulatory responses to the increased m etabolic  
demands induced by exercise, as indicated by their role in m etabolic vasodilation. In 
exercising dogs, resting coronary blood flow was reduced via K a t p  channel blockade 
with glibenclamide, as was the reactive increase in blood flow due to ischaem ia. 
H owever, exercise-induced vasodilation was not prevented (Duncker, Van Zon et al.
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1993). H owever, blockade o f K a t p  channels hindered exercise-induced coronary 
vasodilation when adenosine receptors were inhibited (Duncker, van Zon et al. 1995) 
and this effect became more severe when NO synthase activ ity  was also inhibited  
(Ishibashi, Duncker et al. 1998). Since both adenosine and NO were unaffected by 
blockade o f both pathw ays, neither appear essential for m aintaining either resting 
coronary flow or the increase in coronary flow on exercise. This in turn suggests that, 
under normal conditions, K a t p  channels are im portant for m aintaining coronary 
vasodilation during exercise, but that when they are blocked, adenosine and NO can act 
to increase coronary blood flow (Ishibashi, Duncker et al. 1998). An increased 
dependence on K a t p  channel opening to increase coronary blood flow in exercise is also 
seen in hypertrophied hearts, whereby glibenclam ide alone diminished the exercise- 
induced increase in flow (Melchert, Duncker et al. 1999). A recent study involving  
exercising pigs has shown that even though K a t p  channel activation was not essential 
for exercise-induced vasodilation, it contributes to vasodilation both at rest and during 
exercise in both the system ic and coronary circulations. H owever, pulm onary vascular 
conductance was unaffected by glibenclam ide either at rest or during exercise (Duncker, 
Oei et al. 2001).
Proposed mechanism by which hypoxia triggers vasodilatation
In sm ooth m uscle cells, K a t p  channels are thought to be either directly activated by  
hypoxia, or activated by receptor-coupled signal transduction pathw ays via the release 
o f vasodilator m etabolites from surrounding tissue or endothelial cells. A t the tissue 
and organ level the role that K a t p  channels play in hypoxic vasodilation is well 
established, but this is not the case at the cellular level. In arteries supplying rat 
cremaster m uscle, a lack of effect o f hypoxia on K a t p  current was reported (Jackson  
2000) and in a recent experim ent K a t p  current was undetectable in hypoxic cells from 
arteries supplying rat skeletal muscle (Quayle, Turner et al. 2006). Conversely, in 
sm ooth m uscle cell from pig coronary arteries, K a t p  current was shown to be activated  
by hypoxia (Dart and Standen 1995).
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Even though the latter study would suggest that hypoxia vasodilation in the heart 
results in changes in intracellular nucleotide levels and direct activation o f sm ooth  
muscle K a t p  channels, it is unclear whether this is actually the case. They m ay be 
regulated by oxygen tension independently o f cell m etabolism . The recent data  
suggests that, at the cellular level, changes in cell m etabolism  during hypoxia do not 
activate vascular K a t p  channels since anoxia but not hypoxia activated K a t p  current in 
femoral artery m yocytes, and because inhibition o f cellular energy production was 
insufficient to activate K a t p  current, w ith current activation requiring energy 
consum ption. Furthermore, a relaxant effect o f hypoxia on rat femoral artery was 
observed, and it was suggested that this was m ediated by changes in [C a2+]i through  
m odulation o f calcium channel activ ity  (Quayle, Turner et al. 2006).
65
1.8 A im s and hypotheses
It was hypothesized that the intrinsic m etabolic sensitivity o f K ir6.1/SUR 2B  
dem onstrated in m y initial experim ental analysis could be accounted for by an increase 
in intracellular M gADP upon m etabolic poisoning, and subsequent depletion o f the 
glycolytic and oxidative phosphorylation pathw ays. H owever, I wanted to determine 
if  the channel pore or the sulphonylurea receptor was primarily responsible for this 
apparent intrinsic m etabolic sensitiv ity . Therefore, I set out to deduce:
(1) I f  protein kinases or variations in nucleotide concentration have a predom inant role 
in the regulation of the channel in vitro
(2) I f  the pore o f the channel displays any intrinsic A TP sensitivity, and to create a 
constitu tively  active channel at the membrane in the absence o f SUR
(3) The role o f the N B D s o f the sulphonylurea receptor in the regulation o f  
K ir6.1/SU R 2B
(4) A ny differences in m etabolic regulation between K ir6.1/SUR 2B and K ir6.2/SUR 2B
(5) I f  there are any differences in pharm acology between m etabolically activated  
currents, and those activated upon the addition o f a K a t p  channel opener
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Chapter Two: Materials and Methods
2.1 General Molecular Biology
It will become apparent that in m y thesis several powerful molecular biology  
techniques were used throughout m y experim entation, since the m ajority o f m y data  
was reliant on my ability to m anipulate cloned cD N A  encoding the K a t p  channel 
Kir6.1 and SU R 2B  channel subunits. Due to its length and chemical m onotony, D N A  
was an extrem ely difficult molecule to analyse before the 1970s. The discovery o f  
prokaryotic enzym es that cut and join specific base-pair sequences in double stranded 
D N A , and those that replicate D N A  and reverse transcribe R N A , revolutionised  
m olecular biology. The second major advance was the finding that com plem entary  
single-stranded nucleic acid chains can hybridise to form double-stranded molecules at 
around 65°C (this can occur between D N A /D N A , D N A /R N A  and R N A /R N A ). 
Additionally, the powerful technique we refer to as the Polym erase Chain Reaction  
(PCR) was introduced in the 1970s as was the discovery o f a heat-resistant D N A  
polym erase isolated from therm ophilic bacteria, which together allow the am plification  
o f a particular sequence o f D N A  in the test tube. This is in turn possible, because 
m ethods were developed in the 1970s to determine the sequence o f any nucleotide  
fragm ent, m aking it possible to determ ine the com plete D N A  sequences o f thousands o f  
genes. F inally , advances in microbial genetics found application in molecular biology, 
such as the extensive use o f bacterial plasmids to package and deliver recom binant 
D N A  m olecules into host cells and viral enzym es to reverse transcribe m R N A  into  
cDN A.
Plasm ids exist in m any bacterial species: circular double-stranded D N A  m olecules that 
act as accessory chromosomes that replicate them selves and drive m R N A  transcription 
independently o f the host genome. However, they require the transcription and 
translation m achinery o f the host cell. To allow the efficient delivery o f foreign genetic 
material into either bacterial or eukaryotic cells, such plasmids have been modified to
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allow them  to be used as vectors. M any are now comm ercially available, such as the  
pcDNA3.1 fam ily (Invitrogen, Paisley, U K )  employed in this thesis, the m ain features 
of which are shown in Figure 2.1. These vectors are designed for high level stable or 
transient expression o f the encoded gene in m amm alian cells, and the efficient 
propagation o f the plasmid vector in m any strains o f E.coli.
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pcDNA3.1 (+/-)
5428/5427 bp
Comments for pcDNA3.1 (+)
5428 nudeotides
CMV promoter: bases 232-819 
T7 promoter/priming site: bases 863-882 
Multiple cloning site: bases 895-1010 
pcDNA3.1/BGH reverse priming site: bases 1022-1039 
BGH polyadenylation sequence: bases 1028-1252 
f1 origin: bases 1298-1726 
SV40 early promoter and origin: bases 1731-2074 
Neomycin resistance gene (ORF): bases 2136-2930 
SV40 early polyadenylation signal: bases 3104-3234 
pUC origin: bases 3617-4287 (complementary strand)
Ampidllin resistance gene (bla): bases 4432-5428 (complementary strand) 
ORF: bases 4432-5292 (complementary strand)
Ribosome binding site: bases 5300-5304 (complementary strand) 
bla promoter (P3): bases 5327-5333 (complementary strand)
Figure 2.1  D iagram  to show main features o f  pcD N A 3.1, including the m ultiple cloning site
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Restriction digestion of DNA molecules
The restriction endonuclease activ ity  o f restriction enzym es can be used to m anipulate  
double stranded D N A . They hydrolyse D N A  at specific palindromic nucleotide  
sequences (Sambrook 1989). Some types create blunt ends via cleaving the D N A  at the 
axis o f sym m etry (e.g. E co47III), while some create cohesive ends, i.e. protruding 5’ or 
3’ single-stranded overhangs (e.g. EcoR I) via cleaving on the opposite sides o f the  
sym m etrical axis. A specific condition is required for the optim al activ ity  for each 
restriction enzym e. A specific incubation buffer (provided by the manufacturer) and 
bovine serum album in (BSA), ensure m axim al activ ity . The com ponents o f a typical 
restriction digest are listed below:
5pl D N A
2pl lOx BSA  stock solution (final concentration lOOpg/ml)
2pl 10x Reaction buffer
10.5pl molecular biology grade water (Sigma, Poole, U K )
0.5pl R estriction enzyme (2-10 units)
A unit o f enzym e is typically defined as the am ount required for com plete digestion o f  
lp g  X.DNA in 16 hours at 37°C. D igests were generally incubated for 1-3 hours. In the  
m ajority o f  cases, two restriction enzym es were used in a digest in order to subclone 
D N A  from one plasmid vector to another, whereby a com patible buffer was used such 
that each enzym e had greater than 50% o f its m axim al activity.
Agarose gel electrophoresis
D N A  fragm ents can be separated from each other on the basis o f size using agarose gel 
electrophoresis. This works on the principle that the phosphate groups o f D N A  are 
negatively charged at neutral pH , and therefore migrate under the influence o f an 
electric field. The gel forms a m atrix, and effectively sieves the D N A , whereby the  
migration rate o f linear double stranded D N A  molecules through the gel is proportional 
to the logarithm  o f the number o f base pairs (H elling and Boyer 1974). The m igration
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rate differs depending on the conform ation of the D N A  — supercoiled, nicked circular 
and linearised D N A  molecules all m igrate at different rates (Thorne 1966). D N A  was 
visualised using ethidium  bromide. This is a dye that intercalates between base pairs so 
that D N A  bands can be visualised under ultraviolet light. In the m ajority o f cases a 
0.7% (w/v) agarose gel was m ade, since the effective range o f size separation is between  
0.8 and 10 kilobase pairs (kB) (Sambrook 1989). For a 0.7% (w/v) gel, 420m g  
electrophoresis grade agarose (Invitrogen, U K )  was added to 60ml lx  Tris-Acetate- 
ED TA  (TAE) solution. A 50x TA E stock solution was made using 2M Tris Base (Sigma  
Aldrich, U K ),  50mM ED TA  pH 8.0 and 5.71% (v/v) glacial acetic acid (B D H , UK).  The 
m ixture was microwaved until com pletely dissolved, and then ethidium  bromide (Sigma  
Aldrich , U K )  was added upon cooling from a lOmg/ml aqueous solution to a final 
concentration o f 0.5|lg/m l. The agarose-TAE m ixture was poured into a plastic tray, 
sealed securely w ith autoclave tape and plastic combs placed in the appropriate slots to 
create wells. The gel was allowed to set at room temperature, and then placed into an 
electrophoresis tank containing the running buffer lx  TAE.
D N A  was loaded via the addition o f gel loading buffer. A 6x buffer was made from 
0.25% (w/v) bromophenol blue, 0.25% (v/v) xylene cyanol FF  and 30% (v/v) glycerol 
(all reagents supplied from Sigma Aldrich, Poole, U K ).  Typically 4pl o f 6x gel loading  
buffer was added to 20pl sample. D N A  samples were loaded into their designated wells 
along w ith the standard D N A  molecular weight marker VII (Roche Labs, U K )  to 
determ ine the size of D N A  fragm ents. A gel was typically  run for one hour at lOOmV , 
then viewed under ultra-violet (UV) light at 312nm wavelength in a U V P dual 
in tensity transillum inator ( Upland, California, U SA), equipped with digital video 
camera and m onitor (Sony SSM -121CE ).  Photographs o f the gel image were printed by 
a video graphic printer.
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Extraction and purification o f DNA fragments from agarose gels
A commercial kit is available from Qiagen (Q iaEX  II agarose gel extraction kit, Qiagen, 
Crawley, Sussex) that is able to purify D N A  from an agarose gel with high efficiency. 
This is able to solubilise agarose, and under high salt concentrations bind D N A  
fragments via a resin o f silica-gel particles. Contam inants are removed via a series o f 
washes, and purified D N A  eluted from the resin using distilled water.
The D N A  fragment o f interest was excised from the agarose gel with a scalpel, weighed 
in an eppendorf tube then 3 volum es o f buffer QX1 added to one volum e o f D N A  
fragm ent (100bp-4kb) to dissolve the gel at 50°C for approxim ately 10 m inutes. lOpl o f  
Q IA E X  II resin was added to the solubilised m ixture to bind the D N A , and binding  
was allowed to proceed for a further 10 m inutes at 50°C with regular vortexing to keep 
the resin in suspension. Subsequently, the resin was pelleted at ~17, 900xg in a micro- 
centrifuge for 30 seconds and the supernatant removed. The pellet was washed via  
resuspension and subsequent pelleting with 500pl o f buffer Q X1, followed by two  
additional washes in 500pl buffer PE (a buffer containing ethanol to remove residual 
salt). A fter air drying the pellet at room temperature, the sample was centrifuged with  
20pl distilled water to elute the D N A , which was collected in a clean eppendorf tube. 
Elution was repeated, and the elutates combined to increase the yield of D N A .
Ligation of DNA fragments
In a ligation reaction, a D N A  fragm ent and a vector digested with the same restriction  
enzym es can be spliced together. Compatible cohesive sticky ends were produced by 
digesting the vector and D N A  fragm ent o f interest w ith the same restriction enzym es. 
The cleaved phosphodiester bonds were therefore easily resealed via the D N A  ligase, an 
enzym e that catalyses the form ation o f new phosphodiester bonds between residues 
located at the 5’ terminus o f the D N A  fragment and hydroxyl groups located at the 
3’end. The 5 ’ phosphate groups o f the vector were removed with the enzym e calf 
intestinal phosphatise (CIP), (New England Biolabs, U K )  to prevent re-ligation o f the 
vector termini. In these experim ents Bacteriophage T4 D N A  ligase (N E B , U K )  was
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used which requires the co-factors A T P and Mg2+ (W eiss 1968). The buffer provided 
from the same manufacturer contained 66mM trisHCl, 5mM MgCh, ImM D ithiothreitol 
and ImM A T P, pH 7.5. A control reaction for self-ligation o f the CIP-treated vector  
was set up in parallel w ith each ligation reaction. A typical reaction was set up as 
below;
Control reaction
5pl CIP-treated digested vector 
12pl distilled water 
2pl lOx ligation buffer 
lp l T4 D N A  ligase (1 unit)
Ligation reaction 
5pl CIP-treated digested vector  
12pl digested D N A  fragment 
2pl lOx ligation buffer 
lp l T4 D N A  ligase (1 unit)
It was generally necessary to adjust the molar ratio o f insert to vector D N A  to obtain a 
successful ligation; generally this was 3:1 (insert: vector), i.e.
Mass insert(ng) = 3 x (mass (ng) /length (bps) vector) x mass vector (ng)
Ligation reactions were incubated overnight at 16°C, and the ligated D N A  
subsequently transformed into com petent E.coli.
Procedure for making competent E.coli for transformation
The process o f introducing foreign D N A  into bacteria is known as transformation. For 
practical reasons, chemical transform ation was used, whereby bacteria first need to be 
treated w ith a series of ice-cold buffers containing either CaCh or RbCl to make them  
com petent. Com petent bacteria are in a state whereby they can more readily take up 
foreign D N A . Two different strains o f com petent E.coli were used in my 
transform ation experiments: D H 5 a  and ToplO. The ToplO strain was preferentially 
used since it allows stable replication o f high copy number plasmids, the original 
glycerol stock o f which was purchased from Invitrogen (Groningen, Netherlands) and 
stored at -80°C.
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To replenish com petent E.coli stocks, cells from the glycerol stock were streaked onto  
LB broth (Luria) agar plates using a sterile inoculating loop, incubated at 37°C 
overnight and stored at 4°C thereafter for a m axim um  o f four weeks. LB broth also 
served as the culture medium for E.coli , com position per litre: lOg Tryptone, 5g Y east 
extract and 5g NaCl, and was supplied in tablet form (Sigma, Aldrich, Poole, U K ).  LB  
agar plates were made via the addition o f 1.5g agar (Sigma, Aldrich, Poole, U K )  per 
100ml8 broth, which was m icrowaved to dissolve then poured into 90mm Petri dishes 
(V W R , Merck House, U K )  upon cooling. Plates were left to set at room tem perature 
and stored at 4°C.
W ith reference to ToplO E.coli cells, individual colonies were picked using a sterile 
pipette tip and grown in 3mls LB broth for 7-9 hours in a shaking incubator set at 
400xg and 37°C. 1ml o f starter culture was transferred into a sterile 2L flask containing  
200m l o f LB broth and the cells incubated until the O .D .550 was between 0.450 and 
0.550nm . The cells were transferred into sterile 250ml centrifuge bottles and allowed to 
cool on ice, before being centrifuged at 4000xg for 15 m inutes. The supernatants were 
discarded, and the cells resuspended in 20ml ice-cold RF1 buffer (lOOmM RbCl, 50mM  
MnCl2.4H20, 30mM potassium acetate, lOmM CaCl2.2H20, 15% (w/v) glycerol, pH  
adjusted to 5.8 with 0.2M acetic acid and filter sterilised) and incubated on ice for 15 
m inutes before centrifugation at 2500xg for a further 9 m inutes. The supernatant was 
again discarded and the cells resuspended in 3.5mls ice-cold RF2 buffer (lOmM RbCl, 
lOmM M OPS, 75mM CaCl2.2H20, 15% glycerol, pH adjusted to 6.8 with 0.2M NaOH  
and filter sterilised). All cells were pooled and incubated on ice for 15 m inutes. Cells 
were aliquoted into sterile eppendorf tubes and flash frozen using liquid nitrogen, then  
stored in the -80°C freezer.
Transformation of plasmid DNA
lOOfil o f pre-thawed ToplO E.coli cells were incubated with lp l purified plasmid D N A  
or lOp.1 o f a ligation reaction, incubated on ice for 30 m inutes then heat-shocked at 42°C 
for 90 seconds to introduce the D N A  into the bacterium. Im m ediately after heat-
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shocking, cells were cooled on ice for 2 m inutes, before the addition o f 800pl LB broth, 
then, incubated at 37°C for 30 m inutes. This allowed the expression of the antibiotic  
resistance gene encoded by the plasmid D N A . The transformation m ixture was plated  
onto LB plates containing the desired antibiotic (either 30-100pg/ml carbenicillin or 
30pg/ml kanam ycin). Low carbenicillin plates were used with the m utagenesis kit. 
lOOpl plasmid D N A  was norm ally transformed, but when transforming ligation  
m ixtures the cells were pelleted then resuspended in lOOp.1 fresh LB before plating. The 
plates were incubated at 37°C for 12-16 hours after which tim e discrete colonies were 
observed that were assumed to have arisen from a single transformed bacterium.
Plasmid DNA purification
After transform ation of plasmid D N A  into bacteria, it needs to be purified so that it can 
be sequenced and digested to ensure that the cD N A  has been m anipulated correctly. 
Upon confirm ation o f the sequence, the plasmid D N A  is usually retransformed so that 
it can be amplified in a large scale culture, in turn providing large yields o f plasmid 
D N A . Q IAGEN plasmid purification kits were used, which are based on a modified 
alkaline lysis procedure and the use o f an anion-exchange resin (whereby the positively  
charged D E A E  groups on the surface resin interact w ith the negatively charged 
phosphates o f the DN A backbone) to bind plasmid D N A . The salt concentration and 
pH conditions o f the buffers used determine whether D N A  is bound or eluted from the 
colum n. Low molecular weight im purities, dyes, R N A  and proteins are removed by a 
m edium -salt wash, plasmid D N A  is eluted in a high salt buffer and then concentrated  
and desalted by isopropanol precipitation. The type o f Q IAGEN kit em ployed depends 
on the yield o f purified DN A required. Generally 10-20pg D N A  are obtained using the 
QIAprep Miniprep system , lOOpg of high-or-low copy plasmid/cosm id D N A  using the 
midi kit system  and up to 500pg D N A  using the m axi kit. The QIAGEN plasmid midi 
kit was generally employed, as elaborated.
A single colony derived from transformed bacterium was picked and a starter culture o f  
3mls o f LB medium, containing the appropriate selective antibiotic, inoculated and
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incubated for ~ 8  hrs at 37°C at ~450xg . The starter culture was diluted in 50m ls (in a 
flask o f at least 4 tim es the volum e) and grown for a further 12-16 hrs. The cells were 
harvested by centrifugation at 6000xg for 15 m inutes at 4°C, and the pellet resuspended 
in 4 ml o f buffer PI (resuspension buffer: 50mM Tris.Cl, pH 8.0; lOmM EDTA; 
lOOpg/ml R N ase A). To lyse the pellet, 4 ml o f buffer P2 (lysis buffer: 200mM NaO H , 
1% SDS (w/v)) were added, the lysate mixed gently by inverting the tube and 
incubated at room tem perature for 5 m inutes. The D N A  was precipitated by adding 
4m ls o f chilled buffer P3 (neutralization buffer: 3M potassium  acetate, pH  5.5), and via  
gentle inversion and incubation on ice for 15 m inutes. The samples were centrifuged at 
20,000Xg for 30 m inutes at 4°C, and m eanwhile a Q IA G EN-tip 100 equilibrated by  
applying 4 ml o f buffer QBT (equilibration buffer: 750mM NaCl; 50mM MOPS, pH 7; 
15% isopropanol (v/v); 0.15% Triton X -100 (v/v)), and allowing the column to em pty  
by gravity flow. The sample was filtered to remove the supernatant, which was applied 
to the tip  and allowed to enter the resin by gravity flow. The tip was washed tw ice w ith  
buffer QC (wash buffer: 1M NaCl; 50mM MOPS; pH  7; 15% isopropanol (v/v)) to  
remove the contam inants in the plasmid D N A  preparation, then the D N A  eluted w ith 5 
ml buffer QF (elution buffer: 1.25M NaCl; 50mM Tris.Cl, pH 8.5; 15% isopropanol 
(v/v)) and collected in an oakridge tube. The D N A  was further precipitated w ith 3.5 ml 
room-tem perature isopropanol, m ixed and centrifuged im m ediately at 15,000xg for 30 
m inutes at 4°C. The supernatant was decanted, and the D N A  pellet resuspended in 
500pl ddH20 and transferred to a 1.5ml eppendorf tube, to which 1ml 100% ethanol and 
50pl 3M pH 5.2 sodium acetate were added. The m ixture was vortexed then incubated  
at -80°C for 20 minutes. Finally, the samples were spun at 18,000xg for 30 m inutes at 
4°C, the supernatant removed and 1ml 70% ethanol added to the pellet, and the 
samples spun again under the same conditions for a further 10 m inutes. The 
supernatant was removed, the pellet left to air-dry for ~  15 m inutes, and then  
resuspended in 250pl ddH20.
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The Polymerase chain reaction (PCR)
Cloned cD N A  was m anipulated using PCR for eventual use in biochemical and 
electrophysiological analysis. PCR results in the selective am plification o f a chosen 
region o f a D N A  m olecule (Sambrook 1989). It works on the basis that short 
oligonucleotides can hybridise to the D N A  m olecule, one on either side o f the double 
helix, and act as primers for D N A  synthesis reactions, delim iting the region to be 
amplified. Am plification is usually carried out via a temperature resistant D N A  
polymerase (Taq  or Vent D N A  polym erase), which when added to the primed D N A  and 
incubated, synthesises new com plem entary strands. The m ixture is heated to 94°C so 
that the new ly synthesised strands detach from the tem plate (denaturation), and cooled 
to approxim ately 55°C, enabling the primers to hybridise to their respective positions, 
including positions on the newly synthesised strands (hybridisation). The D N A  
polymerase then synthesises a new strand at 72°C (extension). This cycle o f  
denaturation-hybridisation-extension is repeated, usually 25-30 tim es, resulting in the  
eventual synthesis o f several hundred m illion copies o f the amplified D N A  fragment via  
logarithm am plification. The annealing temperature for individual PCR experim ent is 
determined via calculating the m elting temperature (Tm) for each primer - i.e. a 
tem perature that is low enough to enable hybridization, but high enough to prevent 
m ism atched hybrids from forming;
T m = (4x[G +C] +  (2x[A+T])°C
A feature o f PCR is that nucleotide sequences can be added to the 5’end o f primer 
molecules, which during the PCR are incorporated into the D N A  sequence. In this way, 
PCR fragm ents can be engineered to contain restriction enzym e sites for insertion into a 
particular cD N A  sequence. The com ponents o f a typical reaction m ixture are as follows;
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Component Amount
D N A  tem plate ~50-100ng
Forward primer 5.0 pmoles
Reverse primer 5.0 pmoles
Therm opolymerase buffer 10pl
dN TP mixture* 2pl
Taq D N A  polymerase** 2 units
MgCl2 2pl
ddH 20 to lOOpl
* dN TP m ixture = 25mM dA TP, dCTP, dTTP, dGTP (purchased separately from New  
England Biolabs, Hitchin, U K  as lOOmM solutions and m ixed in 1:1 ratios to produce a 
25mM primer stock)
** Obtained from New England Biolabs
The cycling steps were conducted using a programmable thermal cycler (Flexigene, 
Techne) and typical cycling steps are as below;
Step 1 94°C, 4 minutes Initial denaturation
Step 2 94°C, 1 minute Denaturation
Step 3 55°C, 1 minute Annealing o f primers to ssDN A
Step 4 72°C, 1 minute Elongation o f nascent D N A
Step 5 72°C, 10 minutes Final elongation
Step 6 Hold at 4°C
Cycle from step 2 to step 4 for 30 cycles
The primers used in the standard PCR procedures are as follows:
Delta C48 5’-TCTTCTAGACTACTGGTGCGACAGTTCACTCTT-3’ 
Delta C61 5’-TCTTCTAGACTAGATGGAAGGTTTCTCGTCCAG-3’ 
Delta N13 5’-GGAGGATCCATGCTGGCCCGCATCGCGGCGGAG-3’ 
Delta N33 S’-GGAGGATCCATGGCCCGCTTCATCGCCAAG-S’
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61R 5’-AAGAAGCTTTCATGATTCTGATG-3’
61F 5’-GGAGGATCCCTGGCCAGGAAGAGCATCATC-3’
D elta C48 and C61 were used to truncate the C-terminus o f Kir6.1 by 48 and 61 amino 
acids respectively, D elta N13 and N33 were used to truncate the N-term inus by 13 and 
33 amino acids respectively, and 61R and 61F were used to clone full length Kir6.1. 
Refer to section Chapter 4, Figure 4.1.
PCR Purification
This protocol purifies single- or double-stranded D N A  fragments from PCR and other 
enzym atic reactions, since it is necessary to remove any contam inating proteins that 
m ay interfere w ith subsequent enzym atic steps. Again, a commercially available  
QIAquick kit was employed (Qiagen, Crawely, Sussex). 5 volum es o f Buffer PB  (exact 
form ulation disclosed; contains hydrochloride and isopropanol) were added to 1 volum e 
of PCR sample, mixed and placed in a spin column, and, to bind D N A , centrifuged for 
30 seconds and the flow-through discarded. To wash the D N A , 0.75 ml o f Buffer PE  
(form ulation disclosed) was added to the colum n, which was centrifuged twice for 30 
seconds and the flow-through discarded. To elute the D N A , 30pl dFhO was added to the 
QIAquick membrane, the colum n centrifuged and the supernatant (purified D N A ) 
collected in an eppendorf tube.
Site-directed mutagenesis
The commercially available in vitro QuikChange site-directed m utagenesis kit 
(Stratagene, California, U S A ) was used to make single amino acid point m utations in 
double-stranded DNA tem plates. The desired m utation was introduced via a PCR- 
hased approach using temperature cycling and two synthetic oligonucleotide primers. 
The high fidelity Pfu Turbo D N A  polymerase was used to replicate both D N A  strands 
by extending the m utant oligonucleotide primers. Incorporation o f the m utant primers 
into the newly synthesised D N A  resulted in a m utated plasmid containing staggered 
nicks. Following temperature cycling, the products are treated with D pn  I. This is an
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endonuclease enzym e that specifically digests m ethylated and hem im ethylated D N A , 
with the target sequence 5’-Gm6A T C -3\ Since D N A  isolated from m ost strains o f E.coli 
is dam m ethylated, Dpn  I treatm ent will selectively digest the parental tem plate, thus 
selecting for m utation-containing synthesised D N A . The nicked vector D N A  
containing the desired m utations is then transformed into Epicurian coli X L I-B lue  
com petent bacterial cells. These repair the nicked D N A  and amplify the m utated DN A  
construct. Transformed X L I-B lue com petent cells were spread onto agar plates 
containing 30pg carbenicillin (since the D N A  m utated was contained in pcD N A 3.1), or 
50pg am picillin for the control reactions, and the D N A  was prepared using standard 
molecular biology techniques. It was necessary to comm ercially sequence the cD N A  to 
determ ine whether the desired m utation was incorporated into the sequence (performed 
by Cytomyx, Cambridge, UK).
The m utagenic oligonucleotide primers were designed individually according to the 
desired m utation. Both the forward and reverse primers contained the desired 
m utation, annealing to the sam e sequence on opposite strands. The m utation was in 
the m iddle o f the primer, and they had a minimum GC content o f 40% and terminated  
in one or more G/C bases. Primers were between 25 and 45 bases in length with a T m of  
>78°C, whereby for a primer o f length N  bases:
T m= 81.5 +  0.41(%GC) - 615/N  - % mismatch
A typical m utagenesis reaction was prepared as below in a thin-walled PCR tube:
5pl lOx reaction buffer
Xpl (5-50ng) o f dsDNA tem plate
Xpl (125ng) o f olignucleotide primer 1
Xpl (125ng) o f oligonucleotide primer 2
lp.1 o f dN TP mix
ddFLO to a final volum e o f 50pl
lp l PfuTurbo D N A  polymerase (2.5U/pl)
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For the control reaction, 2pl (lOng) o f pW hitescript 4.5kb control plasmid (5ng/pl) was 
used as the tem plate.
Reactions were subjected to the following cycling parameters:
Step 1: 94°C for 30 seconds Initial denaturation
Step 2: 95°C for 30 seconds Denaturation
Step 3: 55°C for 1 m inute Annealing o f m utant primers to ssD N A
Step 4: 68°C for 2 m inutes per kB of Elongation o f m utant oligonucleotide
plasmid length primers
Cycle from Step 2 to Step 4 for 18 cycles
H old at 4°C
Following temperature cycling, lp l Dpn  I (10 units/pl) was added to each m utagenesis 
reaction, m ixed gently, spun in a micro-centrifuge for 1 m inute and then incubated at 
37°C for 1 hour to digest the parental supercoiled dsDNA.
Before transformation, the D N A  was glycogen precipitated to increase D N A  
concentration (important because >5 kb tem plates were used). Briefly, 2.4 volum es 
100% ethanol, 0.1 volumes 3M sodium acetate, lp l glycogen were added to the reaction 
m ixture, which was vortexed then incubated at -80°C > 30 m inutes. The m ixture was 
then thawed and centrifuged at 20,000g for 30 m inutes at 4°C to pellet the D N A . The 
supernatant was discarded and the pellet washed once with 250pl 70% ethanol and 
recentrifuged. The resultant pellet was resuspended in 5pl molecular biology grade 
water. 3pl D N A  was used to transform X L I-B lue com petent cells according to the 
m anufacturer’s instructions. The expected colony number for the control reactions was 
between 50-800 colonies and that o f the sample transformations 10-1000 colonies 
(dependent o f the base com position and length o f the D N A  tem plate employed).
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M utant strand synthesis 
DNA template denatured, 
mutagenic primers containing 
desired mutation anneal and 
extended
D pnl Digestion of Template
Parental methylated and 
hemimethylated DNA  
digested with Dpnl
Transformation
Mutant molecules 
transformed into competent 
cells for nick repair
Figure 2.2: The principles of site-directed mutagenesis
The following primers were used in site-directed m utagenesis to create point m utations  
in the sulphonylurea receptor o f the reconstituted vascular sm ooth muscle K a t p  
channel, K ir6.1/SUR2B:
T1345N F 5’-GGTGGGCATCTGTGGTCGAAATGGCAGTGGGAAGTCCTCC-3’
T1345N R 5’-GGAGGACTTCCCACTGCCATTTCGACCACAGATGCCCACC-3’
K1349R F S’-GGTCGAACTGGCAGTGGGAGGTCCTCCTTATCCCTGG-S’
K1349R R 5’-CCAGGGATAAGGAGGACCTCCCACTGCCAGTTCGACC-3’
R816Q F 5’-GAGTGGGGGTCAGAGGCAGCAAATCTGCGTGGCACGGGCAC-3’
R816Q R 5’-GTGCCCGTGCCACGCAGATTTGCTGCCTCTGACCCCCACTC-3’
_ J
/
\
\ \
• /
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R816K F 5’-GAGTGGGGGTCAGAGGCAGAAAATCTGCGTGGCACGGGCAC-3’
R816K R 5’-GTGCCCGTGCCACGCAGATTTTCTGCCTCTGACCCCCACTC-3’
K708A F 5’-GGCAAGGAGAAGAGATGATGCTCCACAACCCACTTGGCC-3’
K708A R 5’-GGCAGGGAGAAGAGATGATGCTCCACAACCCACTTGGCC-3’
K1349M F 5’-GCTCGAACTGGCAGTGGGATGTCCTCCTTATCCCTGGC-3’
K1349M R 5’-GCCAGGGATAAGGAGGACATCCCACTGCCAGTTCGACC-3’
DNA Sequencing
To check that the nucleotide sequence was not altered through m anipulating the  
cD N A , sequencing o f plasmid D N A  was achieved through a procedure based on the  
dideoxy nucleotide-m ediated chain-term ination m ethod (Sanger, Nicklen et al. 1977). 
A minimum o f 500ng purified plasmid D N A  per sequencing reaction or lOOng/kb 
purified product per reaction was sent to the D N A  Sequencing Service, CYTOM YX, 
along with the necessary pre-designed sequencing primers. The results were sent via  
email and the chromatogram files viewed using Chromas Version 2.31.
Primers to sequence single point m utations SUR2B:
R816Q/K seq: 5 ’-GGCTTACGCTGCCCAGAAGCC-3’
T1345N /K 1349R  seq: 5’-GCAGTGAAGAAAGTGAACAG-3’
Primers to sequence double point m utation in SUR2B:
K708A seq: 5 ’-GGATACTTCTCATGGGGC-3’
K1349M seq: 5’-CGATCTGTGTGTCAGATATG-3’
83
2.2 Cell culture
The m ajority o f m y studies were performed on immortalised eukaryotic cell lines. The 
H EK 293 cell line (obtained from Dr L Y  Jan, UCSF)  is an immortalised human cell line 
derived from primary embryonic kidney cells transformed with sheared adenovirus type  
5 DN A .
The HEK293 cell line 
Growth conditions and method of subculture and maintenance
Cells were grown and cultured in Minimum Essential Medium (MEM) containing  
Earle’s salts and L-Glutam ine (Invitrogen, U K )  supplemented w ith 1% Penicillin- 
Streptom ycin (from a stock o f lm g/m l streptom ycin and 10,000 units/m l penicillin) and 
10% Foetal Bovine Serum (Invitrogen, UK).  Cells were usually grown in a T75 (75cm2) 
tissue culture flask ( V W R , Merck House, U K )  in a humidified atmosphere o f  95% 
oxygen and 5% CO2 and typically  subcultured when 90% confluent. To passage cells, 
the culture medium was removed and the cells washed twice with Ca2+, Mg2+ free 
Dulbeccos’ phosphate buffered saline (Invitrogen, Paisley, UK).  Cells were detached  
from the flask via incubation for 2 m inutes at room temperature with 1ml 0.25%  
Trypsin (Invitrogen, Paisley, U K )  in PBS. To inhibit the tryptic activ ity , 3mls o f  
growth m edium was added and the cell suspension collected in 15ml falcon tubes 
(Sarstedt, U K ),  and centrifuged at 340g for 3 m inutes. Pelleted cells were resuspended in 
lOmls o f fresh medium, and 1ml o f the resuspension used to seed a new T75 flask. 
During log phase growth, the doubling time o f H EK 293 cells was around 24-36 hours, 
and therefore it was necessary to subculture once weekly. Fresh culture medium was 
applied every 3 days.
Production/revival of frozen stocks
Cells at 80-100% confluence were subcultured as described, but resuspended in culture 
medium containing 10% sterile D im ethyl Sulfoxide (Sigma, Poole, U K ),  and 1ml 
aliquots placed in cryogenic vials (V W R , Merck house, UK).  Cells were gradually  
cooled. A Nalgene freezing jar (V W R , Merck house, U K )  containing room tem perature
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isopropanol was initially used, and then the cryovials were placed in a -80°C freezer for 
6-12 hours before being transferred to liquid nitrogen for long-term storage. Cells were 
revived by rapidly thawing an aliquot at 37°C before inoculation o f a T25 (25cm2) tissue 
culture flask (V W R , Merck House, U K )  containing pre-warmed culture medium, which 
was replaced after 18-24 hours.
HEK293 cells subcloned with the K a t p  channel Kir6.1/SUR2B or Kir6.2/SUR2B
The cD N A  constructs encoding the K a t p  channel pore-forming subunits Kir6.1 or 
Kir6.2 were previously subcloned in pcD N A 3.1/zeo, likewise, the cD N A  encoding for 
SU R 2B  was previously subcloned into pcD N A 3.1. Since these vectors contain a gene 
encoding for resistance to Zeocin and N eom ycin respectively, cells made to stably  
express the K a t p  channel were doubly selected w ith both Zeocin and Geneticin (G418). 
Geneticin was employed since it is an analogue o f neom ycin sulphate. The zeocin 
resistance gene encodes a protein that binds stoichiom etrically to Zeocin and inhibits its 
D N A  strand cleavage ability, thus death only occurs in cells that are non-resistant. The 
stable lines were cultured in the same manner as described, except that MEM 
containing 10% FBS, 344pg Zeocin (Invitrogen, Paisley, U K )  and 727pg/ml Geneticin 
(G418) (Invitrogen, Paisley, U K )  was applied. Frozen stocks o f cells were produced and 
revived as previously described, but the culture medium o f those revived was replaced 
with G418/Zeocin medium 18-24 hours after revival.
CHO-K1 cell line
The CHO-K1 cell line was derived as a subclone from the parental CHO cell line 
initiated from the biopsy o f an ovary o f an adult Chinese ham ster (Puck 1957)and was 
obtained from the American Type Culture Collection (ATCC). Cells were grown in 
(Hams) F I 2 media (Invitrogen, Paisley, U K ),  supplemented with 10% fetal calf serum  
and 1% penicillin/streptom ycin and cultured, frozen and revived as described for the 
H EK 293 cell line.
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C2C12 cell line
This is a subclone o f the m ouse m yoblast cell line (Blau, W ebster et al. 1985), as 
estabbshed by D. Yajfe and 0 .  Saxel in 1977 (Yaffe and Saxel 1977). The C2C12 cell 
line differentiates rapidly, forming contractile m yotubes and producing characteristic 
muscle proteins. Treatm ent w ith the bone morphogenic protein 2 (BM P-2) causes a 
shift in the differentiation pathw ay from m yoblastic to osteoblastic. Cells were cultured 
as described, but it was im portant that they were passaged before reaching confluency  
as this would deplete the m yoblastic population in the culture. Cells were grown in 
MEM supplem ented w ith 10% FB S and 1% P/S.
Aortic and Cardiac Smooth Muscle Cell lines (AOSMC and CASMC)
These are primary hum an cell lines, comprised o f either normal aortic or cardiac cells, 
purchased in the third or fourth passage (for references refer to w w w.lonza.com ). 
Medium and reagents were obtained from Clonetics from CAM BREX. Sm ooth muscle 
cell basal medium (500ml) was supplem ented with 0.5m l hEG F, 0.5m l insulin, 1ml 
hFG F-B, 25ml FBS, 0.5m l giberellic acid (GA)-IOOO. Cells were subcultured when 70% 
to 80% confluent and contained m any m itotic figures throughout the flask (since they  
becam e irreversibly contact inhibited if  allowed to reach confluence). For a T25 flask, 
the m edium  was aspirated, and cells were rinsed with 5 ml o f room temperature H E P E S  
Buffered Saline Solution (H E PE S-B SS). Following aspiration, cells were covered with  
2ml Trypsin/ED TA  solution and trypsinisation allowed to occur until at least 90% of 
the cells were spherical. The trypsin was neutralized with 4m l room temperature 
Trypsin Neutralising Solution (TNS) and the cells transferred to sterile 15ml centrifuge 
tubes. The flask was given a final rinse with 2ml H E PE S-B SS to collect residual cells, 
which were added to centrifuge tube. Harvested cells were centrifuged at 220xg for 5 
m inutes to pellet the cells, all bar 100-200pl o f supernatant was aspirated. The 
remaining was used to resuspend pellet, then the cells diluted in 4-5ml growth medium  
(lm l per 5cm 2). lm l/5cm 2 o f growth medium were added to subsequent flasks, into  
which the desired volum e o f cells were dispensed then incubated at 37°C (5% CO2). 
Growth medium was changed the day after seeding and every other day thereafter.
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Cells under 25% confluency were fed w ith lm l/5cm 2, from 25-45% confluency  
1.5m l/5cm 2, and over 45% confluency 2m l/5cm 2. Cells were not cultured beyond eight 
passages.
Cells were cryopreserved in 80% Clonetics growth media, 10% FBS and 10% DMSO, 
which had been filter sterilised with a 0.2pm filter. Cells were harvested and 
centrifuged, and the pellet resuspended at 500,000 to 2,000,000 cells per ml. 1ml 
aliquots were pipetted into freezing vials and insulated in an isopropanol freezing 
canister. Cells were stored at -70°C overnight, and w ithin 12-24 hours placed in liquid 
nitrogen for long term storage. Cells were revived and returned to culture as quickly as 
possible w ith  minimal handling.
HL-1 Cardiomyocytes
The HL-1 cell line is derived from the AT-1 mouse atrial cardiom yocyte tumor lineage 
(Claycomb, Lanson et al. 1998). This was m aintained in Claycomb Medium (J R H  
Biosciences), which when supplemented w ith O.lmM norepinephrine (Sigma), 10% FBS, 
1% P/S and 4mM L-glutamine (Gibco Life Technologies, Paisley, U K )  will m aintain the 
m ature cardiom yocyte behaviour and differentiated phenotype.
Norepinephrine was made up in 30mM L-ascorbic acid. 80m g norepinephrine was 
added to 25ml acid, and the m ixture filter sterilised with a 0.2pM syringe filter, 
aliquoted into 1ml volumes and stored at -20°C. A 1ml aliquot was added per 100ml 
medium for a O.lmM final concentration. Soybean trypsin inhibitor was made from 
25mg inhibitor (Gibco Life Technologies, Paisley, U K )  dissolved in 100ml PB S, which 
was filter sterilised.
Flasks were pre-coated with gelatin/fibronectin (Difco, U K  & Sigma, U K  respectively) 
before culturing cells (2ml/T25). A sterile 0.02% solution o f gelatin was made, o f which 
199ml was added to 1ml of fibronectin and mixed gently. 6ml aliquots were frozen at -
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20°C. Coated flasks were incubated at 37°C overnight, and the gelatin/fibronectin  
removed before adding cells to flasks.
Cultures were split after full confluence. A T25 flask was rinsed with 3ml 0.05%  
trypsin/ED TA  (Gibco Life Technologies, Paisley, U K ),  then aspirated. An additional 
1.3ml trypsin ED TA was added, the culture incubated for 2 minutes at 37°C, then  
incubated for a final 5-8 m inutes w ith fresh tryspin/ED TA. The trypsin was 
inactivated w ith 1.3ml soybean trypsin inhibitor, and the cells transferred to a 
centrifuge tube. The em pty flask was additionally washed with 5ml o f Claycomb 
Medium (10% FBS, 1% P/S, 4mM L-glutam ine, O.lmM norepinephrine) and added to 
the tube, which was spun at 140xg for 5 m inutes. The subsequent pellet was 
resuspended in 3ml medium, and 1ml was transferred into each o f three T25 flasks 
containing 4m ls o f medium. Cultures were fed with 5ml medium/T25 flask every day.
W hen freezing cells, those harvested from a T75 were resuspended in 1.5ml freezing 
medium (95% FBS and 5% DM SO), transferred to a cryovial which was placed in a 
Nalgene freezing jar containing room temperature isopropanol, which in turn was 
incubated at -80°C. 6-12 hours later, the vial was transferred to liquid nitrogen. W hen  
reviving cells, aliquots were quickly thawed, then centrifuged for 5 m inutes at 1400xg 
and resuspended in 5ml medium before transfer to a T75 flask.
Transfections
The process o f introducing foreign D N A  into a cell line is known as a transfection. It 
was necessary to transfect K a t p  channel subunits into a heterologous system , such as 
the H E K 293 cell line, since once in the cytoplasm , D N A  is transported to the nucleus 
and, using the host cell’s transcriptional and translational m achinery, the encoded 
proteins are over-expressed. In the m ajority o f cells, the D N A  is m aintained  
transiently, since eventually the plasmid is lost as the cells continue to divide. In my  
studies, liposom e mediated gene transfer was used (Itani 1987) to transfect cells 
transiently, whereby com plexes form between positively charged lipids and negatively
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charged D N A  which can then fuse to the cell plasma membrane, facilitating the uptake  
of D N A  via endocytosis. Serum-free medium is used throughout, since serum proteins 
can interfere w ith the form ation of complexes. This m ethod is well characterised, and 
efficient transfections can be achieved with relatively small quantities o f D N A  (0.5- 
1.5pg).
Liposome based transient transfection procedure
Cells were subcultured as previously described, and seeded into 6 well tissue culture 
plates (w ith wells o f 35mm diameter) ( Triple Red, U K ) a t  the necessary cell density to 
reach 70% confluence w ithin 24 hours. For individual transfections 5pl of 2mg/ml 
lipofectam ine (a 3:1 w/w ratio o f the poly cationic lipid DO SPA and the neutral lipid 
DO PE in sterile water) (Gibco Life Technologies, Paisley, U K )  preincubated for 15 
m inutes w ith lOOpl Optimem serum free medium (Gibco Life Technologies, Paisley, U K )  
was added to a m ixture o f 0.8pg-2.0pg plasmid D N A  in lOOpl Optimem. The combined  
DN A-lipid m ixture was incubated at room temperature for 30 m inutes to allow  
com plex formation, and then a further 800pl Optimem added (final volum e 1ml). Cells 
were washed twice with optim em  to remove contam inating serum proteins, incubated  
in the transfection m ixture for at least 5 hours (typically  overnight), before the 
transfection m ixture was replaced with normal culture medium.
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2.3 Immunohistochemistry and immunofluorescence microscopy 
Imm unofluorescence m icroscopy involves the labelling o f antigens by antibodies 
labelled w ith fluorescent groups, and was developed by Coons and Colleagues in 1941. 
The fluorescent microscope em ployed illum inated the sample using epi-illum ination, i.e. 
the specimen was illum inated from the same side as the objective lens, and required a 
dichroic mirror to reflect the excitatory light onto the specimen, whilst transm itting the 
em itted light to the eyepieces. It is only when em ploying epi-illum ination that we can 
make quantitative analysis o f fluorescence. It om its the disadvantage o f reabsorption 
o f em itted light by the specim en, thus lowering the observed fluorescence intensity  
(which is possible at high fluorophore concentrations). Depending upon the fluorophore 
being studied, the excitatory and em itted light can be filtered by optical filters that 
only allow transm ission o f light o f certain wavelengths, whereby the emission filter 
ensures that only light em itted from the sample reaches the eyepiece, and the excitation  
filter ensures that only light o f the appropriate w avelength is incident on the sample in 
question. Slides were viewed under epi-fluorescence illum ination using a Zeiss Axiovert 
100M microscope (Zeiss Instruments, Jena, Germany). Samples were viewed at 400x 
m agnification using a Zeiss 40x (Plan-Neojluar oil immersion) objective w ith lOx 
eyepieces. The objective had a numerical aperture o f 1.41. The microscope was 
equipped w ith a filter set (X F66-1 multiband filter, Omega Optical, Brattleboro, Vermont, 
U SA), comprising a dichroic mirror and emission and excitation filters, which allowed 
the observation o f specimens double labelled w ith rhodamine and fluorescein 
conjugated fluorophores. The emission filter was fitted into a filter wheel (L U D L , 
Hawthorne, New York, USA), and the microscope was equipped with a monochrome 
digital camera (C4742-95, Hamamatsu, Japan)  with the facility to divert the light path  
fully to the camera aperture. Specimens were illum inated by a X enon short arc lamp 
( Ushio Inc., Japan)  integrated with a Polychrom e II monochromator ( T .I .L .L . , 
Photonics G M B H , Planegg, Germany) linked to the microscope via a specially designed 
epi-fluorescence condenser. The wavelength o f excitatory light was controlled via 
analogue voltage.
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A standard procedure for antibody staining o f cells for immunofluorescence microscopy 
was em ployed. The cells to be stained were subcultured and transfected as previously  
described and re-seeded onto 13mm glass coverslips (V W R , Merck house, U K )  in 6 well 
dishes, such that they were approxim ately 70% confluent for staining. All subsequent 
steps were performed at 4°C, and washes w ith PB S were of 10 minutes duration, unless 
otherwise stated. Cells were quickly washed twice with PBS (lOmM phosphate buffer, 
2.7mM KC1, 137mM NaCl, pH 7.4, obtained in tablet form from Sigma, Poole, U K )  and 
then fixed with 4% (v/v) paraform aldehyde solution for 20 minutes. The purpose o f  
fixation is to imm obilise antigens whilst m aintaining cellular structure and 
architecture. Form aldehyde creates a network o f interlinked antigens, via the reaction 
of aldehyde w ith amino groups. Cells were further washed twice w ith PBS, and then  
cells requiring permeabilisation (to allow access o f the antibody to the intracellular 
epitope) were incubated with PB S + 0.2% Triton X -100 (Sigma, Poole, U K )  for 20 min. 
Cells were aspirated then incubated in blocking solution (2% BSA, 5% goat serum in 
PBS) for lh r  to block non-specific protein binding sites, w ith the addition o f 0.1%  
Triton-X  to permeabilised cells. Cell-coated cover slips were transferred to humidified 
chambers. Primary and secondary antibodies were diluted in blocking solution  
(containing 0.1% Triton-X for incubation with permeabilised cells) and aggregated 
material removed via centrifugation at 20,800xg. Cells were incubated with a 1:500 
dilution o f mouse monoclonal HA primary antibody (Covance, U K )  for lh r , then  
washed four tim es with PBS. Cells were then incubated with a 1:300 dilution of goat 
anti-m ouse IgG fluorescein conjugated secondary antibody (Chemicon International) in 
the dark at room temperature for lhr. After a final set o f four washes with PB S at room  
tem perature, the cover slips were air-dried in the dark and mounted with Vectrashield 
(Vector Laboratories). Slides were stored at 4°C and viewed using a computer-based  
image analysis system  (O P E N L A B  3.1; Improvision, Cambridge, U .K .) .
The im m unohistochem istry results obtained are based on the use various derivatives o f  
the anti-H A  antibody to optim ize surface staining. Initially double staining, involving  
the rat anti-H A  (3F10, Roche) antibody followed by either Fluorescein (FITC)-
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conjugated AffiniPure goat anti-rat IgG (Jackson ImmunoResearch Labs, inc.) or A lexa  
Fluor 488 goat anti-rat IgG (Molecular Probes) was employed to detect over-expressed  
HA-tagged protein. In an attem pt to optim ize staining the second generation mouse 
monoclonal H A .11 antibody (Covance) followed by a goat anti-m ouse IgG fluorescein 
conjugated secondary antibody (Chemicon International) was em ployed, as was a anti- 
HA-Fluorescein high affinity (3F10) conjugate (Roche). The later, (a monoclonal 
antibody whose high affinity and low working concentrations resulted in less cross- 
reactivity than other antibodies to the H A-epitope) was found to give preferable 
staining. Thus, all im m unohistochem istry was repeated with this conjugate and 
confirmed the results obtained from prior staining.
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2.4 Procedure for Rubidium-86 (86Rb+) efflux in cultured cells 
Rb+ is an ideal tracer for potassium  channels as it is similar in size, has the same charge 
as potassium  and potassium  channels are permeable to it. Since it is not present in 
biological system s, it is an easy target to detect adding no residual background noise to 
the experim ent. The cell-based 86R b+ efflux assay for the functional analysis o f native  
and recom binant ion channels works on the basis that, when cells are loaded for 
rubidium (a tracer for potassium ), the rubidium distribution between intracellular and 
extracellular space subsequent to channel activation can be determined via the 
m easurem ent o f Cherenkov radiation. The relative am ount o f rubidium in the cell 
supernatant is a direct measure o f channel activ ity . Thus this assay can provide a 
sim ple and relatively inexpensive screening assay for K+ conductance in cultured cells 
to assess the effects o f agonist, blockers, or genetic m anipulations.
Experim ents were conducted in an area designated for handling 86Rb+, behind a shield 
designed to minimise exposure to B- radiation and whole body dosimeters were worn to 
measure cum ulative 86R b+ exposure per m onth. The risk o f contam ination via spillage 
was monitored throughout each experim ent using a Geiger-Mueller detector and waste 
was isolated in sealed, shielded containers for decay. All experim ental m anipulations 
were conducted at room temperature. H EK 293 cells were subcultured and seeded in 6- 
well plates, then transfected (when around 70% confluent) as previously described. It 
was necessary to obtain a transfection efficiency o f at least 80%, and this was 
monitored by sim ultaneous transfection with eGFP. The cells were loaded w ith culture 
medium (2mls/well) containing 0.037M Bq m l'1 86Rb+ overnight in a perspex box at 37°C 
(Shyng, Ferrigni et al. 1998). The following day, the loading medium was removed and 
the cells washed 3 times with 2ml of H E P E S Buffered Saline (HBS) assay medium  
(lOmM H E P E S, lOmM Glucose, 130mM NaCl, 7mM KCL, 2mM CaCh and ImM  
MgCh), pH 7.4. For the tim e course assays, 2ml o f H BS containing either an 
opener/inhibitor o f the K a t p  channel were added per well, the timer im m ediately  
started, and at each desired tim e point 300pl aliquots o f assay medium removed and 
placed into 6ml polyethylene scintillation vials (Packard Biosciences). For experim ents
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whereby one tim e point was exam ined, the entire 2ml o f medium was removed. A t the 
end o f each experim ent, the reaction was stopped via the addition o f 1ml o f H BS plus 
2%  triton to each well for 2 m inutes. The lysates were collected and placed in 
scintillation vials. It should be noted that when investigating the effect o f AM PK  
inhibitors and activators, PK A inhibitors and adenosine receptor antagonists on the 
response o f the K a t p  channel under m etabolic inhibition (Fig 3.13), cells were initially  
incubated for 15 m inutes with the activator/inhibitor, then incubated for an additional 
15 m inutes in com bination w ith the m etabolic inhibitors (activators/inhibitors of  
signalling pathw ays are relatively slow-acting). NaCN and 2-DG were added from a 
concentrated stock to the total volum e o f incubation buffer, so as not to affect the final 
concentrations o f activators/inhibitors.
All vials were assayed for 86R b+ content by m easurement o f Cherenkov radiation in a 
liquid scintillation counter (TriCarb, Packard 2000CA). Cherenkov radiation is refers to 
the electrom agnetic radiation em itted when a charged particle passes through an 
insulator at a speed which exceeds that at which light passes through a vacuum . This 
can be expressed as:
v >v, =  c/n,
n = refractive index of the medium  
c =  velocity  o f light in the medium  
V| = threshold velocity
The percentage efflux at each tim e point was calculated as the cum ulative counts in the 
aspirated solution divided by the total counts from the solutions and the cell lysates, i.e.
86R b+ content o f the medium  
(86Rb+ content o f the medium + 86R b+ content o f the cells)
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R ead in gs o b ta in ed  from  th e  sc in tilla tio n  co u n ter  w ere in itia lly  transferred  to  and  
an a lysed  in  M icrosoft O ffice E x ce l 2 0 0 3 , th en  fu rth er a n a lysed  in  G rap h P ad  P rism  4  
(refer to  general a n a ly sis  sectio n ).
Transfect Channel
expression
Load cells with 86Rb for 24h
— i -----------------------------
*  *  *  ■J. .
■ ■ ■
Measure 86Rb efflux Apply drugs
Figure 2.3: M easurement of 86R b + efflux of transfected HEK293 cells. Cells were loaded
overnight w ith 0.037MBq m l'1 Rubidium -86 in six-well plates. The following day, cells were 
washed several times with HBS and incubated w ith the relevant drug for 15 m inutes. The 86R b + 
content of the supernatant and the cell lysate was assayed by measurem ent of Cherenkov 
radiation in a liquid scintillation counter.
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2.5 The Patch Clamp technique
Electrophysiology
Experim ents using the voltage clamp technique have revealed m any o f the properties o f 
ion channels. This was first developed by Cole, and Hodgkin and Katz in 1949 to allow  
an electrophysiologist to measure the ion currents flowing across a cells membrane 
using two electrodes and a feedback circuit. The squid giant axon was the first 
preparation that could be used to do this.
Basically, two electrodes are placed inside a cell. Transmembrane voltage is recorded 
through one o f these electrodes (the voltage electrode) relative to an outside, ground 
reference. The second electrode is used for passing current into the cell. Briefly, a 
specified holding voltage is m aintained across its membrane, and anytim e the cell 
makes a deviation from this holding voltage, for exam ple, by passing an ion current 
across its membrane, the operational amplifier generates an error signal. The error 
signal is the difference between the holding voltage specified by the experim enter and 
the actual voltage of the cell. The feedback circuit o f the voltage clamp passes current 
into the cell (via the current electrode) in the polarity needed to reduce the error signal 
to zero. Thus, the current is applied in the polarity opposite the current that the cell is 
passing across its membrane, and the clamp circuit provides a current that is the mirror 
image o f the cellular current. This mirror or clamp current can be easily measured, 
giving an accurate reproduction o f the currents flowing across the cell’s membrane 
(albeit in the opposite polarity).
Several variations of the voltage clamp technique were developed to accom m odate 
biological cells that were too small to accept giant electrode assemblies used in the squid 
giant axon. The developm ent o f the gigaseal and patch-clamp m ethods by Erwin Neher 
and Bert Sakmann in 1975, contributed to a profound advance in electrophysiology. 
They discovered that a clean fire-polished glass pipette could fuse with a clean cell 
membrane, creating a seal o f great mechanical stability and exceptionally high 
electrical resistance (Ham ill, Marty et al. 1981).
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The patch clamp technique
This technique is a variation of the single electrode voltage clamp, whereby a single 
electrode is placed in contact w ith the intracellular com partm ent of a cell. That single 
electrode serves both the voltage-recording and current-passing duties that are 
performed by two separate electrodes in two-electrode clamp. A miniature glass micro­
pipette (the patch-clam p electrode) is pressed against the cell membrane, and a piece of 
membrane (the ‘patch’) is positioned within the pipette orifice. A tight seal o f gigaohm  
electrical resistance (a ‘gigaseal’) is formed between the pipette rim and the cell 
membrane, and if the patch contains ion channels m ovem ent o f ions through these 
channels is measured as tiny (picoampere) currents. Due to the high resistance o f the 
gigaseal, the leak current across the seal is insignificant.
Specifically, five configurations m ay be employed:
(1) Cell-attached (on-cell): the pipette makes a gigaseal with the intact cell allowing  
measurements o f single-channel currents.
(2) Inside out: upon cell-attached configuration the pipette is withdrawn while the 
gigaseal is maintained. The inside (cytoplasm ic) side o f the membrane is facing the bath  
fluid. This configuration is used for single-channel recordings w ith the ability to change 
the intracellular solution.
(3) Whole-cell: The average current across the entire surface area o f one cell is measured; 
whereby upon cell-attached configuration vigorous suction (or brief high-voltage  
pulses) is applied to the pipette causing the patch to break. The cytoplasm  and the 
pipette solution are subsequently in direct contact, and after a short time diffusion o f  
cytoplasm ic constituents (molecules and cell organelles) results in identical 
(unphysiological) chemical com position o f the fluids in the cell and in the pipette. In 
this configuration the activ ity  o f all membrane ion channels are measured.
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(4) Outside out: from whole-cell configuration the pipette is gently withdrawn. This 
causes the membrane to break outside the sealing zone. The membrane fragments 
subsequently flip over, reseal, and constitute an inverted membrane patch exposing the 
extracellular side to the bath fluid. This configuration is used for single-channel 
recordings.
(5) Perforated whole-cell: cell-attached configuration is achieved with pore-forming 
compounds (amphotericin B , nystatin) in the pipette solution, which cause perforation  
of the patch allowing small m olecules and ions, but not larger compounds, to cross the 
patch. Consequently, larger m olecules and cell organelles remain within the cell. As 
with conventional whole-cell patch clamp the sum o f all ion channel currents is 
measured.
In m y experim ents, whole cell patch clamping and perforated whole cell patch clamping 
techniques were implemented to measure the average current across the entire surface 
area o f one cell, as exemplified in figure 2.4.
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Figure 2 .4 : The five configurations of the patch-clam p technique. All m ethods sta rt w ith the  
formation of a gigaohm seal between a fire polished patch pipette and the cell m em brane. 
U nitary  currents may be recorded in this cell-attached configuration. F urther m anipulation of 
the patch pipette allows recordings from a small patch of the m em brane in the inside-out or 
outside-out configurations, or from the whole cell under voltage clamp. The inclusion of 
am photericin B in the patch p ipette solution of a cell-attached patch leads to the formation of 
small pores in the membrane beneath the patch p ipette which will pass anions and cations, but 
not o f larger molecules, perm itting voltage clam p of the whole cell (adapted from  Hille; 1992).
The patch-clamp recording setup used in my experiments
N o n -e lec tro n ic  eq u ip m en t for th e  recording o f  w h o le-ce ll currents w as m o u n ted  on  an  
a n ti-v ib ra tio n  tab le  (a p latform  w ith  m in im al m ech an ica l in terferen ce), and  e lec tr ica lly  
sh ielded  b y  a cage. Cells w ere su b cu ltu red  o n to  glass coverslip s (10mm diameter, 
borosilicate glass; V W R , Poole, U K ) th at w ere transferred to  th e  recording ch am b er  
(15m m  diameter; Series 20 Perfusion chamber; Warner Instruments Inc., Ham den, U SA ). 
F or w h o le  cell p atch  clam p in g , th is  w as co n tin u o u sly  perfused to  a d ep th  o f  1 .5 -2 .5m m  
w ith  h igh  K + ex tern a l so lu tio n s  (140m M  KC1, 2 .6m M  CaC b, 1.2m M  M gC b, 5m M  
H E P E S , pH  7.4) by a stan d ard  g ra v ity -d r iv en  perfusion  sy stem  a t a rate  o f
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approxim ately 3ml/min, or a sewer pipe perfusion system  (E V H -9 , Biologic Science 
Instruments) that was positioned over the cell under investigation. For the perforated 
patch clam p m ethod the bath solution contained (in mM) 130 NaCl, 5.42 KC1, 16 
H E PE S, 2.5 CaCh and 1 MgCl2 (pH 7.4). An Ag/AgCl interface was applied to the  
m icropipette electrode. A comm ercially available Ag/AgCl grounding electrode (Axon  
Instruments) was used to earth the bathing solution; an agar/KCl salt bridge, immersed 
in 3M KC1, was used to keep it continuous with the bath solution and to ground the 
bath solution. All recordings were made relative to ground. A conventional inverted  
microscope (Zeiss, Axiovert 25), to which a mercury light source (H B O , 100 W) was 
attached, was used, and on which the recording chamber was mounted. To minimise 
exposure o f the cell to UV  light, a shutter apparatus was used. Fluorescent light 
em itted on exposure o f the cell was filtered through a fluorescein filter set, and then  
directed up through the objective into the microscope eyepieces. Since all recordings 
were o f whole-cell membrane current, the electrode was connected to a unitary voltage  
gain headstage amplifier (H S-2; Axon Instruments, Union City, CA, USA)  containing a 
10MQ resistor. Signals were further amplified by an Axopatch 200B amplifier (Axon 
Instruments), converted from analogue to digital signals by a Digidata 1200B converter, 
and captured and analysed using pClamp software (version 6.0; Axon Instruments). 
Voltage com m ands were generated using pClamp6 software.
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Figure 2.5: Configuration of patch-clamp recording setup. For whole cell recordings, the 
electrode was connected to the headstage amplifier, and the current resolution was determined 
by resistance feedback via a 10MQ resistor in the headstage. Voltage commands were 
performed via pClamp6 software. Signals were further amplified by an Axopatch 200B 
amplifier, and filtered at 500 Hz. Signals were sampled at 1 kHz by a Digidata 1200B converter 
before capture on a computer hard disk.
Application of the whole-cell configuration of the patch clamp
Using a horizontal pipette puller (DM Z-Universal Puller; Zeitz Instruments, Munich, 
Germany) patch pipettes were pulled from filam ented 1.5mm O .D .x l.l7m M  I.D . 
borosilicate glass (Clark Electromedical; Harvard Apparatus, Edenbridge, U K )  and each 
m icropipette tip  fire-polished. M icropipette tips had resistances o f 2.5-3.5 MQ when 
back-filled with pipette solution (107mM KC1, 1.2mM MgCh, ImM CaCb, lOmM 
ED TA , 5mM H E PE S, 0.5mM U D P N a salt, ImM ATPM g salt). The pH o f the pipette  
solution was adjusted to 7.2 using KOH, resulting in a total K+ concentration of  
~140mM. lOOmls were made up at a tim e, filter-sterilised and stored at -20°C as 1ml 
aliquots. A fresh aliquot was defrosted on the day o f each experim ent and incubated on 
ice to prevent the breakdown o f ATP. After filling, the tips o f the patch pipettes were 
coated w ith  Parafilm/mineral oil suspension to reduce the capacitance o f the tip. The 
patch pipette was positioned and lowered over the cell under investigation in the
101
recording chamber using a fine micromanipulator (Sutter Instruments, Navato, CA, 
U SA)  until the polished tip came into contact with the cell membrane. Gentle suction  
was applied via a 2ml syringe until a seal o f high electrical resistance (2-10GQ) was 
obtained. Following a 30-60 second equilibration period, sharp suction was applied and 
the membrane patch consequently ruptured, bringing the contents o f the pipette  
solution into contact with the cell cytoplasm . Cell capacitive transients, indicative o f a 
successful breakthrough, were cancelled via the patch clamp amplifier (whereby a good 
cell capacitance in com bination w ith a low series resistance resulted in a large, quick 
transient). Current-voltage relationships were im m ediately performed to establish that 
the currents were present. Reversal potential was applied by exposing the cell to 
sym m etrical K + solutions and m aintaining a holding potential of OmV at which no net 
current was passed. Current-voltage relationships were monitored over an equilibration  
period o f approxim ately 10 m inutes, during which tim e leaky cells were discarded. 
Thereafter cells were voltage clamped at -lOOmV and agonist/antagonist induced 
currents measured at this holding potential. All recordings o f membrane current were 
made at room temperature.
Application of the perforated whole-cell configuration
The sam e basic procedure was followed as for the whole cell configuration, however 
after a seal (of around 2GQ or above) was obtained, the amphotericin in the patch  
pipette was responsible for perforation o f the cell and to achieve the whole cell 
configuration (without any additional suction). On adjusting the pH with KOH, the  
pipette solution contained (in mM) ~135 KC1, 5 NaCl, 10 EGTA, 10 H E P E S, 1 CaCh 
and 2 MgCh (pH 7.4). 6mg o f purified am photericin B from streptom yces species 
(Sigma) was dissolved in lOOp.1 fresh DMSO, o f which 3.3pl was diluted in 1ml o f pipette  
solution to obtain a working concentration o f (+ /- 20%) 120pg.ini*1. This was sonicated  
before use to ensure complete dilution of the amphotericin. Pipettes were pre-dipped in 
regular pipette solution for around 10 seconds, then back-filled with amphotericin- 
containing pipette solution. A seal was obtained at OmV (as previously described) and 
around ten m inutes allowed for the amphotericin to perforate the cell. A ramp protocol
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was subsequently employed to obtain recordings, at which agonist/antagonist induced 
currents were logged at +50m V . Again, all recordings were made at room temperature.
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Figure 2.6: Perfusion of the patch-clamp recording setup. Solutions were supplied by both a 
standard gravity-driven and fast perfusion system, which was positioned over the cell of 
interest. A vacuum pump was used to remove solutions from the chamber, which was earthed 
by an Ag/AgCl electrode to a waste container. An electrode with an Ag/AgCl interface was also 
used to make recordings of whole cell currents.
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Whole cell capacitance and Series Resistance Compensation
The cell membrane acts as an efficient capacitator, and a significant current injection is 
required to charge the membrane capacitance and to step the membrane to a new  
potential. The tim e course o f the membrane potential change in response to a step in 
current is given by the membrane tim e constant ( t m ) .  I f  the series resistance is known, 
(the resistance in series w ith the cell membrane and current-passing electrode, in 
addition to the resistance o f the cell membrane), the cell membrane capacitance ( C m ) 
can be calculated as follows:
Cm =  XM/Ra,eff
Ra refers to the access resistance o f the pipette (the sum o f the m icropipette resistance 
and residual resistance o f the ruptured membrane patch and the cytoplasm ) and Ra, eff 
refers to the effective value o f Ra after series resistance compensation. An estim ate o f  
the membrane area (A) can be made from the value o f the cell membrane capacitance in 
picofarads (as read from the amplifier), since m ost biological membranes have a 
capacitance close to l.OpF/cm 2. In the subsequent experim ents, all current amplitudes 
were corrected for cell size, and are expressed in picoamperes per picofarads (pA/pF).
A potential difference o f IpxR a,eff is generated when a current (Ip) flows from the 
pipette into the cell through the series resistance. A true potential o f the cell membrane 
can only be obtained on extraction of this potential difference from the command  
potential, since series resistance can contribute a considerable error in whole-cell 
recordings, particularly when currents are large. W hen either the current or voltage is 
clamped, both series resistance and membrane resistance (hence membrane 
capacitance), can be directly calculated; for example:
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Vstep
V=o \  Voltage command
Current
R a,eff — V step/I Cm — TM/Ra,eff
In the voltage clamp mode, this represents the current response to a small voltage step. 
The current transient decays exponentially w ith a tim e constant, Tm, and therefore, 
R a,eff and Cm can be calculated. R a,eff also affects the tim e resolution o f the whole-cell 
patch clam p, whereby in voltage-clam p, application o f a small voltage step will 
generate a transient current that decays exponentially. This is equal to the product o f  
the series resistance and membrane capacitance ( t m  — R a,eff x Cm).
In these studies, the series resistance compensator on the amplifier was used to add 70% 
of IpxR a,eff to the voltage comm and, and to partly rectify the error (since the 
com pensation circuitry is prone to self-am plifying destabilisation, this degree o f  
com pensation was a good result). As described, the whole-cell capacitance was also 
measured using the analogue circuitry of the amplifier by cancelling out a current 
transient in response to a step in voltage.
105
Nernst Equilibrium Potential and Reversal Potential
In a biological membrane, the reversal potential (or Nernst potential) o f a particular ion 
is the membrane voltage at which there is no net flow o f ions from one side o f the 
membrane to the other. For a single-ion system  only, reversal potential is synonym ous 
with equilibrium potential, and their numerical values are identical. The two terms 
sim ply refer to the two aspects o f that potential difference. Equilibrium  refers to the 
fact that the net ion flux at that voltage is zero (that is, the outward and inward rates 
are the same; the flux is in equilibrium). Reversal implies that perturbation o f the 
membrane potential on either side o f the equilibrium potential reverses the net 
direction o f the ion flux. The Nernst Equilibrium Potential is given by:
Ek = (RT/ZF) (ln[ion+]o/[ion+]i)
where R is the gas constant (8.315 J K ^ m o l1), T is the absolute temperature on the 
Kelvin scale, F is the Faraday constant (9.648 x 104 C m ol1), Z  is the valency o f the ion 
(for K+ this is 1), In is the natural logarithm , and [ion] is the extra or intra-cellular 
concentration of the ion concerned. For K+ the potential will be named EK.
The [K +]o is around 5mM in physiological extracellular solution, and the [K +]i is 
approxim ately 130mM. The calculated EK value at 25°C is -83.7mV and at 37°C is - 
87.1m V. In the whole cell patch clamp studies, sym m etrical K+ ion concentrations 
were used: [K+]o — 140mM and [K+]i = 140mM. The calculated E* value at 25°C is OmV. 
In m any excitable cells, since the membrane is permeable to m any other ions, the 
reversal potential (Erev) m ay not be the same as the equilibrium potential. However, 
for electrically quiescent H EK 293 cells stably expressing the K a t p  channel, EK = E rev. 
This is because the cells are over-expressing a channel that is selective to one species o f 
ion (K +), and the voltage inside the cell will equilibrate to the reversal potential o f K +. 
In perforated patch clamp studies, physiological conditions were applied, i.e. [K +]i = 
135mM and [K +]o = 5.42mM, and the calculated EK value at 25°C is -82.6mV.
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2.6 General data analysis
All data are presented as mean +/- SEM, whereby n indicates the number of cells from 
which a recording was taken. The mean, p, is given by: Y.% /N
where % is the value o f each sample, and N is the size o f the sample. The standard 
deviation CT is given by: V (Z(X"P)2/N)
The standard error o f the mean is given by: a  / VN
D ata were analysed using GraphPad Prism 4 for windows (GraphPad Software, San  
Diego California U SA, w w w .graphpad.com).
Since three or more groups o f data were compared, significant differences were tested  
for by em ploying the one-way ANOVA, and where appropriate either the D u nnett’s or 
Bonferroni post-test. ANOVA depends on the assum ption that the populations all have 
the same variance (the B artlett’s test for equal variances was used to test this 
assum ption using GraphPad Prim). The decision to apply a post test was conditional 
on the reported value o f the B artlett’s statistic, and secondly on whether the reported 
value was less than 0.05. Both are m odifications o f the t test that account for m ultiple 
comparisons. The D unnett’s test was widely used in m y analyses to compare the 
various data sets to the control data set o f any given experim ent. The Bonferroni test 
for ‘selected pairs o f columns’ was used less frequently on comparison o f selected data 
sets. Significant differences are indicated as follows: * indicates P  < 0.05, ** indicates P  
<0.01 and *** indicates P  <0.001.
Traces obtained from patch clamp recordings were initially opened and analysed using 
Clampfit 9.0, Axon Laboratory pClamp9.0 to visualise both variations in current and 
voltage with time for the individual sweeps. Representative IV plots for individual
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experim ents were produced in pClamp9. Representative traces for individual 
experim ents were produced by importing data from pClamp9 into Microcal Origin 6.0, 
whereby current (nA) was plotted against tim e (ms). Traces were then opened with  
Adobe Photoshop Elem ents 3.0 and further manipulated. For perforated patch clamp 
and whole cell patch clamp data, current density was calculated at +50m V (pA/pF) and 
-lOOmV (pA/pF) respectively. This was measured for individual sweeps (determined on 
opening data in pClamp 9.0) under any given condition, and data analysed as described 
in GraphPad Prism 4.
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Chapter Three
Characterization o f  K ATP channel current in response to 
metabolic inhibition and signalling pathways
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Chapter Three: Results
Characterization of K a t p  channel current in response to metabolic inhibition 
and signalling pathways
The rubidium flux assay was one o f the principle techniques em ployed in this thesis as a 
screening tool for K a t p  channel functionality. Flux assays utilize ion channel kinetics 
to measure tracer element m ovem ent, in order to dem onstrate functional compound  
interactions, and are becoming increasingly popular as tools for screening com pounds. 
In an optim ized flux assay, m odulation o f ion channel activ ity  m ay produce readily 
detectable changes in radio labeled ionic flux. In fact, technologies based on flux assays 
are currently available in fully autom ated, high throughput format for efficient 
screening. Industrial application o f this assay has shown to be sensitive and precise; 
giving reproducible measurements and accurate drug rank orders which m atch those o f  
patch clamp data. 86R b+ is an ideal tracer for potassium  channels as it is similar is size, 
has the same charge as potassium  and is permeable in potassium  channels. 86R b+ is not 
present in biological system s, and is therefore an easy target to detect adding no 
residual background noise to the experim ent. For more detail please refer to 
m ethodology chapter.
Since this assay has been well characterized (Koster, Sha et al. 1999; M attheakis and 
Savchenko 2001; X u, W ang et al. 2001), it was em ployed to gain more insight into the 
function o f the K a t p  channel. Initial experim ents involved optim ization o f the assay in 
relation to the cell system  em ployed. It was necessary to determ ine optim al 
concentrations o f drugs to establish differences in functionality o f m utated versions o f  
the channel, to establish an utilizable degree o f sensitivity o f the assay, and to establish  
a tim e point at which differences in pharm acology o f the channel would be optim al 
after the addition o f isotope to the cells. H EK 293 cells stably expressing  
K ir6.2/SU R 2B and K ir6.1/SUR 2B were initially employed to achieve these aims. Time 
course assays were conducted, in which the 86R b+ efflux was measured in assay medium
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extracted from cells every 5 m inutes for a total o f 30 m inutes from the addition o f the 
drug, to establish the linear phase o f efflux. Both known KCOs and KCBs were applied 
to the cells to assess pharmacological activ ity . Response o f the channel to m etabolic 
inhibition was also assessed (since one objective o f this thesis was to assess any 
difference in channel regulation under m etabolic depletion). Instead o f rem oving  
oxygen and glucose from cultures, pharmacologic blockade o f m etabolism  was used to 
stim ulate ischemic conditions, providing a rapid and controllable loss o f ATP. Sodium  
cyanide (INaCIN) and 2-deoxy-glucose (2-DG) were used in com bination to induce 
m etabolic inhibition.
The toxicity  o f NaCX results from the high affinity o f cyanide for certain sulfur 
com pounds and m etallic com plexes. The cyanide ion can rapidly combine with iron in 
cytochrom e oxidase a3 (a component o f the cytochrom e aa3 or cytochrom e oxidase  
com plex IV of the electron transport chain in m itochondria) to inhibit this enzym e, 
thus uncoupling mitochondrial oxidative phosphorylation and inhibiting cellular 
respiration, even in the presence o f adequate oxygen stores. Cellular m etabolism  shifts 
from aerobic to anaerobic, with the consequent production o f lactic acid (R ay. Monroe 
et al. 1991). 2-DG abolishes ATP generation through the glycolytic pathw ay. 2-DG is 
an analogue o f glucose and is able to bind to and suppress hexokinase II. an enzym e  
that catalyses the initial m etabolic step in the conversion o f glucose to glucose-6- 
ph osphate during glycolysis. Inhibition o f this rate-lim iting step by 2-DG causes a 
depletion o f [ATP]i and leading to blockage o f cell cycle progression and cell death in 
vitro (X u. Pelicano et al. 2005). This may also involve insufficient ATP supply for N a+- 
K + pump activity. G lycolysis has been shown to preferentially provide ATP for the 
N a+-K + pump, and when ATP supply is inhibited with 2-deoxyglucose, N a+-K + pump 
activ ity  is reduced (Glitsch and Tappe 1993).
The resultant decrease in intracellular ATP on the addition o f m etabolic inhibitors 
opens K a t p  channels. Pinacidil was the KCO applied to the Kir6.2/SL R2B stable cell 
line, and levcromakalim to K ir6.1/SLR 2B expressed in IIEK 293 cells since these have
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found to be the most effective agonists for each (refer to Introduction, section 1.2). 
The results represent the cum ulative data obtained from three experim ents, and each 
drug was applied to three wells (of a six well plate) per experim ent, therefore the 
average 86R b+ efflux deducted at each tim e point for each drug is effectively taken from 
9 samples.
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Figure 3.1: 8r,R b+ efflux time course assay on H EK 293 cells stably transfected with the
potassium channel K ir6.1/SUR2B (A) & (B), stably transfected with K ir6.2/SU R 2B (C) & (D) 
and transiently transfected with K ir6.1/SU R 2B (E) & (F). Efflux was measured every 5 
m inutes from the addition o f the drug, for a total o f 30 minutes, and was calculated as % efflux  
o f initial 86R b+ content. The KCOs pinacidil and levcromakalim were applied to the 
K ir6.2/SUR2B and Kir6.1/SUR2B cell lines respectively. The control represents DMSO diluted  
in H BS. The same control is shown for each pair o f results, which represent data obtained from  
the same experim ent. Data are shown as + /- SEM, whereby n= 9.
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It is apparent that, in the case o f cells both stably and transiently expressing the K a t p  
channel, the KCO levcromakalim or pinacidil increased rubidium efflux (reflecting 
channel opening), whereas glibenclam ide reversed this effect. This was the case when  
the channels were m etabolically inhibited, and glibenclamide reversed the observed  
increase in efflux. The concentrations o f drugs applied are those that have been shown  
to be efficient on this cell line (Cui, Giblin et al. 2001; Cui, Tran et al. 2002; Quinn, 
Giblin et al. 2004; M uzyamba, Farzaneh et al. 2007), as has the com bination of  
m etabolic inhibitors applied (K am ouchi. Van Den Bremt et al. 1997). The control 
assay shows that the cells, stably and transiently expressing either potassium  channel 
had a basal level flux. It was necessary to transiently transfect cells, since future assays 
were to utilize H EK 293 cells transiently transfected with recom binant channel protein. 
It was necessary to achieve and m aintain a robust transfection efficiency (of at least 
80%) in each well to generate a signal that was sufficiently detectable with this assay, 
and to effectively detect changes in efflux levels in response to different 
pharmacological agents. Again, for this experim ent (and unless stated otherwise, all 
subsequent experiments) three wells o f cells were individually transfected for the  
application o f each drug per experim ent, which were repeated three times (unless stated  
otherwise), therefore data are shown as + /- SEM , whereby n=9. The data is 
summarized below, at a single time point, whereby response o f the K a t p  channel to 
openers and closers was measured at the linear phase (approxim ately 15 m inutes after 
addition). From the previous figure we can deduce that at this tim e point a m axim al 
difference between effluxes for each condition was generally achieved.
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Condition
% Mean Efflux
> Kir6.1/SUR2B (transiently exp ressed )
Kir6.2/SUR2B (stably ex p ressed )
Kir6.1/SUR2B (stably ex p ressed )
Ml + lO|iM Glib
2.5mM NaCN + 20mM 2-DG (Ml) 
10nM Pin/Lev + 10|aM Glib 
10nM Pinaddil/Levcromakalim 
Control
Figure 3.2: Summary o f the effects o f variation in pharm acology on the K a t p  channel, 15
m inutes after application of the K v r p  channel opener/closer. 86R b+ efflux was measured in 
K ir6.1/SU R 2B and Kir6.2/SUR2B stable lines, and on cells H EK 293 cells transiently  
transfected with K ir6.1/SUR2B. Efflux was calculated as %  efflux o f initial 86R b+ content. 
The KCOs pinacidil and levcromakalim were applied to the Kir6.2/SUR2B and K ir6.1/SU R 2B  
cell lines respectively. The control represents DMSO diluted in HBS. Data are shown as + /- 
SEM, whereby n=9. *** PcO.OOl compared to control, (ns) P>0.05 compared to control.
It is ap p aren t th at after 15 m in u tes , s ig n ifica n t d ifferences in  ch an n el p h a rm a co lo g y  are 
observed  in  b o th  H E K 2 9 3  cells w h ere th e  ch an n el is exp ressed  s ta b ly  and tra n s ien tly . 
T herefore, for all fu ture ex p er im en ts , 86R b + efflu x  w as m easured  at th is  t im e  p o in t to  
assess p h arm aco logy . In  in itia l exp er im en ts , g lu cose  w as o m itted  from  th e  H B S , b u t
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this was found not to affect channel functionality (data not shown). Therefore, for all 
subsequent experim ents glucose was included in the H BS since its inclusion was more 
representative o f the physiological setting. Channel opening was significantly induced 
using the m etabolic inhibitors NaCN and 2-DG in com bination (PcO.OOl), but prior to 
their application in subsequent experim ents, I wanted to determine if each drug alone 
could efficiently induce m etabolic inhibition (i.e. if inhibition o f the electron transport 
chain or glycolysis alone was sufficient for m etabolic depletion in the v icin ity  o f the 
K a t p  channel). In cardiac m yocytes, it has been shown that blockade o f glycolysis 
alone is sufficient to induce channel opening (Dugravot, Grolleau et al. 2003). 
Sim ilarly, 2-deoxy-glucose alone has been shown to activate single channels in patches 
from cells from guinea pig urinary bladder (Bonev and Nelson 1993), and cyanide alone 
to activate whole cell currents and 43-pS single channels in pig urethral cells (Teramoto 
and Brading 1996). Figure 3.3  shows the effectiveness o f each m etabolic inhibitor on 
K a t p  channel opening.
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Figure 3.3: The effect of Metabolic Inhibitiors on the K \tp  channels Kir6.1/SUR2B and 
Kir6.2/SUR2B (expressed stably). 2.5mM NaCN and 20mM 2-DG were applied individually, 
and w ith 10p.M Glibenclamide. Response was measured 15 m inutes after addition of the drugs, 
and efflux was calculated as % efflux of initial 86R b+ content. The KCOs pinacidil and 
levcromakalim  were applied to the Kir6.2/SUR2B and Kir6.1/SUR2B cell lines respectively. 
The control represents DMSO diluted in HBS. D ata are shown as +/- SEM, whereby n=9. 
PcO.OOl compared to control, (ns) P>0.05 compared to control.
o  * * *
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It is apparent that both m etabolic inhibitors need to be applied in com bination to 
induce channel opening, since the efflux observed when 2.5mM NaCN and 20mM 2-DG  
are applied separately does not differ from that o f the control, and is not reduced on the  
addition o f glibenclamide. This indicates that both oxidative m etabolism  and 
glycolysis need to be inhibited sim ultaneously to deplete [ATP]i concentrations to a 
level sufficient to induce K a t p  channel opening.
A tim e course has been established, and an optim al tim e point at which to measure 
86R b+ efflux in H EK 293 cells stably and transiently expressing K a t p  channels using a 
com bination o f channel openers and closers. I thought it would be interesting to screen 
other cell system s natively expressing K a t p  channels to assess pharm acological 
response, and to determine if  there was another suitable model that could be applied in 
further experim ental design. Therefore, both aortic and coronary artery sm ooth muscle 
cell lines (AOSMC and CASMC respectively), C2C12 cells and HL-1 cells were screened 
for sensitivity to this assay. Experim ents were conducted as previously described, and 
under conditions o f serum depletion (for 24 hours) to induce growth arrest and increase 
K a t p  channel expression. B oth conditions provided similar results. Those under 
conditions o f serum depletion are shown.
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Ml + 10nM Glib
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Figure 3.4: Measurement o f 86R b+ efflux o f native potassium channels (principally
Kir6.1/SUR2B) in AOSMC and CASMC system s after 24 hours serum depletion. Efflux was 
measured 15 minutes after addition o f the drugs, and was calculated as % efflux o f initial 86R b+ 
content. The control represents DMSO diluted in H BS. Data are shown as + /- SEM, whereby 
n=9. *** PcO.OOl compared to control, ** P=0.001-0.01 compared to control, * P=0.01-0.05  
compared to control, (ns) P>0.05 compared to control
I t  is a p p a re n t th a t  on ly  m etab o lic  in h ib itio n  h ad  a s ig n ifican t effect on  sm o o th  m uscle 
ch an n e l o pen ing , th e  effect o f  w hich  is n o t reversed  v ia  g libenclam ide. B ack g ro u n d  
efflux  is also h igh  (especially  in  th e  co ro n ary  sm o o th  m uscle cells) in d ica tin g  d e tec tio n  
o f efflux from  o th e r  p o tass iu m  ch an n e l fam ilies, an d  im p ly in g  th a t  th e  re su lt is n o t 
u n iq u e  to  th e  K a tp  channel. T h e  sam e ex p e rim en t w as rep ea ted  fo r th e  C2C12 an d  
HL-1 cell lines, w hich  th e  lab  h as ex p e rtise  in c u ltu rin g , an d  w hich  express en dogenous 
K a tp  channels.
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“ 2.5mM NaCN + 20mM 2-DG (Ml)
— 10|iM Pin + 10nM Glib
— 10|iM Pinacidil
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Figure 3 .5 : Measurement o f 86R b+ efflux o f  native potassium  channels in HL-1 and C2C12 cell 
system s. Efflux was measured 15 m inutes after addition of the drugs, and was calculated as % 
efflux o f initial 8f’Rb+ content. The control represents DMSO diluted in H BS. D ata are shown 
as + /- SEM, whereby n=9. *** PcO.OOl compared to control, (ns) P>0.05 compared to control.
For the C2C12 cell line, there is no significant change in efflux compared to the control, 
and again basal efflux is relatively high, indicating the detection of a varied population  
of potassium channels. For the HL-1 cell line, metabolic inhibition again induced 
channel opening, but glibenclamide was unable to reverse this effect and no response to 
pinacidil was observed. C2C12 cells are thought to predominantly express Kir6.2/SUR1 
and Kir6.2/SUR2A (Liu, Gao et al. 1996) and HL-1 cells Kir6.2/SUR2A (Fox, Jones et 
al. 2005) hence the KCO of choice.
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Since no significant difference in pharmacology7 was detected in these native cell 
system s using the employed assay, and since a high level o f noise (i.e. bassal efflux) was 
detected, it was determined that H E K 2 9 3  cells stably expressing the desired K atp 
channel were the preferred model system . In this cell line, the presence o f background  
K+ channels is substantially lower, and the channel introduced is expressed at a high  
enough level for accurate m easurem ents o f variation in efflux. Also it has been shown  
that we can recapitulate m any aspects o f native channel regulation in a H E K 2 9 3  
heterologous expression system  (Quinn, Cui et al. 2003; Quinn, Giblin et al. 20 0 4 ; Kang, 
Ng et al. 2 0 0 6 ).
The patch clamp technique was applied in the whole-cell configuration to supplem ent 
data acquired from the 86R b+ flux assay. Initially, H EK 293 cells stably and then  
transiently expressing K ir6.1/SUR 2B were patch-clam ped to ensure that I was able to 
apply the technique to reproduce existing data (Quinn, Cui et al. 2003; Cui, Giblin et al. 
2001).
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Figure 3 .6 : Examples o f K ir6.1/SUR2B currents in stably transfected H E K 293 cells as recorded 
by the whole-cell patch clamp configuration. Voltage clamp recordings were obtained under 
sym m etrical K+ conditions, and were evoked during 200ms voltage steps between -lOOmV and 
+50m V  in lOmV increments from a holding potential o f OmV (A) Representative traces for each 
o f the conditions: control (external solution with DMSO), 10p.M levcrom akalim , lOfiM 
levcromakalim with lOpM glibenclamide and IOjjM levcromakalim w ith ImM barium chloride. 
All effects were reversible with subsequent washout, and all currents were recorded in 
sym m etrical 140mM K+, and with 0.5mM U D P  in the patch pipette. The tim e taken to achieve 
a response in relation to the control is given (B) Representative I/V traces for each o f the 
conditions (pA/pF), whereby each trace reverses at OmV (C) Current/Density bar chart to 
represent mean data for the response o f K ir6.1/SUR2B to the KCO and KCBs *** PcO.OOl 
compared to control, (ns) P>0.05 compared to control (n=5).
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Figure 3.7: Exam ples o f K ir6.1/SUR2B currents in transiently transfected H E K 293 cells as 
recorded by the whole-cell patch clamp configuration. Voltage clamp recordings were obtained  
under sym m etrical K+ conditions, and were evoked during 200ms voltage steps between - 
lOOmV and +50m V in lOmV increments from a holding potential o f OmV (A) R epresentative 
traces for each of the conditions: control (external solution with DMSO), 10pM levcrom akalim , 
10p.M levcromakalim with 10pM glibenclam ide and IOjiM levcromakalim with ImM barium  
chloride. All effects were reversible with subsequent washout, and all currents were recorded in 
sym m etrical 140mM K+, and with 0.5mM U D P  in the patch pipette. The tim e taken to 
achieve a response in relation to the control is given (B) Representative I/V traces for each o f  
the conditions (pA/pF), whereby each trace reverses at OmV (C) Current/Density bar chart to 
represent mean data for the response o f K ir6.1/SU R 2B the KCO and KCBs *** P<0.001 
compared to control, (ns) P>0.05 compared to control (n=7).
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Currents recorded from the K ir6.1/SU R 2B cell line were stim ulated on the addition o f  
KCO (lOpM levcromakalim) and inhibited on the addition of 10pM glibenclam ide and 
ImM BaCla. The data was reproducible for channels both stably (Figure 3.6)  and 
transiently expressed (Figure 3.7). Perforated patch clam ping was used to confirm the 
response o f the K a t p  channel to m etabolic inhibition. This is an experim ental m ethod  
that best preserves the physiology o f intact cells. Perforated patch clam ping is a good 
compromise between good electrical access and preservation of intracellular milieu. As 
a consequence o f disrupting the patch o f membrane under the pipette tip, as in whole 
cell recordings, the com ponents o f the cytoplasm  are replaced by the pipette fluid. 
There are various situations where replacement o f the cytoplasm  is undesirable, for 
exam ple if  the subject o f study involves intracellular signalling, whereby classic w hole­
cell recording could dilute or wash out crucial elements in the signalling cascade. It was 
necessary to apply the perforated patch m ethod to study m etabolic inhibition o f the 
channel, since the result observed may be either at the level o f the channel or be an 
indirect effect involving various signalling factors. It was also necessary to m aintain  
the intracellular nucleotide concentrations so the effects o f m etabolic inhibition on the 
channel could be accurately assessed. The perforated patch method allowed this 
because the perforations created by am photericin B were too small for larger molecules, 
such as nucleotides, to pass. Therefore, any change in nucleotide concentration within  
the cytoplasm  was due to the effects o f m etabolic inhibition, and not due to interchange 
between the cytoplasm  and the cell exterior.
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Figure 3.8: Effect o f metabolic inhibition on the K \ t p  channel K ir6.1/SU R 2B current as 
dem onstrated by the perforated patch-clam p method. Currents were evoked under 
asym m etrical conditions via voltage clamp recordings over 1000ms voltage steps between - 
150mV and +50m V from a holding potential of -80mV, with 15s between sweep starts (A) 
Representative traces for each o f  the conditions: external solution with DMSO, m etabolic  
inhibitors (2.5mM NaCN and 2 0 m \l 2-DG) and metabolic inhibitors with glibenclam ide. The 
tim e taken from perforation to the current recorded under each condition is given (B) 
Representative I/V traces for each o f the conditions (pA/pF), whereby each trace reverses at - 
80mV (C) Current/Density bar chart to represent mean data for metabolic inhibition o f the 
K ir6.1/SUR2B channel currents. *** P<0.001 compared to control, (ns) P>0.05 compared to 
control (n=7).
128
♦ 50 mV
(A)
control 
t = 2 mins
0.5nA
500ms
-150 mV 1000 ms
2.5mM NaCN + 20mM 2-DG (Ml) 
t = 15 mins
Ml ♦ 10|iM Glib 
t = 18 mins
(B)
Current (nA)
-80 -60 -40 -20
Voltage (mV)
Ml + 10fiM Glib
2.5mM NaCN ♦ 20mM 2-DG(MI) 
Control
129
(C)
Current Density at 
+50mV pA/pF 60
* * *
Ml + 10jiM Glib
2.5mM NaCN + 20mM 2-DG(MI) 
Control
Condition
Figure 3.9: Effect of metabolic inhibition on the K vrp channel K ir6.2/SU R 2B current as 
dem onstrated by the perforated patch clamp method. Currents were evoked under 
asym m etrical conditions via voltage clamp recordings over 1000ms voltage steps between - 
150mV and +50m V from a holding potential o f -80mV, with 15s between sweep starts (A) 
Representative traces for each o f the conditions: external solution with D \lS O , m etabolic 
inhibitors (2.5mM NaCN and 20mM 2-DG) and metabolic inhibitors with glibenclam ide. The 
tim e taken from perforation to the current recorded under each condition is given, whereby  
control represents DMSO in bath solution (B) Representative I/V traces for each o f  the 
conditions (pA/pF), whereby each trace reverses at -80mV (C) Current/Density bar chart (to 
represent mean data for metabolic inhibition o f the Kir6.1/SUR2B channel currents. *** 
PcO.OOl compared to control, (ns) P>0.05 compared to control (n=7).
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The data obtained is consistent w ith that obtained by the 86R b+ flux assay. The K a t p  
channels K ir6.1/SUR2B and K ir6.2/SUR 2B open in response to m etabolic inhibition, 
the effect o f which is reversed by glibenclamide. This confirms that the assay is a 
valuable tool for screening for their functionality, and assessing K a tp  channel current in 
response to depletion o f ATP.
The importance that cellular signalling pathways are thought to play in K a t p  channel 
regulation was discussed in the introduction. A series o f preliminary experim ents were 
conducted to determine whether external signalling factors, such as AM PK , play a role 
in the response o f the channel to variation in intracellular nucleotide concentration; 
specifically to the depletion o f ATP levels that are induced by m etabolic inhibition.
I initially thought it would be interesting to look at the role that PK A and adenosine 
m ay play in the regulation of K ir6.1/SU R 2B. Aside from variation in A T P /A D P  ratio, 
the phosphorylation o f ion channels by protein kinases is an im portant m echanism  by 
which membrane excitability is regulated by cell signalling pathways. It has previously  
been established that H EK 293 cells possess the relevant cellular signalling m achinery 
for PK A-m ediated channel m odulation. It has been shown that that forskolin, a direct 
activator o f adenylate cyclase, is able to elevate cAM P in H EK 293 cells, and that 
cAM P binds to the regulatory subunit o f PK A  which activates K ir6.1/SU R 2B. It was 
confirmed that PKA activates K ir6.1/SUR 2B by the application o f Rp-cAM PS, which  
com petes for cAMP binding to the regulatory subunit o f PK A. In whole-cell patch  
clamp experim ents, when Rp-cAM PS was included in the patch pipette and forskolin in 
the bath solution, forskolin no longer stim ulated K ir6.1/SUR 2B current (Quinn, Giblin 
et al. 2004).
It has also been shown that the vasodilator adenosine plays an indirect role in the 
regulation of K atp  channels to cause membrane hyperpolarisation, and that it acts 
through the adenylyl cyclase (AC)-protein kinase A (PKA) pathw ay (Bruch, Rubel et 
al. 1998). In sm ooth muscle cells isolated from rabbit or rat mesenteric or porcine
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coronary arteries, adenosine activated glibenclam ide-sensitive K a tp  currents and the  
AC-PKA pathway was implicated (Dart and Standen 1993: Kleppisch and Nelson  
1995).
To determine any involvem ent o f adenosine and PKA in the m etabolic regulation of the 
K a tp  channel, the ability o f the PKA inhibitors, H-89 and KT5720, and adenosine 
receptor antagonists, Quinoxaline and SCH58261. to reverse the efflux observed on the 
application o f forskolin and m etabolic inhibitors to K ir6.1/SLR 2B was compared. 
10p,M forskolin was applied as this has previously been shown to be effective in the  
activation of K ir6.1/SUR2B currents (Quinn. Giblin et al. 2004). 250nM H -89 and
6.5pM o f KT 5720 o f the PKA inhibitors were applied. These are com m only used, and 
the I C 5 0  values have been established, these being 135nM for H-89 and 3.3flM for 
KT5720 (Davies, Reddy et al. 2000). The adenosine receptor antagonists, SCH58261 
and Quinoxaline, were chosen on the basis o f literature searches, as were the doses 
applied (60nM and IOO11M respectively) (Belardinelli. Shryock et al. 1996: Belardinelli. 
Shryock et al. 1998; Baraldi. Tabrizi et al. 2003: Novellino, Cosimelli et al. 2005).
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Figure 3.10: T h e  effect o f  P K A  in h ib ito rs  (H -8 9  & K T 5720) and ad en osin e  recep tor  
a n ta g o n ists  (Q u in oxa lin e  & S C H 58261) in response to  increased  86R b + efflu x  ob served  
on  th e  ap p lica tio n  o f  e ith er  m eta b o lic  in h ib itors or forskolin  to  th e  K a tp  ch a n n e l 
K ir6 .1 /S U R 2 B . Efflux was measured 30 m inutes after the addition o f drugs, and was 
calculated as %  efflux of initial 86R b+ content. The control represents DMSO diluted in H BS. 
Data are shown as +/- SEM, whereby n=5. *** PcO.OOl compared to control, (ns) P>0.05
compared to control.
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In this setting, 10pM forskolin increased K ir6.1/SUR 2B efflux significantly beyond the 
basal level (P<0.001), and to a similar degree as the metabolic inhibitors 2.5mM NaCN  
and 20mM 2-DG. This is consistent with previous literature (Quinn, Giblin et al. 2004). 
As expected, the PKA inhibitors reduced efflux observed on the application o f  
forskolin, but not that induced via the m etabolic inhibitors. The adenosine receptor 
antagonists did not reverse the efflux observed 011 the application o f either m etabolic 
inhibitors or forskolin. This result would imply that even though PK A and adenosine 
may play a role in K ir6.1/SUR 2B regulation, they are probably not involved in channel 
opening when ATP is depleted, i.e. m etabolic regulation of the channel. It is possible 
that SCH58261 and Quinoxaline did not reduce forskolin-induced efflux due to the 
specific adenosine receptor that was targeted, which may not be involved in the AC- 
PK A  pathw ay.
It has previously been shown that regulation o f K ir6.1/SUR2B via PK A occurs because 
of direct channel phosphorylation 011 serine and threonine residues in the cytoplasm ic  
domains o f Kir6.1 and SU R 2B . Two PK A consensus sites in Kir6.1 (T234, S385) and 
two in SU R 2B (T633, S I465) were recognised via the consensus site recognition  
program in Prosite for PKA: http://ca.expasy.org/tools/scnpsite.htm l, and it was 
hypothesised that channel activation is largely mediated via phosphorylation at S385A  
in Kir6.1 and T633 and S1465 residues in SU R 2B . Point m utations in these regions 
removed the stim ulation observed by PK A  and forskolin (a direct activator o f  
adenylate cyclise, able to elevate cAM P in H EK 293 cells) in an electrophysiological 
setting. The 86R b+ assay was conducted to compare the effect o f m utation o f these 
phosphorylation sites on the m etabolic stim ulation of the channel. These m utants 
(previously generated within the lab) were transiently transfected with Kir6.1 (in the 
case o f SU R 2B  mutants) or SU R 2B  (in the case o f Kir6.1 mutants) into H E K 293 cells, 
so that each channel complex contained one point m utation. The assay was applied as 
described previously.
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Figure 3.11: The effect o f point m utations on the PKA consensus sites T234 and S385 in Kir6.1 
on the functionality o f K ir6.1/SUR2B as shown by 86Rb+ efflux. The m utations were expressed  
alone or in combination. Efflux was measured 15 minutes after the addition o f drugs, and was 
calculated as % efflux of initial 86R b+ content. The control represents DMSO diluted in H BS. 
Data are shown as +/- SEM, whereby n=9. *** PcO.OOl compared to control, ** P=0.001-0.01  
compared to control, * P=0.01-0.05 compared to control, (ns) P>0.05 compared to control.
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M utation o f the PK A phosphorylation sites in Kir6.1 appears to have no effect on the  
response o f the channel to the KCO or to m etabolic inhibition, and all responses seen 
are significant compared to the control. Even though Kir6.1 S385 appears to be critical 
for channel phosphorylation by PK A  (Quinn, Giblin et al. 2004), m utation o f this 
residue does not affect the previously observed pharmacology observed in this setting. 
H owever, channels containing the S385 m utation would appear to have a lower level 
efflux than those containing T234, which m ay support the proposal that the S385 
residue is responsible for basal activ ity  o f the channel (Quinn, Giblin et al. 2004).
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Figure 3.12: The effect o f point m utations on the PKA consensus sites T633 and S1465 in 
SU R 2B  on the functionality o f K ir6.1/SU R 2B as shown by 86R b+ efflux. The m utations were 
expressed alone or in com bination. Efflux was measured 15 minutes after the addition of drugs, 
and was calculated as % efflux o f initial 86R b+ content. The control represents DMSO diluted in 
HBS. Data are shown as +/- SEM , whereby n=9. *** PcO.OOl compared to control, **
P=0.001-0.01 compared to control, * P=0.01-0.05 compared to control, (ns) P>0.05.
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Again, m utation of the identified PK A phosphorylation sites in SU R 2B  appears to 
have no effect on the response o f the channel to .the KCO or to m etabolic inhibition, 
despite the fact that they have been shown to be responsible for channel activation  by  
PK A  in H EK 293 cells. It should be noted that channels containing SU R 2B  and Kir6.1 
phosphorylation m utations have been shown to be activated using a potassium  channel 
opener (Quinn, Giblin et al. 2004).
It was subsequently investigated whether AM PK has a potential role in the response o f  
the channel to metabolic inhibition, using a com bination of known AM PK activators 
and inhibitors. AM PK, a sensor o f peripheral energy balance, is phosphorylated and 
activated when energy sources are low. Basically, if the rate o f A T P consum ption  
exceeds its  production, A D P will tend to  rise and will be converted to AM P by the 
enzym e adenylate kinase. The rise in level o f the activating ligand AM P, coupled with  
the fall in the level of the inhibitory nucleotide ATP, activates AM PK, and then  
switches o ff ATP consuming processes and switches on catabolism in an attem pt to 
redress the balance (refer to introduction, section 1.6). It is expected that under 
conditions o f m etabolic inhibition, thereby ATP depletion, activation of AM PK would 
potentially have an indirect effect on channel efflux. The 86Rb+ flux assay was applied 
as previously described to investigate this effect using the K ir6.1/SUR 2B stable cell 
line. The choice and dose o f activator, i.e. 500pM AICAR, lOmM phenformin and 
lOmM m etform in (Rubin, Magliola et al. 2005; W oollhead, Scott et al. 2005; Zhang, He 
et al. 2007) or inhibitor, 200nM Compound C, 200pM C75, lpM  iodotubericidin and 
50nM staurosporine (Fluckiger-Isler and W alter 1993; Massillon, Stalm ans et al. 1994; 
Meggio, Donella Deana et al. 1995; Lee. H wang et al. 2003; Kim, Miller et al. 2004; 
Landree. H anlon et al. 2004; McCullough. Zeng et al. 2005)were chosen on the basis o f  
literature searches. Generally these compounds are not specific in the targeting o f  
AMPK activ ity , especially Staurosporine, and affect a variety o f protein kinases. It 
was necessary to apply a dose o f inhibitor/activator that would target AM PK w ithout 
disrupting the activ ity  o f other signalling pathways. The data displayed in Figure 3.13  
was obtained from a preliminary experim ent to deduce if the applied doses o f these
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Figure 3.13: The effect o f AMPK activators (AICAR, metformin, phenformin) and inhibitors 
(staurosporine, iodotubericidin, C75, com pound C) on the response o f the K a t p  channel 
K ir6.1/SUR2B to metabolic inhibition as shown by 86Rb+ efflux. Efflux was measured after 
incubation with activator/inhibitor for 15 m inutes, followed by incubation with m etabolic  
inhibitors for 15 minutes, and was calculated as % efflux of initial 86Rb+ content. The control 
represents DMSO diluted in H BS. D ata are shown as +/- SEM, whereby n=6. *** P<0.001, ** 
P=0.001-0.01, * P=0.01-0.05 compared to m etabolic inhibition.
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These initial observations would indicate that all three AM PK activators applied 
significantly reverse the response o f the channel to metabolic inhibition, i.e. decrease 
efflux (P<0.001), whereas the AM PK inhibitors increase the effect o f the channel to  
metabolic inhibition. The response o f the channel to metabolic inhibition after the  
application o f glibenclamide is also shown as a control. It is expected that upon  
activation, AM PK preserves A T P levels within the cell, increasing the A T P /A D P  ratio 
which results in Katp channel closure, and therefore the decreased efflux observed. 
Conversely, inhibition would prevent AM PK from replenishing ATP levels w ithin the 
cell when depleted, therefore channels would remain in the open state and percentage 
efflux would remain at the same level if  not increase. The activators and inhibitors 
applied have been known to dem onstrate non-specific activ ity  (for exam ple  
staurosporine is a potent inhibitor o f m any kinases, including PKC and PKG and C75 is 
a fa tty  acid synthase inhibitor); we can not be certain whether these observations are 
the result o f the sole involvem ent o f AM PK. It has been shown that PKC can regulate 
AM PK activ ity  by increasing Serine 428 phosphorylation of LK B1, resulting in the  
association o f LKB1 with AM PK  and consequent AM PK Threonine 172 
phosphorylation of LKB1. I began to use genetic tools to further understand this 
result. H EK 293 cells were transfected with a constitutively active kinase ( a l 312) and 
the dom inant negative inhibitor (otlD N ) o f endogenous AM PK (Woods and Azzout- 
Marniche 2000). The same AM PK  activators and inhibitors applied to determine if  the 
result observed in Figure 3.13  held true, whereby it was speculated that any variation  
of this result would indicate that AM PK does indeed influence Katp channel regulation. 
However, the result obtained was inconclusive.
To summarise, the Katp channels K ir6.1/SUR2B and K ir6.2/SUR2B were shown to be 
m etabolically responsive, i.e. open on [ATP]i depletion, via both the rubidium flux  
assay and the perforated patch-clam p method. H EK 293 cells stably expressing the 
channel were shown to be the best system  on which to apply the 86Rb+ flux assay and 
observe a pharmacological response. In the other cell system s there would appear to be
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considerable background noise from other native K+ channels, and if another system  
was to be considered to observe native Katp channel efflux in future experim ents, one 
would probably have to block the basal efflux o f other native K+ channels to reduce 
background noise. Even though cellular signalling factors have been shown to be 
involved in K ir6.1/SUR2B regulation, it is not clear from my experim ents whether they  
contribute to the m etabolic regulation o f the channel. W ith reference to the Chapter 
one, section 1 .6 , this may be the case in the native setting, but it is clear from the data 1 
have shown so far, that the channel is intrinsically m etabolically sensitive. Therefore, 
in subsequent chapters I have primarily chosen to look at the regulation of the channel 
at the level o f the channel- i.e. the intrinsic role that the pore-forming subunit and the 
sulphonylurea receptor play in the m etabolic response o f the channel.
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Chapter Four
Determination o f the functionality and surface expression o f  
K ir6 .1 /S U R 2B  after truncation o f  the N- and C-terminus o f
the pore-forming subunit
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Chapter Four: Results
Determination of the functionality and surface expression of K ir6 .1 /SU R 2B  
after truncation of the N- and C-terminus of the pore-forming subunit
It has previously been shown that co-expression of SUR and Kir6.jc is necessary to 
generate significant plasmalemmal K + currents (Inagaki, Tsuura et al. 1995; Tucker. 
Gribble et al. 1997; Aguilar-Bryan and Bryan 1999: Zerangue, Schwappach et al. 1999). 
and this observation triggered a number of studies on the cell biology o f channel 
com plex formation (Makhina and Nichols 1998: Zerangue. Schwappach et al. 1999). 
Mutant forms of Kir6.2 with a C-terminal truncation of 26 (Kir6.2AC26) or 36 amino 
acids (Kir6.2AC36) produce currents in the absence o f SUR1 subunits (Tucker, Gribble 
et al. 1997). This was shown by the currents recorded from oocytes injected with  
m R N A  encoding Kir6.2AC36/AC26. and it was deduced that they were not only capable 
o f independent expression, but that they were also intrinsically sensitive to 
m etabolically induced changes in cytosolic nucleotide levels. Kir6.2AC26/AC36 has 
since served as a useful tool to understand the role o f each subunit in channel gating by 
nucleotides and pharmacological agents (Gribble, Tucker et al. 1997; Babenko. 
Gonzalez et al. 1999; Koster, Sha et al. 1999; Proks. Gribble et al. 1999; Reimann. 
Tucker et al. 1999: Cui, Tinker et al. 2003: Saraya. Yokokura et al. 2004: Lu. Hong et 
al. 2005). The knowledge that Kir6.2AC36 could be forced to express channel activ ity  
independently of SUR (Tucker, Gribble et al. 1997), together with an assay that was 
capable o f detecting surface expression of Katp channels in Xenopus oocytes, was used to 
map an ER localization signal in Kir6.2 and then in SLR1 (Zerangue, Schwappach et 
al. 1999). Similar signals are also found in Kir6.1 (Zerangue. Schwappach et al. 1999) 
and SL R 2 (Konstas, Dabrowski et al. 2002). This RKR m otif either prevents the 
export o f the protein from the ER and/or retrieves it from the golgi. Deletion of this 
m otif allows each protein to express independently (Tucker, Gribble et al. 1997: 
Zerangue, Schwappach et al. 1999).
143
However, it was not certain if it was possible to express Kir6.1 independently. 
Constructs were previously made by Yi Cui in which the C-terminal 48 and 61 am ino  
acids were truncated (rem oving the R X R  m otif), and these constructs were only shown  
to be functional when expressed with SU R2R . It was thought necessary to investigate  
this further.
Additionally, deletion o f the N-term inus o f Kir6.1 when expressed in com bination with  
SUR1 has been found to increase basal activ ity , i.e. that occurring in the absence o f  
nucleotide diphosphate (Babenko and Bryan 2001). N-terminal truncation o f Kir6.1 
was not found to compromise the response to Mg-nucleotide-dependent stim ulation by 
SU R 1, and progressively larger deletions (AN 13. AN21 and AN33) increased the open 
probability, with m axim al effect seen with AN33 (Babenko and Bryan 2001).
Based on this existing evidence, various AN-Kir6.1-AC truncation m utants were made 
to delineate if  Kir6.1AC is indeed only functional in the presence o f a sulphonylurea  
receptor, or if  Kir6.1AC shows intrinsic ATP/m etabolic sensitivity in the absence o f  
SU R. It was also o f interest to deduce whether Kir6.1AN could further increase any  
basal activ ity  observed. N- and C-terminal truncation m utants were made via  
conventional PCR. A plasmid encoding Kir6.1 with an HA epitope introduced into the 
extracellular M l and H5 domains (Kir6.1-eHA) was kindly provided by Dr LY Jan. 
and sub-cloned into the m amm alian expression vector pcDNA3.1/Zeo prior to my 
experim ents. The HA epitope is a nine amino acid sequence (Y P Y D V P D Y A ) present 
in the human influenza virus hem agglutinin protein, and is recognized by the high 
affinity rat monoclonal isolate (3F10, Roche). W ith reference to Figure 4 .1 . pre­
optim ised PCR conditions were applied to generate the various truncation m utants 
from Kir6.1-eHA using the primers listed in Chapter 2.
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1 = Kir6.1
2 = Kir6.1
3 = Kir6.1
4 = Kir6.1
5 = Kir6.1
6 = Kir6.1
7 = Kir€.1
8 = Kir6.1
9 = Kir6.1
AC48
AC61
AN13
AN 33
AN13 + AC48 
AN 13 + AC61 
AN 33 + AC48 
AN 33 + AC61 
full length
(1436 bps) 
(1397 bps) 
(1543 bps) 
(1481 bps) 
(1397 bps) 
(1358 bps) 
(1337 bps) 
(1298 bps) 
(1580 bps)
6106 bps
1515 bps
1482 bps
(C)
13 aa 
33 aa 
13 aa 
13 aa 
33 aa 
33 aa
Kir6.lAN13
Kir6.lAN33
N -term inus Full length Kir6.1 C-terminus (RKR motif)
Kir6.1AC48 < —
Kir6.lAC61 < ---------
Kir6.1AC48 + AN 13
Kir6.1 AC61 + AN 13
Kir6.lAC48 + AN33
Kir6.1 AC61 + AN33
48 aa
61 aa
48 aa 
61 aa 
48 aa 
61 aa
Figure 4.1: Generation o f the AN-Kir6.1-eHA-AC truncation m utants via conventional PCR. 
(A) Analysis o f PCR products via agarose gel electrophoresis. Full length Kir6.1-eH A was 
generated as a positive control (Lane 9). A standard D N A  Molecular W eight Marker VII 
(0.359, 0.492, 0.710, 0.992, 1.164, 1.482, 1.515, 1.882, 1.953, 2.799, 3.639, 4.899, 6.106, 7.427, 
8.576 kbp) was used to determ ine the length o f the fragments (Roche, U K ). The length o f  each  
PCR fragment is indicated in the text box (B) Restriction digest o f truncated PCR fragm ents 
sub-cloned into pcDNA3.1 using the restriction enzym es B am H l and X b a l. (C) Diagram to 
compare each o f successive truncations w ith full length Kir6.1 and to depict the number o f  
amino acids removed in each case. D eletion o f the C-terminus removes the R K R  m otif.
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Since pcD N A 3.1 co n ta in s  b o th  T7 an d  S P 6  p ro m o ters  e ith e r side o f th e  p o ly lin k e r s ite  
( in to  w hich  th e  m u ta n ts  w ere in se rted ), in d iv id u a l clones w ere sent fo r seq u en c in g  w ith  
T7 an d  S P 6  p rim ers (th erefo re  th e  sequence w as checked in  b o th  th e  5’ an d  3’ d irec tio n s  
respective ly ). A n ex am p le  o f a seq u en c in g  tra c e  o b ta in ed  is show n in  Figure 4 .2 . T hese  
re su lts  confirm ed  th a t th e  correc t tru n c a tio n s  w ere in tro d u ced .
Figure 4.2: An example chrom atogram  result that was opened with the software programme 
Chromas to confirm the generation o f a truncated Kir6.1 m utant, in this case Kir6.1AN33 
(cloned into pcDNA3.1) that was sequenced using a T7 primer. A clean sequence was indicated  
by peaks that were evenly spaced with each only having one colour. This exam ple result 
indicated that the quality o f the tem plate and primer was good. The Chromas programme 
enabled conversion of the sequence into FAST A format, enabling a nucleotide-nucleotide blast 
search to be conducted on the NCBI website (http://w w w .ncbi.nlm .nih.gov).
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Prior to testing the functionality o f the AN-Kir6.1-AC truncation m utants, I wanted to 
determine whether removal o f the C-terminus o f Kir6.1 enabled its independent 
expression. Imm unofluorescent staining was performed in permeabilised and non- 
permeabilised cells according to published protocols (Cui, Tran et al. 2002; Giblin, 
Quinn et al. 2002; M uzyamba, Farzaneh et al. 2007). CHO-K1 cells were used, since 
the assay did not appear to work in H EK 293 cells. This phenomenon has also been 
described by other investigators (M argeta-M itrovic 2002).
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In absence o f SUR2B with SUR2B
A: Kir6.1
B: Kir6.1AC48
C:
Kir6.1AC61
D: Kir6.1AN13
E: Kir6.1 AN33
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Figure 4 .3 : Surface staining o f  Kir6.1-HA N- or C-terminal deletion m utants in non- 
permeabilised cells, expressed w ith (left panel) and without (middle panel) SU R 2B . Im ages of  
permeabilised cells in which Kir6.1AN13/AN33 (E&D) were overexpressed in the absence o f  
SU R 2B  are also shown as a control (indicative that recombinant protein was retained  
intracellularly). All images were captured at the same exposure (1 second) and m agnification  
(400x), and were not subject to any other form of enhancement other than the addition o f green 
pseudocolour when opened in Adobe Photoshop. The white scale bar represents 50pm.
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Kir6.1 was expressed with and w ithout SU R 2B  as a control, to show that the presence 
o f the sulphonylurea receptor was required for its translocation to the cell surface. B oth  
Kir6.1AC48 and Kir6.1AC61 translocated to the cell surface in the absence and presence 
o f SU R 2B  (Figure 4.3b&c), however Kir6.1AN13 and Kir6.1AN33 were surface 
expressed only in the presence o f SU R 2B  (Figure 4.3d&e). Permeabilisation revealed 
the presence o f channel protein (Figure 4.3d&e  right panel). The white pixels seen in 
the permeabilised im ages represent saturation o f fluorescent signal.
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In absence o f SUR2B with SUR2B
A: Kir6.1AN33/AC48
50m M
B: Kir6.1AN33/AC61
C: Kir6.1 AN13/AC61
D: Kir6.1AN13/AC48
Figure 4.4: Surface staining o f Kir6.1-HA N- and C-terminal deletion m utants in non- 
permeabilised cells, expressed with (left panel) and without (right panel) SU R 2B . All images 
were captured at the same exposure (1 second) and magnification (400x), and were not subject 
to any other form o f enhancem ent other than the addition o f green pseudocolour when opened 
in Adobe Photoshop. The white scale bar represents 50pm.
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All four double N- and C- term inus truncated m utants o f Kir6.1 translocated to the cell 
surface in both the presence and absence o f SU R 2B  (Figure 4.4a,b,c&d). It is also 
interesting to note that, despite the non-quantitative nature o f this assay, the  
sulphonylurea receptor appears to increase surface expression of the Kir6.1 m utants  
that are able to traffic independently.
The results obtained in Figures 4.3 &  4.4  were expected. In Kir6.1AN13 and 
Kir6.1AN33 the R K R  m otif is still present, therefore the channel is only surface 
expressed in the presence o f SU R 2B  (whereby this m otif is masked). Representative  
permeabilised images are shown for Kir6.1AN13 and Kir6.1AN33 to show that on 
rupture o f the cell membrane reconstituted channel protein is detected, and hence that 
the blank images shown are not the result o f failure o f the transfection procedure. For 
all other Kir6.1 truncations the R K R  m otif is absent, hence the channel pore is 
expressed both in the presence and absence o f SU R 2B in non-permeabilised cells.
Before proceeding to look at the functionality o f the various AN-Kir6.1-AC m utations, I 
have side-tracked slightly, and have discussed a recently published study in which this 
im m unohistochem istry assay was applied (M uzyamba, Farzaneh et al. 2007).
Experim ents were performed to support the localization observed in confocal 
microscopy studies o f m utant Kir6.2/SUR1 complexes which result in congenital 
hyperinsulinism  (CHI) (M uzyam ba, Farzaneh et al. 2007), and to validate the assay 
and hence the data shown in the previous two figures.
Kir6.2 and SUR1 are encoded by the genes A B C C 8  and K C N J11  respectively, 
m utations in which lead to CHI (also known as Persistent H yperinsulinaem ic  
H ypoglycaem ia o f Infancy (PH H I) and formerly known as Nesidioblastosis)(K ane, 
Shepherd et al. 1996). Under normal circumstances, high levels o f glucose in the cell 
result release o f insulin from pancreatic 6-cells. However, 6-cells in individuals with  
CHI secrete insulin despite low blood glucose levels (Aguilar-Bryan and Bryan 1999;
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Miki, Nagashim a et al. 1999). It is thought that the P-cell is persistently depolarized 
because o f abnorm ally m odulated or absent K a t p  channels (Thomas. Cote et al. 1995; 
Dunne, Cosgrove et al. 2004). M utations in SUR1 and Kir6.2 that lead to a loss o f  
channel function have also been shown to be major causes o f CHI (Sharma, Crane et al. 
2000; H uopio, Shyng et al. 2002), and defective trafficking of channel protein is one 
mechanism whereby some SUR1 m utations lead to loss o f channel function and 
consequently onset o f this disease. S U R l m utations that cause trafficking defects 
located w ithin or downstream o f N B D 2 have been reported (Sharma, Crane et al. 1999; 
Cartier, Conti et al. 2001; Partridge, Beech et al. 2001; Taschenberger, Mougey et al. 
2002), as have m utations located in the first transmembrane domain (TM0). The latter 
can be corrected by sulfonylureas, and the rescued channels are fully functional.
Previous studies o f channel m utations that were isolated from patients and expressed in 
various system s, indicate that a m ajority of described m utations lead to nonfunctional 
channels, and that this is in part because the channel protein fails to traffic properly 
(Kane, Shepherd et al. 1996; O tonkoski, Ammala et al. 1999; Sharma, Crane et al. 1999; 
Partridge, Beech et al. 2001).
R ecently, two patients were identified with complex DN A m utations. The first was 
hom ozygous for two m utations in S U R l, D1193V (TMD2) and R1436Q (located in 
N B D 2) resulting in typical diffuse CHI and severe hyperinsulinism. A second patient 
had inherited two S U R l m utations from his father, G228D (CL3) and D1471N  (N BD 2). 
and m utation V 15721 (N B D 2) from his mother, resulting in focal CHI. H am ster S U R l 
and m ouse Kir6.2 clones were used to introduce the desired m utations using the 
Stratagene QuikChange kit. since the lab has expertise in m anipulating them. To 
mimic the fact that the patients had m utations on the same chromosome, the S U R l 
m utations D1193V and R1436Q (SU R l D1193V/R1436Q) and G228D and 1)1471 
(S U R l G 228D /D 1471N ) were made in the same cDNA construct. These were 
engineered by Dr M uzyamba.
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As part o f a study to determine the consequences o f DNA variations on K a t p  channel 
function, im m unohistochem istry was performed on cells expressing the m utant channel 
protein to observe if  there was any membrane delivery o f the channel com plex  
(M uzyamba, Farzaneh et al. 2007). The individual S U R l m utants were expressed with  
mouse Kir6.2-HA (Kir6.2 with an extracellular antigenic haem agglutinin epitope tag  
engineered between the H5 segm ent and TMD1), which was a gift from Dr Jan (John. 
Monck et al. 1998; Zerangue, Schwappach et al. 1999).
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Figure 4.5: Surface staining of w ild-type and m utant Kir6.2/SUR1 K vtp channel com plexes in 
permeabilised (left panel) and non-permeabilised (right panel) CHO-K1 cells (refer to m ethods). 
M utations reside in S U R l at R1436Q and D1193V, and are expressed alone or in com bination. 
All images were captured at the same exposure (1 second) and m agnification (400x), and were 
not subject to any other form o f enhancement other than the addition o f  green pseudocolour 
when opened in Photoshop. The white scale bar represents 70pm.
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W hen Kir6.2-HA was expressed alone, there was only staining in permeabilised cells 
(Figure 4.5a). However, when expressed with S U R l, there was staining in both  
permeabilised and non-permeabilised cells, indicating significant membrane delivery o f  
the com plex (Figure 4.5b). The single S U R l D1193V and S U R l R1436Q translocated  
Kir6.2-HA to the plasma membrane, as indicated by staining in non-permeabilised cells 
(Figure 4.5c&d). However, the double m utant failed to do so, as indicated by staining  
in permeabilised cells only (Figure 4.5e).
These observations confirmed the data obtained by confocal microscopy co-localization  
experim ents, whereby S U R l D1193V  and S U R l R1436Q translocated Kir6.2-GFP to 
the plasma membrane, whereas the double m utant failed to do so and K ir6.2-GFP was 
located intracellularly (M uzyam ba, Farzaneh et al. 2007).
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Non-Permeabilised Permeabilised
Figure 4.6: Surface staining o f w ild-type and m utant Kir6.2/SUR1 K a t p  channel com plexes in 
permeabilised (left panel) and non-permeabilised (right panel) CH 0-K 1 cells. M utations reside 
in S U R l at G228D and D1471N  (expressed alone or in combination) and at V15721. All images 
were captured at the same exposure (1 second) and magnification (400x), and were not subject 
to any other form o f enhancem ent other than the addition of green pseudocolour when opened  
in Adobe Photoshop. The white scale bar represents 70pm.
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S U R l G228D, S U R l D 1471N and S U R l G228D/D1471N all failed to translocate  
Kir6.2-HA to the cell surface (Figure 4.6a,b&c), whereas the coexpression o f S U R l  
VI572I w ith Kir6.2-HA led to staining in both permeabilised and non-permeabilised  
cells (Figure 4.6d).
Again, these observations are consistent with the co-localization experim ents in which  
S U R l G228D, S U R l D1471N and S U R l G228D/D1471N all failed to translocate  
K ir6.2-GFP to the plasma membrane, whereas S U R l Y1572I did (M uzyam ba, 
Farzaneh et al. 2007).
It should be emphasized that the conditions used for permeabilization led to a number 
o f cells detaching, which accounts for the lower apparent density seen with the 
permeabilised samples. Transfection efficiency was high in both permeabilised and non- 
permeabilised cell samples (~70% ) as determined by parallel transfection o f the 
reconstituted channel D N A  with GFP. Since the results from this assay and the 
confocal microscopy studies were consistent (M uzyamba, Farzaneh et al. 2007), it was 
deemed to be a valid m ethod o f m onitoring surface expression of channel complexes.
Since I was confident that truncation o f the C-terminus of Kir6.1 removed the RK R  
m otif, allowing it to be expressed independently o f SU R 2B, the previously described N- 
and C-terminal truncation m utants were initially expressed with SU R 2B, and channel 
functionality tested with the 86R b+ flux assay.
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Figure 4.7: The effect o f truncation o f either the N or C terminus of Kir6.1 on the function o f  
the K ir6.1/SU R 2B as shown by 86R b+ efflux. Efflux was measured 15 m inutes after the  
addition o f drugs, and was calculated as % efflux o f initial 86R b+ content. The control 
represents DMSO diluted in H BS. Data are shown as +/- SEM, whereby n=9. *** PcO.OOl 
compared to control, ** P=0.001-0.01 compared to control, * P=0.01-0.05 compared to control, 
(ns) P>0.05 compared to control.
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W hilst Kir6.1AC48/SUR2B, K ir6.1AN 13/SUR2B and Kir6.1AC61/SUR2B all 
dem onstrate normal functionality (i.e. show a comparable response to each condition as 
that o f K ir6.1/SUR 2B), K ir6.1AN 33/SUR2B would appear to be non-functional since 
efflux does not differ significantly from the control when either the K a t p  channel 
opener or m etabolic inhibitors are applied (Figure 4 . 7). Therefore, whilst truncation o f  
up to 61 am ino acids from the C-terminus and 13 amino acids from the N-term inus o f  
Kir6.1 does not appear to affect the functionality o f K ir6.1/SUR2B, truncation o f 33 
amino acids from the N-term inus has a significant effect. The control efflux observed 
for Kir6.1AC61/SUR2B would appear low in comparison to the other two functional 
m utants, whereby reversal o f efflux by glibenclamide is below the level o f the control. 
H owever, we can not rule out the possibility that variation in basal efflux between the  
functional m utants is due to variation in transfection efficiency.
It is interesting to note that l^ir6.1 13/S IT R2^3 is functional, whereas
K ir6.1AN33/SUR2B would appear to be a ’dead’ m utant, an observation which opposes 
the previous findings o f Babenko and Bryan. They found that progressively larger 
deletions o f the N-term inus o f Kir6.1 increased the P o (m a x ), with an apparent saturation  
o f the effect at AN33. This successive increase in the channel open state would 
presumably infer a gradual increase in basal efflux.
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Figure 4 .8 : The effect o f truncation of both the C&N terminus of Kir6.1 on the function o f the  
K ir6.1/SUR2B as shown by 86Rb+ efflux. Efflux was measured 15 m inutes after the addition of 
drugs, and was calculated as % efflux o f initial 86R b+ content. The control represents DMSO  
diluted in H B S. The data represent means +/- SEM for three different experim ents performed 
in triplicate (n=9). *** PcO.OOl compared to control, ** P=0.001-0.01 compared to control, * 
P=0.01-0.05 compared to control, (ns) P>0.05 compared to control.
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The double truncation m utants containing the N-term inal 33 amino acid deletion also 
appear to be non-functional (i.e. Kir6.1AN33/AC48 and Kir6.1AN33/AC61). Therefore, 
deletion o f the N-term inal 33 am ino acids o f Kir6.1, either w ith/w ithout truncation of  
the C-terminus, yields a non-functional reconstituted channel. The control efflux  
observed for Kir6.1AC48/AN13 and Kir6.1AC61/AN13 is similarly reduced on the  
addition o f glibenclamide (P<0.05), which is again indicative that functional channels 
display a basal efflux in the absence o f stim ulation by a KCO or metabolic inhibition.
It was subsequently deduced whether any o f these m utants could be functionally  
expressed under the same conditions in the absence o f SU R 2B, or whether the  
sulphonylurea receptor was absolutely required for the pharmacological response to 
m etabolic inhibition observed. Even though no response to levcromakalim was 
expected, since its binding site resides on SU R 2B , this was applied as a control (for 
which to compare the response to m etabolic inhibition).
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Figure 4 .9 : Deduction o f the functionality of Kir6.1AC48/AN13 and Kir6.1AC48 expressed in 
H E K 293 minus the sulphonylurea receptor. Efflux is also compared with that in untransfected  
H EK 293 cells and cells transfected with Kir6.1, whereby the same conditions were applied to 
elicit a response. Efflux was measured 15 minutes after the addition o f drugs, and was 
calculated as % efflux o f initial 86R b+ content. The control represents DMSO diluted in H BS. 
The data represent means + /- SEM for three different experiments performed in triplicate 
(n=9).
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Kir6.1AC48 and Kir6.1AC48/AN13 were previously shown to be functional and to show  
a relatively high level o f efflux under each of the conditions applied. However, when  
expressed in the absence of the sulphonylurea receptor, there was no obvious response 
to the pharmacological agents applied in comparison to the control (Figure 4.9). The 
fact that these Kir6.1 m utants do not appear to respond independently to m etabolic 
inhibition, is indicative that they do not possess the same intrinsic nucleotide activ ity  
as that previously demonstrated for Kir6.2 by Tucker and colleagues.
An experim ent was sim ultaneously conducted to establish the basal level o f efflux in 
H EK 293 cells, and to confirm that Kir6.1 is unable to function as an independent 
entity  in the absence o f the sulphonylurea receptor (Figure 4.9). H EK 293 cells display  
around 3% basal efflux, which is not amplified on the addition o f the non-functional 
subunit. This suggests that the results obtained from this assay so far have arisen from 
the introduction o f recom binant D N A  encoding the K a t p  channel, and not due to some 
other anom aly. It is also interesting to note that the basal level o f efflux is around 6%  
higher in cells expressing AN-Kir6.1-AC than in those expressing Kir6.1. This could be 
due a variation in transfection efficiency, or due to some unidentified intrinsic factor. 
However, it would appear that if  Kir6.1 is able to get to the membrane in the absence o f  
the sulphonylurea receptor, it displays a higher basal efflux. This is investigated  
further in the proceeding chapter.
The whole-cell patch clam ping technique was applied to confirm the validity o f the 
86R b+ flux data obtained for selected Kir6.1 truncation m utants. Current/Density bar 
charts are shown to represent mean data, and representative traces are shown for one 
m utant.
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Figure 4.10: D ata to represent patch clamp recordings obtained from H EK 293 cells transiently  
transfected with Kir6.1AC48/AN13 & SU R 2B . Kir6.1AC48 & SU R 2B and Kir6.1AN33 & 
SU R 2B . V oltage clamp recordings were obtained under symmetrical K + conditions, and were 
evoked during 200ms voltage steps between -lOOmV and +50m V  in lOmV increments from a 
holding potential o f OmV (A) Representative traces for each o f the conditions for Kir6.1AC48. 
Traces are shown for the control current (external solution with DMSO), 10JJ.M levcromakalim, 
10pM levcromakalim and 10pM glibenclamide and lOjlM levcromakalim with ImM BaCI* (B) 
R epresentative I/V traces (pA/pF) for Kir6.1AC48 under each condition, whereby each trace 
crosses the holding potential at OmV (C) Current/Density bar chart to represent mean data for 
the response o f Kir6.1AC48 & SU R 2B , Kir6.1AC48/AN13 & SUR2B and Kir6.1AN33 & SU R 2B  
to the applied KCO and KCBs. The data represent means + /- SEM (n=6) *** PcO.OOl 
compared to control. ** P=0.001-0.01 compared to control, (ns) P>0.05 compared to control.
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Both Kir6.1AC48/AN13/SUR2B and Kir6.1AC48/SUR2B respond to the KCO and KCB 
as expected, whereas Kir6.1AN33 would appear to be non-functional (Figure 4.10). This 
data confirms that obtained using 86R b+, further indicating the validity o f this assay. 
N ote that m etabolic inhibitors were not applied using the whole-cell patch clam p  
m ethod, the reasons for which were described in the previous chapter.
Mutant Functional 
with SUR2B
Surface expressed 
with SUR2B
Functional 
without SUR2B
Surface expressed 
without SUR2B
Kir6.1 AC61 yes yes no yes
Kir6.1 AC48 yes yes no yes
Kir6.1 AN 13 yes yes no no
Kir6.1 AN33 no yes no no
Kir6.1 AN13/AC48 yes yes no yes
Kir6.1 AN13/AC61 yes yes no yes
Kir6.1 AN33/AC48 no yes no yes
Kir6.1 AN33/AC61 no yes no yes
Table 4.1: Summary of the functionality and surface expression of AN-Kir6.1-AC truncation 
mutants
The table summarizes the key findings obtained from the Kir6.1 truncation m utants. 
All were surface expressed in the presence o f SU R 2B. Those that were surface 
expressed in the absence o f the sulphonylurea receptor and functional in its presence 
were Kir6.1AC61, Kir6.1AC48, Kir6.1AC48/AN13 and Kir6.1AC61/AN13. Kir6.1AC48 
and Kir6.1AC48/AN13 were unable to function independently, suggesting a lack o f  
intrinsic ATP sensitivity. However, since they demonstrated increased basal activ ity , 
their pharm acology was subsequently investigated using the K a t p  channel pore 
blockers BaCb and PN U -37883A . In fact, the latter proved to be a useful tool to study  
m etabolic regulation o f the K a t p  channel, this being the focus o f the next chapter.
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Chapter Five
The application o f  K ATP channel inhibitors to infer the role o f  
the pore-forming subunit in channel regulation under
metabolic inhibition
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Chapter Five: Results
The application of K a t p  channel inhibitors to infer the role of the pore-forming 
subunit in channel regulation under metabolic inhibition
P N U -3 7 8 8 3 A  is a n o v e l n o n -su lp h o n y lu rea  K a t p  ch a n n el in h ib ito r , w h ich  a lth o u g h  w as  
o r ig in a lly  d ev e lo p ed  on  th e  b a sis  o f  its  w ea k  d iu retic  e ffec ts , sh ow ed  so m e s e le c t iv ity  for  
th e  v a scu la r  K a t p  ch a n n e l (H u m p h r e y , S m ith  et al. 1996). E a r ly  ex p er im en ts  in  rat 
m esen ter ic  artery  sh o w ed  th a t  P N U -3 7 8 8 3 A  in h ib ited  b lood  v esse l r e la x a tio n  in d u ced  
b y  K CO s (M eisheri, H u m p h r e y  et al. 1993), and  in  vitro  ex p er im en ts  sh o w ed  th a t  it 
s ig n if ic a n tly  reversed  h y p o te n s io n  p rod u ced  b y  crom ak a lim , p in acid il and m in o x id il in  
ra ts , c a ts  an d  d ogs (M eish eri, H u m p h rey  et al. 1993). F u rth erm o re , 
e le c tr o p h y s io lo g ic a l ex p e r im e n ts  d e m o n stra ted  th a t  ev en  th o u g h  P N U -3 7 8 8 3 A  w a s n ot 
a b le  to  in h ib it  current in  card iac  an d  sk e le ta l m y o c y te s , it  w as ab le  to  se le c t iv e ly  in h ib it  
K a t p  cu rren ts a c tiv a te d  b y  le v cro m a k a lim  in sin g le  sm o o th  m u scle  ce lls  iso la ted  from  
rat m esen ter ic  artery  (W ellm a n , B a r r e tt-J o lle y  et al. 1999).
S u b seq u en t ex p er im en ts  w ere d esig n ed  to  m ore d irec tly  address th e  issu e  o f  th e  s ite  o f  
a c tio n  o f  P N U -3 7 8 8 3 A  (C ui, T in k er  et a l. 2 0 0 3 ), w h ereb y  its  e ffects  on  four ty p e s  o f  
clon ed  K a t p  ch a n n e ls  s ta b ly  exp ressed  in  th e  H E K -2 9 3  cell lin e  w ere in v e s t ig a te d  v ia  
th e  w h o le -ce ll co n fig u ra tio n  o f  th e  p a tch -c la m p  tech n iq u e . I ts  effect on  th e  current 
g en era ted  b y  K ir6.2A C 26 w a s  a lso  ex a m in ed . In h ib it io n  o f  th e  p u ta t iv e  sm o o th  m u scle  
c lo n es K ir 6 .1 /S U R 2 B  and K ir 6 .2 /S U R 2 B  (IC 50 6pM  and  15pM  resp e c tiv e ly ) w as  
s ig n if ic a n tly  greater  th a n  in h ib it io n  w ith  e ith er  th e  p an crea tic  or P cell or card iac  
c lo n es, w h ereb y  th e  S U R  recep tor  a ffec ts  drug b in d in g  to  th e  pore. P I \U -3 7 8 8 3 A  
in h ib ited  cu rren ts g en era ted  b y  ex p ressin g  K ir6.2A C 26 a lon e (IC 50 5p M ). b u t w h en  
exp ressed  w ith  S U R 2 B  th is  w as increased  to 38pM . T h ese fin d in g s are fu rth er  
co n firm a tio n  th a t P N U -3 7 8 8 3 A  h as a degree o f  va scu la r  s e n s it iv ity , p r o v id in g  ev id e n c e  
for a h e tero m eric  ch a n n e l stru ctu re , w ith  th e  ch an n el pore co m p o sed  o f  K ir6.1 and  
K ir6.2  su b u n its  (T era m o to  2003).
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P N U -3 7 8 8 3 A  w a s th erefore  d eem ed  as a u se fu l m ean s o f  in v e s t ig a tin g  th e  fu n c t io n a lity  
o f  th e  A N -K ir6 .1-A C  m u ta n ts  g en era ted , p a rticu la r ly  th e  b asa l e ff lu x  o b serv ed  in  
C h ap ter 4  (F igu re  4 .9 )  w h en  ex p ressed  in  H E K 2 9 3  cells . A d ose-resp on se  e x p e r im e n t  
w as in it ia lly  con d u cted  on  H E K 2 9 3  cells s ta b ly  ex p ressin g  K ir 6 .1 /S U R 2 B  u sin g  th e  
86R b + flu x  a ssa y . P N U -3 7 8 8 3 A  h ad  n ot b een  app lied  in  th is  se tt in g  b efore, and  it w a s  
n ecessa ry  to  d eterm in e  th e  d o se  required  to  s ig n ific a n tly  reduce ch an n el e ff lu x , w h ereb y  
e fflu x  w a s  in d u ced  b y  10pm  lev cro m a k a lim .
2 5 -i
20-
15-R esponse  
(% efflux on addition 
of PNU-37883A) 10 -
-3 .5 -3.C- 6.0 -5 .5 -5 .0 -4 .5 -4.0
Log [M] PNU-37883A
Figure 5.1: Dose response curve to determ ine concentration at which the potassium  channel 
inhibitor, PN U -37883A , results in m axim al inhibition o f Kir6.1 conductance. Efflux was 
induced by the application o f the KCO levcrom akalim  (lOpM). 86R b+ efflux, plotted as a 
percentage efflux on application o f  P N U -37883A . was measured 15 minutes after the addition  
o f lpM , 3pM, lOpM, 30pM, lOOpM and ImM respectively to H EK 293 cells stab ly  transfected  
w ith K ir6.1/SU R 2B. D ata are shown as + /- SEM, whereby (n) = 9 and pIC.s<> = 5 . 1
T h e  % in itia l e ff lu x  ob served  o n  th e  a p p lica tio n  o f  th e  KCO w as a p p r o x im a te ly  22% . 
and is co m p a ra b le  w ith  p rev io u s  d a ta  (F igure  3 .2 ) .  M axim al in h ib it io n  o f  m ean  
K ir 6 .1 /S U R 2 B  e fflu x  w as seen  a fter  th e  a d d itio n  o f  lOOpM P N U -3 7 8 8 3 A  (h en ce  th is  
w a s th e  a p p lied  d ose  in  su b seq u en t ex p er im en ts), w h ereb y  th e  drug p o te n c y  w a s  
d eterm in ed  v ia  th e  [C 50 v a lu e  for current in h ib itio n  (~ 10p M ). T h is  is s im ilar  to  th e  IC 50 
o f  P N U -3 7 8 8 3 A  in h ib it io n  o n  th e  K ir 6 .2 /S L R 2 B  and K ir6 .1 /S L  R 2 B  cell lin es  
p rev io u sly  d eterm in ed  v ia  p a tch  c la m p in g  (Cui, T in k er et al. 2003). B aC E  a lso  in te r a c ts
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w ith  th e  p ore-form in g  su b u n its , b u t sh o w s less se le c t iv ity  b e tw een  th e  K a t p  c h a n n e l  
su b ty p e s . Im M  B aC b  w as ap p lied  sin ce  th is  p ore-form in g  su b u n it in h ib ito r  h as b een  
in  w id e u se  in  a n u m b er  o f  d ifferen t sy s te m s , and  it h as p rev io u sly  been  sh o w n  b y  a 
form er m em b er  o f  th e  lab , Q u in n  K V , th a t th is  is an o p tim a l co n c e n tr a tio n  to  
e ff ic ie n tly  b lo ck  th e  K a t p  ch a n n e l current in th e  w h o le-ce ll p a tch  c la m p  m o d e at a 
h yp erp o la r ised  p o te n tia l. B a C b  is less p o ten t in  com p arison  w ith  g lib en c la m id e  in  
b lo ck in g  K a t p  ch a n n e ls  and  a r e la tiv e ly  h igh  co n cen tra tio n  is required for s ig n ifica n t  
b lo ck in g  (N e lso n  and  Q u a y le  1995). B ariu m  b lock  o f  K ir cu rren ts in creases w ith  
m em b ra n e  h y p erp o la r isa tio n . O n in crea sin g  th e  m em b ran e to  a m ore h y p erp o la r ised  
v o lta g e  in  th e  p resen ce o f  b a r iu m , th e  in crease  in  b lock  b y  barium  occurs o v er  sev era l 
h u n d red  m illiseco n d s (Q u a y le , M cC arron et a l. 1993). It is th o u g h t th a t  bariu m  b in d s  
to  a s ite  in  th e  pore to  p rev en t K + m o v e m e n t th ro u g h  th e  ch an n el. A ssu m in g  th a t  th e  
b in d in g  s ite  lies w ith in  th e  m em b ra n e  v o lta g e  fie ld , m em b ran e h y p erp o la r isa tio n  w ill 
fa v o u r  b in d in g  o f  p o s it iv e ly  ch arged  io n s  to  th e  s ite . T h e  sim p lest e x p la n a tio n  is th a t  
th e  b arium  b in d in g  s ite  lies w ith in  th e  ch a n n e l pore (Q u ay le . M cCarron e t al. 1993).
B ased  on  th e  ev id en ce  d iscu ssed , b o th  bariu m  ch lorid e  and P N U -3 7 8 8 3 A  w ere a p p lied  
to  A N -K ir6 .1-A C  to  d eterm in e  i f  a n y  b asa l current ob served  v ia  e ff lu x  cou ld  be  
reversed .
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Figure 5.2: Effect o f potassium  channel inhibitors on H EK 293 cells transfected with Kir6.1 
truncated m utants. These are compared with experiments to establish the effect o f 100JJ.M 
PN U -37883A  and ImM BaCh on the basal flux in untransfected H EK 293 cells, and cells 
transfected w ith Kir6.1. Mean 8f,R b+ efflux of HEK293 cells transiently transfected with Kir6.1 
or AN-Kir6.1-AC terminal truncated m utants (minus sulphonylurea receptor) 15 m inutes after 
addition o f drugs. Efflux was calculated as % efflux o f initial 86R b+ content. The control 
represents DMSO diluted in H BS. Data are shown as + /- SEM, whereby n = 9. *** PcO.OOl 
compared to control, (ns) P >0.05 compared to control.
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All four truncation m utants display basal activ ity  when expressed in the absence o f the  
sulphonylurea receptor, and this is reversed on the addition o f a known Kir6.x-specific 
inhibitor (P<0.001). It is apparent that both lOOpM PNU-37883A and ImM BaCb 
were able to bind to the pore-forming subunit independently o f the sulphonylurea  
receptor, and that truncation o f Kir6.1 at either the N- or C-terminus does not affect 
the ability o f the inhibitor to bind. The fact that lOOpM PN U-37883A and ImM BaCb  
would appear to block any basal current to the same degree, would also indicate that 
the dose o f BaCh applied gives an inform ative response. Therefore, even though it has 
been shown that these m utants do not display metabolic sensitivity in this setting, they  
do show some constitutive activ ity . These findings are strengthened by the fact that  
Kir6.1 expressed in H EK 293 cells independently o f the sulphonylurea receptor does not 
respond to either inhibitor. It is also interesting to note that Kir6.1AC48 and 
Kir6.1AC61 appear to show a higher basal activ ity  when the N-term inus is also  
truncated (i.e. Kir6.1AC48/AN13 and Kir6.1AC61/AN13) prior to the addition o f Kir6.x- 
specific inhibitors.
Neither inhibitor has an effect on the basal current seen in H EK 293 cells. The basal 
efflux observed on transfection o f the pore-forming subunit only is considerably lower 
than that observed upon transfection of AN-Kir6.1-AC, is comparable to that observed 
for untransfected H EK 293 cells, and is not affected by the addition o f lOOpM PN U - 
37883A nor ImM BaCb. This indicates that both inhibitors are indeed acting on the 
recom binant channel introduced, and that the introduction of truncated channel 
protein is specifically responsible for the increased basal efflux observed.
B oth Kir6.1AC48 and Kir6.1AC48/AN13 were subsequently expressed w ith SU R 2B , and 
the ability o f PN U -37883A  and BaCb to reverse efflux observed on the addition o f KCO 
and m etabolic inhibitors deduced. It was interesting to determine whether a pore 
blocker could substitute for lOfiM glibenclamide, which acts on the sulphonylurea  
receptor, to produce the result observed in Figures 4 .7  and 4.8. Since it has also been
172
shown that the potency of PN U -37883A  was seven-fold greater on Kir6.2AC26 than  
Kir6.2AC26/SUR2B, it was also o f  interest to determine whether the sulphonylurea  
receptor could m odulate the response of AN-Kir6.1-AC.
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Figure 5.3: Effect o f potassium  channel blockers on AN-Kir6.1-AC truncation m utants 
expressed with SU R 2B . Mean 86Rb+ efflux o f HEK 293 cells transiently transfected with either 
Kir6.1AC48/SUR2B or Kir6.1AC48/AN13/SUR2B measured 15 minutes after addition o f drugs. 
The efflux was calculated as % efflux o f initial 86Rb+ content. The control represents DMSO 
diluted in H BS. Data are shown as +/- SEM, whereby n = 9. *** PcO.OOl compared to control, 
** P 0.001-0.Olcompared to control, (ns) P>0.05 compared to control. The ability o f both  
PN U -37883A  and BaCb to reverse the efflux observed on metabolic inhibition o f the channel 
are also directly compared.
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The result displayed in Figure 5.3  is very interesting, and somewhat unexpected. The 
same general result is observed for both Kir6.1AC48 and Kir6.1AC48/AN13 in that when 
expressed with SUR2B, both ImM BaCh and lOOpM PNU-37883A are able to reverse 
to efflux induced on the addition o f KCO. However, neither pore blocker is able to 
reverse the efflux induced on the addition of the metabolic inhibitors (2.5mM NaCN  
and 20mM 2-DG). This is the converse of the result displayed in Chapter 4, Figures 4 .7  
and 4 .8 , whereby 10pM glibenclamide was able to reverse the efflux observed on the 
addition o f both KCO and metabolic inhibitors (PcO.OOl). Before any further 
conclusions were drawn as this stage, the necessary control was conducted in which the 
same experiment was conducted on the Kir6.1/SUR2B stable cell line as shown in 
Figure 5.4.
Ml + BaCI2
Lev + BaCh
Condition
Ml + 
PNU-37883A
Lev + 
PNU-37883A
* * *
* * *
* * *
Ml + 1mM BaCI2 
Ml + 100nM PNU-37883A 
2.5mM NaCN + 10^M Glib (Ml) 
IOjjM Lev + 1mM BaCI2 
10jiM Lev + 100^M PNU-37883A 
10|iM Levcromakalim 
Control
% Mean Efflux
Figure 5.4: Effect o f potassium channel inhibitors on the Kir6.1/SUR2B stable cell line. The 
ability lOOpM PN U -37883A  and ImM BaCb to reverse the efflux previously shown to be 
induced w ith a KCO and m etabolic inhibitors was investigated. Mean tt6R b+ efflux was 
measured 15 minutes after addition of drugs. Efflux was calculated as % efflux o f initial 86R b+ 
content. The control represents DMSO diluted in HBS. D ata are shown as + /- SEM , whereby n 
=  9. *** PcO.OOl compared to control, (ns) P>0.05 compared to control. The ability  o f  both  
PN U -37883A  and BaCb to reverse the efflux observed on metabolic inhibition o f the channel 
are also directly compared.
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The application of IOOjiM PN U -37883A  and ImM BaCh reduced the efflux observed on 
the addition o f KCO to the K ir6.1/SUR 2B stable cell line to a similar extent as that 
observed for glibenclamide. Neither the application o f lOOpM PN U-37883A nor ImM  
BaCh showed a reduction of efflux induced by the addition o f metabolic inhibitors to a 
similar extent as that observed for glibenclamide (Figure 3.2). Therefore, when the  
cloned equivalent o f the vascular K a t p  channel, K ir6.1/SUR2B, is expressed in 
H EK 293 cells the increase in efflux (compared to the basal level observed) induced by 
both the KCO and m etabolic inhibitors is reversed by both glibenclamide, but to a 
lesser degree via inhibitors that bind to the pore-forming subunit (there appears to be 
around a 20% reduction). Therefore, the degree o f reversal o f efflux induced via 
m etabolic inhibition depends on where the inhibitor binds to the K a t p  channel, i.e. the 
pore-forming subunit or the sulphonylurea receptor. However, when either Kir6.1AC48 
or Kir6.1AC48/AN13 is expressed w ith SU R2B this scenario is exaggerated. Although  
both Kir6..*-specific inhibitors and glibenclamide are able to reverse the efflux induced 
by the KCO, the efflux induced upon metabolic inhibition can only be reversed by a 
KCB that binds to the sulphonylurea receptor. It is possible that metabolic depletion 
induces conformational change within the reconstituted channel that prevents the 
Kir6.*-specific inhibitors from binding to the Kir subunit. W hen either the N- or C- 
terminus o f Kir6.1 is truncated this result is exaggerated. In an attem pt to support this 
possibly controversial observation, this experiment was repeated using the perforated 
patch-clamp m ethod, to deduce whether this result was reproducible under a different 
setting.
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Figure 5.5: The effect o f the K a t p  channel inhibitor PN U -37883A  on the reconstituted channel 
Kir6.1AC48/AN13/SUR2B in the presence of a KCO and metabolic inhibitors, as demonstrated  
by the perforated patch-clam p m ethod. Currents were evoked via voltage clamp recordings 
over 1000ms voltage steps between -150mV and +50m V from a holding potential o f -80mV, 
with 15s between sweep starts. (A) Representative traces for each of the conditions: external 
solution with DMSO, 10pM Levcromakalim, lOpM Levcromakalim with lOOpM PN U -37883A , 
m etabolic inhibitors (2 .5 m \l NaCN and 20mM 2-DG) and metabolic inhibitors with 100p.M 
PN U -37883A . The time taken to achieve a response in relation to the control is given (note 
that glibenclamide was flushed out before the addition o f metabolic inhibitors). (B) 
Representative I/V traces for each o f the conditions (pA/pF), whereby each trace crosses the  
holding potential at -80mV. (C) Current/Density bar chart to represent mean data o f the
reconstituted channel currents under each condition *** PcO.OOl compared to control, (ns) 
implies P>0.05 compared to control (n=6). The ability of PN U-37883A to reverse the efflux  
observed on the addition o f m etabolic inhibitors and KCO of the channel are also directly 
compared.
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The data obtained from this patch-clam p experim ent supports that obtained from the  
86R b+ flux assay. The addition o f lOOpM PN U -37883A  reduced the increased current 
passed on the addition o f lOpM levcromakalim, but is unable to reduce the increased 
current observed on the addition o f m etabolic inhibitors. This supports the idea that a 
conform ational change occurs within the channel under metabolic inhibition that 
prevents the normal binding o f either ImM BaCh or lOOpM PN U -37883A . 
Interestingly, the reversal potential remained consistent throughout the experim ent, 
indicating that the potassium  conductance is unaffected. A similar experim ent was 
therefore conducted to investigate the effect o f the Kir6.:x>specific inhibitors on 
Kir6.1AC48/AN13 expressed w ithout SU R 2B , primarily to deduce if  it was able to 
reduce any basal current observed.
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Figure 5.6: The effect of the K a tp  channel inhibitor PNU-37883A on the reconstituted channel 
Kir6.1AC48/AN13. The ability of lOOpM PNU-37883A to reverse basal efflux and th a t induced 
by m etabolic inhibitors was investigated using the perforated patch-clamp m ethod. Currents 
were evoked via voltage clamp recordings during 1000ms voltage steps between -150mV and 
+50mV from a holding potential of -80mV, with 15s between sweep starts. (A) Representative 
traces for each of the conditions: Control (external solution with DMSO), lOOpM PNU-37883A, 
m etabolic inhibitors (2.5mM NaCN and 20mM 2-DG) and metabolic inhibitors w ith IOOjiM 
PNU-37883A. The time taken to achieve a response in relation to the control is given (B) 
R epresentative I/V traces for each of the conditions (pA/pF), whereby each trace crosses the 
holding potential a t -80mV. (C) C urrent/D ensity bar chart to represent mean data  of the
reconstituted channel currents under each condition *** PcO.OOl compared to control, (ns) 
P>0.05 (n=6)
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This result is once again comparable w ith that observed with the flux assay, and 
provides further evidence that the pore is not intrinsically m etabolically sensitive. 
Kir6.1AC48/AN13 exhibits basal current which is reduced on the addition o f lOOpM 
PN U -37883A . W hen expressed alone this m utant is insensitive to m etabolic inhibition, 
therefore the current passed does not exceed that observed for the control. Similarly, 
the reversal potential remains the same under each condition applied, therefore 
potassium channel conductance is unaffected.
Subsequently, a series o f experim ents were conducted in which the functionality o f  
Kir6.2AC26 was investigated when expressed both alone and with SU R 2B, to determine 
how the response o f a m utant known to express current at the membrane in the absence 
of SU R , compared to Kir6.1AC48/AN13. Kir6.2AC26 was previously engineered by Yi 
Cui by introducing a stop codon into Kir6.2 using site-directed mutagenesis.
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Figure 5.7: Effect o f  potassium channel Kir6.jc-specific inhibitors on HEK 293 cells transfected  
with Kir6.2AC26. The ability IOOjiM PN U -37883A  and ImM B ad? to reverse the efflux  
induced w ith a KCO and m etabolic inhibitors was investigated. Mean 86Rb+ efflux was 
measured 15 minutes after addition o f drugs. Efflux was calculated as % efflux o f initial 86R b+ 
content. The control represents DMSO diluted in H BS. Data are shown as + /- SEM, whereby n 
= 9. *** PcO.OOl, ** P 0.001-0.01 compared to control, *P = 0 .0 1 -0 .0 5  com pared  to  con tro l, 
(ns) P >0.05 compared to control.
W h en  K ir6.2A C 26 w as exp ressed  a lon e , no response to  th e  KCO p in acid il w as ob served  
(w h ich  is n o t surprising d u e to  th e  ab sen ce o f  a su lp h on y lu rea  receptor to  w h ich  it  
b in d s). H o w ev er , s ig n ifica n t resp on se  to  th e  m etab o lic  in h ib itors 2 .5m M  N aC N  and  
20m M  2-D G  w as ob served , w h ich  w as reduced on th e  ad d ition  o f  e ith er  Im M  B aC l2 or 
lOOpM P N U -3 7 8 8 3 A  (PcO.OOl). T h is correlates w ith  th e  p rev iou s o b serv a tio n  th a t  
K ir6.2A C 26 h as in tr in sic  m eta b o lic  se n s it iv ity  (T ucker, G ribble et al. 1997) and  th a t  
P N U -3 7 8 8 3 A  is ab le  to  in h ib it current generated  b y  exp ressin g  K ir6.2A C 26 a lo n e  (C ui, 
T inker et al. 2003). C om parison  o f  th is result w ith  th e  p erfora ted -p atch  d a ta  d isp la y ed  
in Figure 5 .6 , and th e  86R b + flu x  d a ta  d isp layed  in  F igure 4 .9 , in d ica tes  th a t th ere  is a
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difference in m etabolic sensitivity between Kir6.1AC48/AN13 and Kir6.2AC26. 
Furthermore, it is now reasonable to assume that the increased flux observed on the  
application o f m etabolic inhibitors is representative o f intrinsic ATP sensitivity o f the  
pore-forming subunit. F inally, a series o f experim ents were conducted (primarily as a 
control) to ensure that when expressed with SU R 2B, Kir6.2AC26 displays normal 
pharm acology (i.e. that the sulphonylurea receptor can restore normal functionality).
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Figure 5 .8 : The effect o f a KCO and metabolic inhibitors on H EK 293 cells transiently  
expressing Kir6.2AC26 both with and without SU R 2B. Mean 86Rb+ efflux was measured 15 
m inutes after addition o f drugs. Efflux was calculated as % efflux of initial 86R b+ content. The 
control represents DMSO diluted in HBS. D ata are shown as + /- SEM, whereby n = 9. *** 
PcO.OOl, (ns) P >0.05 compared to control.
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W hen Kir6.2AC26 is expressed with SU R 2B , normal pharmacology is restored. A 
significant response to both the KCO as well as to metabolic inhibition is observed, and 
the increase in efflux induced is reversed by both glibenclamide and the Kir6.x-specific 
inhibitor (as for K ir6.1/SUR 2B). As expected, when Kir6.2AC26 is expressed alone the 
increase in efflux in response to m etabolic inhibition is not reversed by glibenclamide 
due to the absence of a sulphonylurea receptor.
The following table summarises the key findings deduced in this chapter, i.e. the  
response o f the various truncation m utants, expressed either with or w ithout SU R 2B , 
to the Kir6.jc-specific inhibitors.
Mutant channel
Response to 
Ml?
Response to pore blockers 
after Ml after KCO
constitutively
active?
Kir6.lAC61/AN13 ne ne ne yes (++)
Kir6.lAC48/AN13 ne ne ne yes (++)
Kir6.lAC61 ne ne ne yes (+)
Kir6.lAC48 ne ne ne yes (+)
Kir6.1 +SUR2B yes (++) yes(+) yes (++) na
Kir6.lAC48 + SUR2B yes (++) ne yes (++) na
Kir6.1AC48/AN13 + SUR2B yes (++) ne yes (++) na
Kir6.2AC26 yes (++) yes (++) na yes
Kir6.2AC26 + SUR2B yes (++) yes (++) yes (++) na
Table 5 .1 : Table to sum m arise response o f AC-Kir6.* -AN to KCO and m etabolic inhibition, and 
the degree o f constitutive activ ity  observed, ne = no observable effect, na = not applicable 
( ++)  =  obvious activ ity , (+) =  less obvious activ ity .
AN-Kir6.1-AC truncations were engineered via a standard PCR procedure in an attem pt 
to create a m utant o f the pore-forming subunit o f the channel which displayed intrinsic 
ATP sensitivity in the absence of the sulphonylurea receptor, as is the case for 
Kir6.2AC26. This was made on the premise that it would serve as a useful tool for 
determining whether drugs that act on K a t p  channels do so by interacting with Kir6.2 
or with SU R 1, and for exam ining functional interaction between Kir6.2 and SU R 1.
186
In the previous chapter it was shown that Kir6.1AC48 and Kir6.1AC48/AN13 did not 
display efflux in response to the applied m etabolic inhibitors in the absence o f a 
sulphonylurea receptor. However, they displayed a relatively high basal efflux. In this 
chapter it was shown that this basal efflux was effectively reduced by the Katp channel 
inhibitors PN U-37883A and BaCb. Interestingly, Kir6.1AC48/AN13 and 
Kir6.1AC61/AN13 passed a higher basal efflux than when the C-terminus alone was 
truncated, indicating that deletion o f the N-terminus enhanced the ability o f the 
Kir6.1AC48 (expressed w ithout SU R 2B) to pass current. It was for this reason that the 
ability o f the functionality o f Kir6.1AC48/AN13 was investigated via the perforated 
patch-clam p method when expressed alone and with SU R2B.
Kir6.1AC48/AN13/SUR2B showed an increase in efflux on the application of KCO and 
m etabolic inhibitors, but the later was not reduced on the application of pore blockers. 
This is the converse o f the earlier observation in which glibenclamide was able to 
reverse efflux induced from either KCO or metabolic inhibitors. In comparison, neither 
PN U -37883A  nor BaCb reduced the current passed by K ir6.1/SUR2B when  
m etabolically inhibited to the same extent as that previously observed by 
glibenclamide. Therefore, both data obtained from 86R b+ flux and patch clam ping 
would indicate under conditions o f ATP depletion, the channel undergoes 
conform ational change that prevents efficient binding of both BaCb and PN U -37883A . 
but does not affect binding o f glibenclamide to the sulphonylurea receptor. Deletion of 
the N- and C-terminus attenuates this observation, in that both BaCb and PIVU- 
37883A do not appear to interact with the channel, or interact but do not affect the 
ability of the channel to pass current.
We observe a different scenario for Kir6.2AC26, which when expressed in the absence o f  
SU R 2B was responsive to m etabolic inhibition, which was reversed by both BaCb and 
PN U-37883A. This confirms the previously observed constitutive activ ity  of 
Kir6.2AC26, and em Ph asizes the difference between Kir6.1AC48 and Kir6.2AC26 in
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their intrinsic sensitivity to m etabolically induced changes in cytosolic nucleotide levels. 
The efflux passed by Kir6.2AC26/SUR2B under metabolic inhibition was reversed by  
PN U -37883A , but likewise not as effectively as glibenclamide, but the effect was more 
pronounced than for Kir6.1AC48/AN13.
There is obviously a difference in the role that the pore-forming subunits Kir6.1 and 
Kir6.2 play in the m etabolic sensitivity o f the reconstituted K a t p  channel, and it would  
appear that the sulphonylurea receptor has a greater importance in the regulation o f  
K ir6.1/SUR 2B than K ir6.2/SUR 2B. The importance o f the sulphonylurea receptor in 
channel regulation is the focus o f the next chapter.
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Chapter Six: Results
The role o f  the Sulphonylurea receptor in  K a t p  channel regulation
My previous studies have focused on the consequences o f truncation of the pore-forming 
subunit on the functionality o f the K a t p  channel, whereby Kir6.1AC48 and 
Kir6.1AC48/AN13 were surface expressed in the absence o f the sulphonylurea receptor, 
but did not respond to MI when expressed independently. This was suggestive o f an 
absence o f intrinsic ATP sensitivity; the converse of that observed by Tucker and 
colleagues for Kir6.2. The importance o f the sulphonylurea receptor as a regulatory  
subunit was discussed in the Introductory chapter, section 1.1 (the ABC Superfamily). 
W ith specific reference to F igure 1 .5 , I switched my attention to the role that SU R 2B  
plays in the functionality o f Kir6.1 and Kir6.2-containing channels. It was o f interest 
to begin to understand the molecular mechanisms of how nucleotides regulate Kir6.1 
containing complexes and to possibly delineate the region involved.
To investigate the roles o f the individual N B D s o f SU R 2B, Yi Cui had previously 
employed site-directed m utagenesis to exchange the lysine residue in the W a m otif o f  
either NBD1 or N B D 2 with alanine (K708A and K1349M respectively). In other ABC 
transporters, these m utations were shown to abolish ATP binding and/or hydrolysis 
(Azzaria, Schurr et al. 1989; Carson and Welsh 1995; Ko and Pedersen 1995; Ueda, 
Inagaki et al. 1997; Ueda, Komine et al. 1999). In SU R1, these m utations prevent 
activation by Mg-nucleotides (Gribble, Tucker et al. 1997; Shyng, Ferrigni et al. 1997).
It was subsequently deemed desirable to engineer a double NBD  mutant to observe the 
sim ultaneous effect o f exchanging both lysines in the Wa motifs on the functionality o f  
K ir6.1/SUR2B. SU R 2B K708A (contained in pcDNA3.1) was used as a tem plate to 
introduce the K1349M m utation, and SU R2B K1349M (again contained in pcD N A 3.1) 
was used as a tem plate to introduce K708A. Both m utations were introduced via site- 
directed mutagenesis, and were sequenced to ensure that the correct constructs had
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b een  engineered . T h e d a ta  in  F igu re  6.1  sh o w s th e  in itia l assessm en t, v ia  86R b +efflu x , 
o f  th e  e ffec t o f  exp ressin g  th ese  S U R 2 B  N B D  m u ta n ts  w ith  K ir6.1 on  ch a n n e l 
fu n c tio n a lity .
Condition
% Mean Efflux
Kir6.1/SUR2B 
> K708A/K1349M
Kir6.1/SUR2B K708A
Kir6.1/SUR2B K1349M
Ml + 10(aM Glib
2.5mM NaCN + 20mM 2-DG (Ml) 
10}xM Lev + 10uM Glib 
10(iM Levcromakalim 
Control
Figure 6.1: The effect o f m utating the W \ m otif lysine of N B D s 1 and 2 o f the sulphonylurea  
receptor on the functionality o f the K a t p  channel Kir6.1/SUR2B. Mean 86R b+ efflux o f 
H EK 293 cells transiently transfected with Kir6.1 and with SU R 2B K 708A /SU R 2B K1349M or 
with SU R 2B K708A/K1349M 15 m inutes after the addition o f drugs. Efflux was calculated as 
% efflux o f initial 86R b+ content. The control represents DMSO diluted in H BS. D ata are 
shown as +/- SEM, whereby n =  9. *** PcO.OOl compared to control, (ns) P > 0.05  compared to 
control.
191
It is evident that when only one o f the Walker motifs is m utated, K ir6.1/SU R 2B  
displays normal functionality. This is in line with previous evidence that SU R 2B  
K1349M gives consistently low level activ ity  when expressed with Kir6.1 in inside-out 
patches (Yi Cui). However, when both motifs are m utated functionality is lost, i.e. the  
channel does not respond to the KCO levcromakalim or to the m etabolic inhibitors. 
This suggests that the W a m otifs are not only responsible for nucleotide binding, but 
that abolition o f the key lysine residue renders the channel inactive to KCOs and 
metabolic inhibition. W hen these regions are mutated individually, they appear to be 
able to com pensate for the other’s loss o f function. This is an interesting observation  
since previous reports would suggest that these motifs act synergistically and 
sym m etrically to coordinate nucleotide binding, with functional evidence indicating  
that cooperative interaction rather than the independent contribution of each N B D  is 
critical for K a t p  channel regulation (Zingman, Hodgson et al. 2002). It should be noted  
that the basal efflux observed in this experim ent is relatively high and consistent for 
each m utant. This is likely to be due to natural variation in the transfection efficiency, 
which could be a result of differences in the growth phase, and due to the various 
cellular signaling pathways that are known to affect K a t p  channel regulation, which in 
turn could affect gene expression.
I then went on to determine whether m utation of both nucleotide binding domains in 
K ir6.2/SUR2B would affect the previously observed functionality o f the channel, or 
whether the result observed in Figure 6.1 was unique to Kir6.1-containing channels.
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Condition
% Mean Efflux
Kir6.1 & SUR2B 
V K708A/K1349M
Kir6.2 & SUR2B 
K708A/K1349M
Ml + 10jiM Glib
2.5mM NaCN + 20mM 2-DG (Ml) 
10jj.M Lev/Pin + 10^M Glib 
10nM Levcromakalim/Pinacidil 
Control
Figure 6.2: Comparison o f the functionality o f Kir6.1/SUR2B and K ir6.2/SUR2B, whereby  
SU R 2B  contains m utations in both the W v m otif lysines o f both NBD1 and N B D 2. Mean 
86R b+ efflux of H EK 293 cells transiently transfected with the reconstituted channel 15 m inutes 
after the addition o f drugs. Efflux was calculated as % efflux of initial 86R b+ content. The 
KCOs Pinacidil and Levcromakalim were applied to the Kir6.2-containing and Kir6.1- 
contianing channels respectively. The control represents DMSO diluted in H BS. D ata are 
shown as +/- SEM, whereby n =  9. *** PcO.OOl compared to control, (ns) P >0.05 compared to 
control.
In te r e stin g ly , w h en  th e  d ou b le  N B D  m u ta n t is exp ressed  w ith  K ir6 .2 , th e  ch a n n e l 
w ou ld  appear to  fu n ctio n  n orm ally  (d ata  for K ir6.1 & S U R 2 B  K 708A /K 1349M  is sh o w n  
as a d irect com p arison ). T herefore, th e  W a  m o tif  ly sin es do n ot appear to  p la y  th e  sam e  
lev e l o f  im p o rta n ce  in  th e  regu la tion  o f  K ir6.1 and K ir6.2 co n ta in in g  ch an n els. B ea r in g  
in  m ind th a t K ir6 .2  is fu n ctio n a l in  th e  ab sen ce o f  S U R  (T ucker, G ribble et al. 1997), it  
is p ossib le  th a t K ir6.2 h as som e u n iq u e  in trin sic  p rop erty  th a t co m p en sa tes  for th e  loss  
o f  th ese  residues d esp ite  th eir  p rev io u sly  d em on stra ted  im p ortan ce  (A zzaria , Sch u rr e t  
al. 1989; Carson and W elsh  1995; K o an d  P edersen  1995; G ribble, T u ck er e t al. 1997; 
S h y n g , Ferrign i et al. 1997; U ed a , In agak i e t al. 1997). It w as n ecessary  to  confirm
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these findings with the perforated-patch clamp technique. However, some preliminary 
data is first shown, in which signature linker domain K a t p  channel m utants were 
similarly screened.
Using site-directed m utagenesis, the m utations G1443D and G1449D were previously  
introduced into the carboxy-term inal signature linker domain of SU R2B by Yi Cui, i.e. 
the glycine at residues 1443 and 1449 of SU R2B were mutated to aspartic acid. 
Residue G1443 is situated very close to the ‘linker’ region of NBD2 that is proposed to 
couple nucleotide hydrolysis to downstream actions in several ABC proteins (Sm it, 
W ilkinson et al. 1993; Carson and W elsh 1995). Residue G1449 lies directly w ithin it. 
These m utations were chosen because equivalent residues in the linker regions o f the  
cystic fibrosis conductance regulator (CFTR) nucleotide binding folds have previously  
been im plicated in activation o f CFTR chloride channels by ATP hydrolysis (Sm it, 
W ilkinson et al. 1993; Carson and W elsh 1995). Also, when the corresponding
m utations were similarly introduced into SUR1, i.e. G1479D and G1485D (Shyng,
Ferrigni et al. 1997), they failed to respond to activation by diazoxide and stim ulation  
by M gADP. In turn, the observations that stim ulation of K a t p  channels by A D P and 
by diazoxide both require Mg2+ and hydrolysable nucleotides (Findlay 1988; Lederer 
and Nichols 1989) suggest that the two processes m ay share common molecular 
mechanisms. Both diazoxide and M gADP activate K a t p  channels in the presence o f  
inhibitor concentrations o f A T P, and both processes require Mg2+ and hydrolysable 
nucleotides (Findlay 1988; Lederer and Nichols 1989). It was as such thought that 
G1479D and G1485 may affect channel activity, presumably by affecting binding  
and/or hydrolysis o f ATP, or by affecting the transduction o f nucleotide binding and 
hydrolysis to channel opening and closing (Shyng, Ferrigni et al. 1997). In the
preliminary experiments shown, both Kir6.1 and Kir6.2 were expressed with SU R 2B
G1443D and SU R 2B G1449D to observe the effect o f these m utations on the response 
of the channel to the KCO and metabolic inhibition.
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Condition
* * *
* * x
* ★ *
* * *
* * *
% Mean Efflux
> Kir6.2/SUR2B 
G1443D
Kir6.2/SUR2B 
> G1449D
Kir6.1/SUR2B 
> G1449D
Kir6.1/SUR2B 
f  G1433D
Ml + 10^M Glib
2.5mM NaCN + 20mM 2-DG (Ml) 
10mM Lev/Pin + 10nM Glib 
10^M Levcromakalim/Pinacidil 
Control
Figure 6.3: The effect o f introducing a single m utation into the linker dom ains o f  the  
sulphonylurea receptor on the functionality o f the K a t p  channel K ir6.1/SU R 2B and 
K ir6.2/SUR2B. Mean 86Rb+ efflux o f HEK 293 cells transiently transfected w ith Kir6.1 and 
SU R 2B  G1449D or G1443D or w ith Kir6.2 and SU R 2B G1449D or G1443D 15 m inutes after 
the addition o f drugs. Efflux was calculated as % efflux o f initial 86R b+ content. The KCOs 
Pinacidil and Levcromakalim were applied to Kir6.2-containing and K ir6.1-containing channels 
respectively. The control represents DMSO diluted in H BS. Data are shown as + /- SEM, 
whereby n = 9. *** PcO.OOl compared to control, (ns) P>0.05 compared to control.
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W hen G1443D and G1449D were expressed individually with Kir6.1 and Kir6.2, no 
change in functionality o f the reconstituted K a t p  channel was observed, suggesting that 
the linker in N B D 2 is not involved in nucleotide binding. Therefore, it would appear 
that nucleotide hydrolysis is o f fundam ental importance for channel regulation, 
whereas signal transduction in the first nucleotide binding pocket (via the linker 
sequence) is less critical for regulation o f K ir6.1/SUR2B. This is somewhat surprising 
and conflicts the preliminary observation that G1449D does not demonstrate activ ity  in 
inside-out patches, as previously shown in our laboratory. Since there is thought to be 
functional asym m etry o f the N B D s, and an involvem ent o f the signature linker 
sequence in signal transduction, it could be assumed that m utation o f the linker 
sequence o f N B D 2 would affect K a t p  channel activation of NBD1 by M gADP (Figure 
6 .2 ).
Since there appears to be a key difference in the regulation of Kir6.1-containing and 
Kir6.2-containing channels (at the level o f the channel), with K ir6.2/SUR 2B  
functionality seemingly unaffected my m utation of the Wa m otif of NBD1 and the W a 
m otif and signature linker sequence o f N B D 2. The data observed in Figure 6.3  was as 
such confirmed via perforated patch-clamping.
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+ 50 mV
(A)
0.5nA
500 ms
Control 
t = 2 mins
2.5mM NaCN + 20mM 2-DG (Ml)
t = 5 mins
10|iM Pinacidil 
t = 7 mins
Ml + 10|iM Glib 
t = 8 mins
10nM Pin + 10^M Glib 
t = 10 mins
Current (nA)
-20-80 -60 •40
V oltage (mV)
Ml ♦ 10nM Glib
— 2.5mM NaCN ♦ 20mM 2-DG (Ml)
— 10mM Pin ♦ 10^M Glib
— 10^M Pinacidil
r— i Control
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(C)
150-,
Current Density  
at +50mV pA/pF 75_
* ★ *
C l
Ml + IOjiM Glib
2.5mM NaCN + 20mM 2-DG (Ml) 
10|iM Pin + 10jiM Glib 
10|iM Pinacidil 
Control
Katp channel opener/closer
Figure 6.4: The effect o f m utating both the W \ motifs of the K a t p  channel K ir6.2/SU R 2B on 
channel functionality (i.e. Kir6.2 & SU R 2B K1349M/K708A) as demonstrated by the  
perforated patch-clamp m ethod. Currents were evoked via voltage clamp recordings were 
evoked over 1000ms voltage steps between -150mV and +50mV in lm V  increments from a 
holding potential of -80mV. with 15s between sweep starts. (A) Representative traces for each  
o f the conditions: external solution with DM SO, 10pM Levcromakalim, IOjiM Levcromakalim  
w ith IOOjiM PNU-37883A, m etabolic inhibitors (2.5mM NaCN and 20mM 2-DG) and m etabolic 
inhibitors with lOOfiM PN U -37883A . The time taken from perforation to the current recorded 
under each condition is given (note that that the KCO and KCB were washed out prior to  the 
induction of metabolic inhibition). (B) Representative I/V traces for each o f the conditions 
(pA/pF), whereby each trace crosses the holding potential at -80mV. (C) Current/Density bar 
chart to represent mean data o f the reconstituted channel currents under each condition *** 
P<0.001, (ns) implies P>0.05 compared to control (n=5)
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+ 50 mV
-80 mV___
1000 ms-150 mV
(A) 0.5nA
Control 
t = 2 mins
500ms
10nM Levcromakalim 
t = 7 mins
10nM Lev + 10|iM Glib 
t = 10 mins
(B)
Current Density at 
+50mV pA/pF
2.5mM KCN + 20mM 2-DG (Ml) 
t = 5 mins
1 5 0 -  
125-1  
100-  
7 5 -  
5 0 -
Ml + 10nM Glib 
t = 8 mins
Ml + 10^M Glib
2.5mM NaCN + 20mM 2-DG (Ml) 
10)iM Lev + 10^M Glib 
10nM Levcromakalim 
Control
Katp channel opener/closer
Figure 6.5: The effect o f m utating both the W a  motifs o f the K a t p  channel K ir6.1/SU R 2B  (i.e. 
Kir6.1 & SU R 2B K1349M /K708A) on channel functionality as demonstrated by the perforated  
patch-clam p method. Currents were evoked via voltage clamp recordings were evoked during  
1000ms voltage steps between -150mV and +50m V in lm V  increments from a holding potential 
of -80mV, with 15s between sweep starts. (A) Representative traces for each o f the conditions: 
external solution with DMSO, IOjiM Levcromakalim, 10p.M Levcromakalim w ith 100|iM  P N U -  
37883A, metabolic inhibitors (2.5mM NaCN and 20mM 2-DG) and m etabolic inhibitors w ith  
lOOpM PN U -37883A . The tim e taken from perforation to the current recorded under each  
condition is given (note that that the KCO and KCB were removed before the induction o f  
metabolic inhibition). (B) Current/Density bar chart to represent mean data o f the  
reconstituted channel currents under each condition *** PcO.OOl, (ns) implies P>0.05 (n=6)
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These results confirm those observed w ith the 86R b+ flux assay in Figure 6.2. The 
double SU R 2B nucleotide m utant affects the functionality o f Kir6.1 but not Kir6.2- 
containing channels. This observation highlights the importance o f the presence o f the  
N B D s in the metabolic regulation o f K ir6.1/SUR2B and emphasizes that regulation is 
at the level o f the channel as opposed to via other external factors.
Four additional point m utations were made in SU R2B in accordance w ith work 
conducted by Yergani and colleagues (Vergani, Lockless et al. 2005), whereby it was 
established that dynamic N B D  dimerization occurs as the molecular m echanism  that 
couples A TP binding and hydrolysis cycles to cyclic changes in transm embrane 
domains. The residues Arginine 555 and Threonine 1246 of the CFTR were m utated  
since they are thought to be functionally coupled. The charge-removing m utation  
R555Q slowed CFTR channel closing, consistent with Arginine 555 being part o f  the  
com posite N B D 2 catalytic site (whereby the positive charge o f Arginine 555 is thought 
to help stabilize the partial negative charges developed on the phosphate o f the A T P  
molecule). Conversely, the charge-conserving m utation R555K slowed channel 
opening, which could be explained if the R555K m utation were to weaken or rem ove a 
hydrogen bond between NBD1 and N B D 2 that is absent in the closed, ground, state  
but present in the transition state for channel opening. Additionally, the apparent 
affinity for ATP was not influenced by the m utation R555K, but was by m utation  
T1246N when examined alone and with R555K. On deduction of the relative location  
of these two residues to each other in the ATP hydrolysis cycle it was concluded that 
ATP binding occurs before the formation of a closely apposed N B D 1-N B D 2 dimer 
(Vergani, Lockless et al. 2005).
Based on these observations, the corresponding m utations were introduced into SU R 2B  
via site-directed mutagenesis. These were R816Q, R816K and T1345N . F inally , in 
other ABC-ATPases, m utating the key lysine in the W a m otif to arginine drastically  
reduces or abolishes hydrolysis. CFTR channels carrying the corresponding m utation, 
K1250R, have prolonged open burst duration. This is indicative o f slowed hydrolysis at
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the CFTR’s N BD 2 catalytic site. As such, the corresponding m utation was also 
introduced into SU R2B (K1349R). Preliminary data, in which these m utants were 
screened using the 86Rb+ flux assay to assess abolition of functionality in preparation  
for further analysis, is shown in Figure 6.6.
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Condition ns
* * *
* * *
* * *
Kir6.1/SUR2B R816K
Kir6.1/SUR2B T1345N
> Kir6.1/SUR2B R816Q
Kir6.1/SUR2B K1349R
% Mean Efflux
Ml + 10|iM Glib
2.5mM NaCN + 20mM 2-DG (Ml) 
10nM Lev + 10|iM Glib 
10jiM Levcromakalim 
Control
Figure 6.6: The effect o f m utating Arg 816, Thr 1345 and Lys 1349 of the sulphonylurea  
receptor on the functionality o f the K a t p  channel K ir6.1/SUR2B. Mean 86R b+ efflux o f  
H EK 293 cells transiently transfected with Kir6.1 and SU R 2B K 1349R /R 816Q /R 816K /T1345N  
15 minutes after the addition of drugs. Efflux was calculated as %  efflux o f initial 86R b+ 
content. The control represents DMSO diluted in H BS. D ata are shown as + /- SEM , whereby n 
= 6. *** PcO.OOl compared to control, (ns) P >0.05 compared to control.
2 0 2
Mutation of Arginine 816 (R816K or R816Q), residing three positions after the  
signature linker sequence in the NBD1 tail, does not appear to affect the functionality  
of Kir6.1/SUR2B. M utation of Threonine 1345 (residing in the Wa phosphate-binding  
loop in the NBD2 head) or Lysine 1349 (residing in the W a motif, specifically the  
phosphate binding loop to arginine) similarly does not appear to affect pharmacology. 
This is consistent with the previous result, whereby mutation of Lysine 1349 to  
xMethionine did not abolish the functionality of Kir6.1/SUR2B (Figure 6.2). On visual 
observation it would appear that there may be a slight reduction in the response to  
metabolic inhibition on the introduction of R816K or T1455N, indicating that A TP  
binding or hydrolysis may be affected to a degree. However, this would need to be 
investigated further, possibly by conducting similar experiments to those o f Vergani 
and colleagues (Vergani, Lockless et al. 2005).
K708A T1345N
K1349R
K1349M
G1443DR816K
R816Q G1449D
N B D 2N B D 1
Figure 6.7: Diagram depicting the sulphonylurea receptor to indicate the m utations th at were 
introduced into NBD1 and N B D 2. K708A represents m utation o f the lysine in the W \ m otif o f  
N B D 1, and K1349R/K1349M  and T1345N m utation o f the lysine and threonine respectively o f  
the W \ m otif. R816K/R816Q and G 1443D/G1449D represent m utations affecting the signature 
linker sequence o f NBD1 and N BD 2 respectively.
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Figure 6.7  summarizes the m utations that were screened in this chapter to further 
understand the importance o f the sulphonylurea receptor in the metabolic regulation o f  
the K a t p  channel. Only sim ultaneous m utation o f K708A and K1349M SU R 2B  
affected the functionality o f Kir6.1-containing channels. The fact that the individual 
m utations o f NBD1 and N B D 2, and m utations in the linker sequence did not appear to 
affect the normal response to the various pharmacological agents goes against the  
previous evidence that there is functional asymm etry of the NBD s. However, it is 
possible that the residues m utated were not o f key importance to the catalytic cycle in  
the N B D  sites in both K ir6.1/SUR 2B and Kir6.2/SUR2B. This is discussed further in 
the subsequent chapter.
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Chapter Seven: Discussion
To introduce this chapter, I would like to highlight that all-in-all this thesis has 
highlighted the usefulness o f the 86R b+ flux assay as a technique, with a high enough 
sensitivity and specificity to screen for ion channel functionality (on condition that the  
transfection efficiency o f recombinant ion channels was at least 80%). It proved useful 
in the screening o f a variety o f recombinant ion channels relatively quickly, and since 
the results that I deemed to the m ost significant were confirmed via either whole-cell or 
perforated patch-clamping, we can assume that the data obtained is an accurate 
depiction o f the way in which the recombinant K a t p  channels respond to the various 
pharmacological agents applied. Undoubtedly, patch clamping is the gold standard for 
determining ion-channel functionality, providing high quality and physiologically  
relevant data o f ion channel function at the single cell or single channel level (Ham ill, 
Marty et al. 1981). No other existing technology can provide such a direct, precise and 
detailed measurem ent o f the activity of an ion channel down to the single-molecule 
level. However, it has a relatively low throughput and reproducibility. There are m any  
automated recording techniques under development, for example the Port-a-Patch (an 
automated electrophysiology work station). This is based on a planar, microstructured 
glass chip, and enables autom atic whole cell patch-clamp measurements (Brueggemann, 
George et al. 2004). It is conceivable that with time, such technologies will replace the 
use o f radioactive assays. In the meantime, I am confident that 86Rb+ flux is an 
accurate screening tool.
7.1 Rationale for conducting these studies
The objective o f this thesis was to assess the metabolic sensitivity o f the K a t p  channel 
K ir6.1/SUR2B, and to begin to understand the molecular mechanism responsible for 
this. It was originally hypothesised that Kir6.1 would be a hormonal rather than a 
predominant m etabolic sensor. It has frequently been observed that smooth muscle 
contains a current that is less sensitive to changes in metabolism and the channels 
responsible are directed by hormonal inputs and protein kinase activity. The opening
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of these channels is absolutely dependent on the presence of nucleotide diphosphates 
and the inhibition by ATP is m uch less marked. This has been described as the K n d p  
current. In native vascular sm ooth muscle tissues, vasodilators such as CGRP activate  
analogous currents through a PK A dependent mechanism, and this m odulation  
accounts for a substantial portion o f the vasodilatation (Quayle and Standen 1994). In  
contrast vasoconstrictors, in particular angiotensin II, inhibit the channel by activating  
protein kinase C (Kubo, Quayle et al. 1997). It was proposed that K ir6.1/SUR2B is the  
molecular counterpart o f vascular smooth muscle ATP-sensitive K+ channel, w ith  
properties analogous to th at o f the K n d p  current. It appears, from the work that has 
been conducted in both our and other laboratories, that Kir6.1/SUR2B m ay indeed 
constitute the K a t p / K n d p  channel in the vascular smooth muscle.
A number of studies had previously addressed the molecular mechanisms o f nucleotide 
regulation of the ‘m etabolically sensitive’ Kir6.2 containing channel com plexes 
(predominantly K ir6.2/SUR1 and Kir6.2/SUR2A) (Shyng and Nichols 1997; Babenko, 
Gonzalez et al. 1999; Ueda, Komine et al. 1999; Dong, Tang et al. 2005). In contrast, 
little was known o f the molecular details o f how nucleotides regulate Kir6.1 containing  
complexes.
To recap, there are some interesting paradoxes. At the functional level, K ir6.1/SUR2B  
is less ATP sensitive: A T P stim ulates channel activity at submillimolar concentrations, 
with activity peaking at ImM, and only moderate inhibition occurring above this 
(Yamada, Isom oto et al. 1997). Channel opening is absolutely dependent on the 
provision of nucleotide diphosphates and does not occur in their absence. However, at 
the biochemical level, fluorescent derivatives o f ATP can bind with similar affinities to 
the C-termini o f Kir6.1, Kir6.2 and K ir l.l  (Yanoye, MacGregor et al. 2002). Overall, 
there is a fundamental gap in our understanding of what accounts for these profound 
differences given the com m onality o f the expressed sulphonylurea receptor and the high 
hom ology between Kir6.1 and Kir6.2.
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Vascular and non-vascular sm ooth muscle m ay express Kir6.2 in addition to Kir6.1 and 
SU R 2B, and Y i Cui reported that the diverse range o f unitary conductance reported for 
sm ooth muscle K a t p  channels m ay be due to co-assembly of Kir6.1 and Kir6.2 to form  
channels, w ith different combinations o f the pore-forming subunits and their associated  
SU R 2B subunits (Cui, Tinker et al. 2003). Therefore, in this thesis I set out to assess if  
K ir6.1/SUR2B displays any m etabolic sensitivity and to compare the m etabolic 
regulation o f K ir6.1/SUR2B with that o f Kir6.2/SUR2B. I wanted to elucidate if  the 
pore-forming suhunit accounted for any differences in regulation at the molecular level 
(given the com m onality o f the sulphonylurea receptor, SUR2B).
Using both the 86R b+ flux assay and the perforated patch-clamp technique, I deduced 
that K ir6.1/SUR2B was indeed m etabolically responsive (Figures 3.2  & 3.8). 
Inhibition o f both oxidative m etabolism and glycolysis depleted [ATP]i levels and 
increased A D P levels to a sufficient level to induce channel opening (Figure 3.3). Since 
Kir6.1 -containing channels have been reported not to be activated by depletion o f ATP  
(Yamada, Isom oto et al. 1997), this was an interesting result in itself. Because the role 
that cellular signalling pathways (as assessed via the involvem ent of AM PK, adenosine 
and PK A) did not appear to be so clear-cut, I placed more emphasis on the regulation of 
K ir6.1/SUR2B at the m etabolic level (i.e. directly by ATP and MgADP) as opposed to 
regulation by protein kinases.
ATP and non-hydrolysable derivatives bind to determinants in the N- and C-terminus 
of Kir6.2 to result in channel inhibition (Koster, Sha et al. 1999; Vanoye, MacGregor et 
al. 2002). In contrast, M gADP is known to interact with the nucleotide binding 
domains o f SUR at the W a and W b motifs in a complex fashion to increase the activ ity  
of the channel complex (Shyng, Ferrigni et al. 1997; Ueda, Komine et al. 1999). 
Therefore, I looked at the role that both the pore-forming and sulphonylurea receptor 
suhunits play in the m etabolic regulation of the channel. It would appear from these 
combinative results that Kir6.1 is not primarily responsible for metabolic sensitivity o f  
the channel, but that SU R 2B is likely to be.
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7.2 The role o f the pore-forming subunit in channel regulation 
-Studies involving removal o f  the N- and C-terminus to allow independent expression 
It was found that Kir6.2AC26 can be expressed and function independently, and that  
this makes it a useful tool for determining whether drugs act on K a t p  channels do so by  
interacting with Kir6.2 or w ith SU R 1, and for examining the functional interaction  
between Kir6.2 and SUR1 (Tucker, Gribble et al. 1997). Therefore, I similarly deleted 
the C-terminus (hence removal o f the RK R motif) o f Kir6.1 to allow its independent 
expression. The N-term inus o f Kir6.1 was also deleted, since this was thought to  
increase basal activity when expressed in combination with SUR2B in the absence o f 
nucleotide diphosphate (Babenko and Bryan 2001).
Surface staining revealed that removal o f the RK R m otif o f Kir6.1 did indeed allow  
independent surface expression, whereas when present the pore was not trafficked to 
the cell membrane (Figure 4 .3), which was the case for Kir6.1 and Kir6.1-AN. Deletion  
of the C-terminus did not obliterate functionality when Kir6.1 was expressed with the 
sulphonylurea receptor, however this did not allow its independent functional 
expression (Figure 4 .9 ), i.e. Kir6.1-AC did not display intrinsic ATP sensitivity as was 
previously shown by Tucker and Colleagues for Kir6.2-AC (Tucker, Gribble et al. 1997).
Another key observation was that Kir6.1-AN33/SUR2B was non-functional (Figure 4 .7  
& Figure 4.10). It has been reported that N-terminal truncation of Kir6.1 was not 
found to compromise the response to Mg-nucleotide-dependent stim ulation by the 
sulphonylurea receptor, and that progressively larger deletions (AN13, AN21 and AN33) 
increased the open probability, with maximal effect seen with AN33 (Babenko and 
Bryan 2001). The data displayed in Figures 4.6 and 4.9  would indicate that this is not 
necessarily the case.
It has also been shown that the deletion of residues 2-10 and 20-30 o f N-term inus of  
Kir6.2 are associated with a significant increase in open probability in absence of A TP,
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but that intrinsic ATP sensitivity was not affected in co-expressed channels (Koster, 
Sha et al. 1999). It is thought that the normal role o f N-terminus may be to destabilise 
the open state under the influence of SUR1. This action may be blocked by physical 
tethering o f the N-terminus to SU R 1, and is therefore absent both after deletion o f the 
Kir6.2 N-term inus, or upon expression of Kir6.2 w ithout SUR1. This would explain  
lack o f additivity o f the effect o f N- and C-terminal deletions expressed without SUR1  
(Koster, Sha et al. 1999). Similarly, it has been shown that deletion o f more than half 
of the N-term inus o f Kir6.2 has no effect on intraburst kinetics, and that the rate o f  
transition which terminates a burst and decreases fraction of time channel spends in 
interburst closed states (Babenko, Gonzalez et al. 1999) is decreased. N-term inal 
Kir6.2 m utants have been shown to have an extremely high open probability in absence 
of nucleotides. They also dem onstrate a decreased apparent ATP-sensitivity, which is 
consistent with the involvem ent o f the N-terminus in a transition to an interburst 
closed state that preferentially binds inhibitory ATP (Babenko, Gonzalez et al. 1999).
All-in-all previous data has demonstrated that the two cytoplasmic domains of Kir6.2 
make additive contributions to ATP-inhibitory gating via different mechanisms; the N- 
terminus controls the transition to an ATP-sensitive interburst state, the C-terminus 
interacts with ATP. Deletions o f the C-terminus do not affect intrinsic ATP sensitivity  
of the channel, but allow generation of functional channels in absence of SU R1. 
Deletions o f N-terminus, do not generate functional channels w ithout SU R1, but 
stabilise the open channel, leading to apparent reduction in ATP sensitivity in absence 
of SUR1. In fact, the N-term inus m ay function to transduce a destabilizing effect o f  
SUR1 on open state. It is therefore somewhat surprising that both 86R b+ flux and 
patch-clamp data indicate that Kir6.1AN33/SUR2B is non-functional. Even though it 
has been shown that truncations o f 40 amino acids or beyond of Kir6.2 did not generate 
functional channels in the presence o f SUR1 (Koster, Sha et al. 1999), and that 
Kir6.2AN53 failed to produce functional channels when expressed with SUR1  
(Babenko, Gonzalez et al. 1999), one would assume that the high open probability o f
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K ir6.1AN 33/SURl seen by Babenko and Bryan in 2001 would correspond to a high  
basal flux.
It is possible that these differing observations are due to the fact that Kir6.1-AN was 
expressed w ith a different sulphonylurea receptor. In may be possible that N-term inus 
of Kir6.1 does not play the same destabilising role in SUR2B-containing channels as 
Kir6.1/SUR1. This would need to be investigated further; however the data that I 
obtained is convincing and consistent: deletion o f the N-terminal 33 amino acids 
reduces functionality of both Kir6.1 and Kir6.1-AC when expressed with SUR2B.
-Studies using K a t p  channel inhibitors specific to Kir6.x
Even though Kir6.1-AC48 did not display intrinsic metabolic sensitivity, it displayed  
significant basal efflux in comparison to H EK 293 cells or to those expressing Kir6.1 
alone (Figure 4.9). The same was also true for Kir6.1AC48/AN13. Therefore, truncated  
pore-forming subunits that were found to be expressed at the cell membrane in the  
absence o f the sulphonylurea receptor would also appear to display a higher basal 
efflux. This basal efflux was reduced by the drugs which bind to the Kir6.x subunit, i.e. 
BaCh and PNU-37883A, indicating that the pore was still able to pass a small am ount 
of current even though it was not able to ‘sense’ changes in nucleotide levels. PN U -  
37883A has also been shown to block current passed by Kir6.2AC26 (Cui, Tinker et al. 
2003). Therefore, truncation o f the pore-forming subunit would not appear to affect the  
ability o f inhibitors specific to Kir6.x to bind to Kir6.2-containing channels.
Kir6.1, Kir6.1AC48 and Kir6.1AC48/AN13 were subsequently expressed with SU R 2B , 
and the ability o f and BaCh to reverse efflux induced upon metabolic inhibition, and 
via the application of a KCO investigated. Both Kir6.A: inhibitors were able to reverse 
m etabolically induced flux as seen for glibenclamide, and truncation of reconstituted  
channel com pletely abolished reversal (Figures 5.3, 5.4 and 5.5). Therefore, under 
conditions o f nucleotide depletion, the ability of the inhibitors to bind to Kir6.1 would
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appear to be disrupted, and truncation of the pore at the N- and C-terminus enhances 
this effect. B oth PN U -37883A  and BaCk are still able to bind to the pore when 
expressed w ith the sulphonylurea receptor in this system , since they are able to reverse 
efflux induced by the KCO. This was a very interesting observation, and both 86R b+ 
flux and the perforated patch-clamp method yielded a consistent result (Figure 5.5). 
This m ay be an example whereby enhancem ent/inhibition o f ligand binding to one 
subunit is affected by co-expression with another subunit. It should also be considered 
that the presence/absence o f nucleotides influences ligand binding. Since the nucleotide 
pool is significantly depleted under metabolic inhibition, this m ay explain the 
discrepancy in this result. I believe the m ost likely scenario to explain this result is that 
nucleotide depletion affects the sterical conformation of the NBDs, affecting the overall 
conform ation o f the sulphonylurea receptor, which in turn affects the conformation of  
the pore-forming subunit and the ability of inhibitors specific to Kir6.x to bind. 
Truncation o f the pore-forming subunit influences conformational change ‘transm itted’ 
to the pore. It is interesting that K ovalev and colleagues showed in their experim ents 
using the Xenopus oocyte system  that PNU-37883A sensitivity was not affected by  
KCOs or metabolic inhibition (K ovalev, Quayle et al. 2004). However, they also 
showed that PN U-37883A shows selectivity for channels containing Kir6.1, whereas I 
have shown (Figure 5 .7  &  Figure 5.6), as have Cui and colleagues, that Kir6.2- 
containing channels do show some sensitivity for PNU-37883A (Cui, Tinker et al. 2003). 
Since we both used the H EK 293 expression system , it is possible that the oocyte system  
affected PN U -37883A sensitivity.
Y i Cui observed that Kir6.2AC26 shows a greater sensitivity to PN U-37883A when 
expressed alone than when expressed with SUR2B (Cui, Tinker et al. 2003). The 
potency o f the drug was seven-fold greater on Kir6.2AC26 current than  
Kir6.2AC26/SUR2B. The presence of SUR may in some way hinder access to, or 
modify the conformation o f a drug binding site on the pore-forming subunit. It is also 
interesting to note that the SU R subunit can also have an effect on the potency o f  
PNU-37883A, with the IC50 ranging from about 5pm with SU R2B to 32pm with SUR1
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(Surah-Narwal, X u  et al. 1999). It is possible that SUR2B conferred a lower potency o f  
PN U-37883A to the pore than when it was expressed alone. It would be interesting to 
co-express SUR1 with the truncated Kir6.1 pore-forming subunit to determine whether 
the result observed remained true. We should bear in mind that that the dependence o f  
SUR is seen for the inhibitory potency o f ATP on K a t p  channels, even though Kir6.*; 
has clearly been identified as the site of inhibitory ATP action (Tucker, Gribble et al. 
1997). Similar enhancements have also been observed, whereby the co-expression of  
Kir6.1 w ith SU R 2B increases SU R 2B affinity for PNU-99963 via interaction between  
these two types o f subunits (Cui, Tinker et al. 2003). Also, SUR2B expressed with  
Kir6.1 has a higher affinity for glibenclamide than SUR2B alone (Russ, Hambrock et 
al. 1999).
Since a dose-response curve was conducted to assess the ability of PN U-37883A to 
reverse Kir6.1/SUR2B efflux induced by a KCO, we can assume that the potency o f  
PN U -37883A was not an influencing factor, and that high enough dose of PN U -37883A  
was applied to observe the ability o f PNU-37883A to reverse any efflux passed when  
the pore was expressed alone, or with SU R2B. However, we should not rule out the 
possibility that a higher dose o f Kir6.x inhibitor is required to inhibit the channel under 
conditions o f metabolic inhibition.
I observed a different scenario for Kir6.2AC26, which when expressed in the absence of 
SU R2B was responsive to m etabolic inhibition, and for which efflux induced on 
metabolic inhibition was reversed by both Kir6.^-specific inhibitors (Figure 5.7). W hen  
Kir6.2AC26 was expressed with SU R 2B, efflux induced by both metabolic inhibition  
and the KCO was reversed, but again this was not as pronounced as when glibenclamide 
was applied (Figure 5.8). This m ay be indicative that any sterical change that m ay  
occur within the channel when the nucleotide level is depleted is consistent for Kir6.1 
and Kir6.2-containing channels. In any case, the data obtained confirms the previously  
observed constitutive activ ity  o f Kir6.2AC26, and emphasizes the difference between
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Kir6.1AC48 and Kir6.2AC26 in their intrinsic sensitiv ity  to m etabolically induced 
changes in cytosolic nucleotide levels (Figure 5 .7  &  Figure 5.6).
7 .3  The R ole o f  the Su lphonylurea receptor in  channel regulation  
Perhaps the m ost interesting, and som ew hat controversial, result obtained in this thesis 
was obtained via assessing the functionality  o f K ir6.1/SU R 2B engineered to contain a 
m utation w ithin  the Wa m otifs o f  NBD 1 and N B D 2 (Figure 6.1). In other ABC 
transporters, the m utation o f these residues has been shown to abolish A T P binding 
and/or hydrolysis (Azzaria, Schurr et al. 1989; Carson and W elsh 1995; Ko and Pedersen  
1995; Ueda, Inagaki et al. 1997; U eda, Komine et al. 1999), and in SU R 1, these  
m utations prevent activation by M g-nucleotides (Gribble, Tucker et al. 1997; Shyng, 
Ferrigni et al. 1997; Gribble, Tucker et al. 1998).
Campbell and colleagues recently built a N B D  dimer model o f SUR1 (Campbell, 
Sansom et al. 2003). In this model, the W a m otif o f both N B D s interacted w ith the P* 
phosphate o f A T P. Consistent w ith this finding, high-affin ity ATP binding to site 1 o f  
SUR1 or M RP1 has been shown to be abolished by m utation o f the W a lysine in N B D 1, 
and m utation  o f the W a lysine in N B D 2 prevented the ability o f M gADP to stabilize 
ATP binding at N B D l (Ueda, Inagaki et al. 1997). Sim ilarly, the independent or 
combined m utation  o f the lysine residues in the W a m otif o f N B D l and N B D 2 o f SUR1 
(K 719 and K 1384 respectively), abolished channel activation  by both M gADP and 
M gATP (Gribble, Tucker et al. 1997; Shyng, Ferrigni et al. 1997). This loss o f M gADP  
binding and activation can be explained by the fact that the W a lysine interacts with  
the P-phosphate o f the nucleotide in the N B D  dimer model (Campbell, Sansom et al. 
2003). The model also suggests th at both A TP binding at N B D l and M gADP binding 
at site 2 are essential for nucleotide activation o f SU R 1.
In Chapter 6, it was deduced via 86R b+ flux, and confirmed by the perforated patch- 
clamp m ethod, that both N B D s need to be m utated sim ultaneously to obliterate 
normal functionality  o f K ir6.1/SU R 2B  (Figure 6.1 &  Figure 6.5). W hen the
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corresponding m utations were introduced into K ir6.2/SU R 2B, channel functionality  
was not affected (Figure 6.2 &  Figure 6.4). W ith reference to the introductory chapter, 
Figure 1 .9 , th is data does not support the previous model proposed by M atsuo and 
colleagues, whereby the synergistic action o f the N B D s o f SU R is required for the 
nucleotide action o f the K a t p  channels by SU R  subunits (M atsuo, Kimura et al. 2005).
Reim ann and colleagues reported that the Wa m utation o f N B D 2 o f SU R 2A  (K1348A) 
abolished the channel activation by M gA D P, whereas the corresponding m utation o f  
N B D l (K 707A ) did not. This supports the idea that N B D 2 o f SU R  is essential for 
M gAD P activation  by SU R  (Reim ann, Gribble et al. 2000). On the other hand, Gribble 
and colleagues reported that both W a  m utations (K719A and K1345A) are required to 
abolish channel activation  by M gA D P (Gribble, Tucker et al. 1997). It was 
subsequently found that the K708A m utation o f SUR1 affects 8-azido-ATP binding not 
only to N B D l but also N B D 2 (M atsuo, Kimura et al. 2005). Therefore, nucleotide 
binding at N B D l could also be im portant for M gADP activation by affecting  
nucleotide binding at N B D 2, and vice-versa. In fact, nucleotide binding experim ents 
have revealed that when M gAD P directly binds to N B D 2, or is produced upon 
hydrolysis o f bound M gATP, a conform ational change in N B D 2 transduces another 
conform ational change in N B D l, to stabilize ATP-binding at N B D l (M atsuo, Kimura 
et al. 2005). Sim ilar cooperativity has been found for nucleotide binding to the two  
N B D s o f S U R 2A  and SU R 2B  (M atsuo, Tanabe et al. 2000). It is som ew hat surprising 
therefore, that individual m utation o f the W a m otifs o f N B D l and N B D 2 o f SU R 2B  
does not affect the response o f the channel to m etabolic inhibition (Figure 6.1).
It is also interesting that m utation o f the glycine residue both within and just outside 
the signature linker sequence o f N B D 2 o f SU R 2B  did not affect channel functionality  
(Figure 6.3), considering that there is thought to be functional asym m etry o f the N B D s  
and an involvem ent o f the signature linker sequence in signal transduction. Also, when  
the corresponding m utations were introduced into SU R 1, i.e. G1479D and G1485D  
(Shyng, Ferrigni et al. 1997), they failed to respond to activation by diazoxide and
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stim ulation by M gAD P. M utation o f  the conserved serine in the signature linker 
sequence o f  either N B D l or N B D 2 (S830 and S1482 respectively), has been shown to 
reduce (S830) and abolish (S1482) K a tp  channel activation by M gAD P (M atsuo, 
Dabrowski et al. 2002). This is further evidence that the signature linker sequence is 
involved in signal transduction, and is further evidence for the proposed functional 
asym m etry o f  the N B D s. In the model proposed by Campbell and colleagues, the linker 
serine interacts w ith the P-phosphate o f A T P and the backbone o f the W a glycine in 
both N B D s (Cam pbell, Sansom et al. 2003).
On the whole, given the previous evidence discussed, the data obtained from m utation  
o f the N B D s and signature linker sequence is surprising (Figures 6.1-6.5). The N B D  
dimer m odel created by Campbell and colleagues was created for SU R 1, and it is 
possible that the key residues involved in nucleotide interaction and transduction differ 
in SU R 2B . It would also appear th at replacement o f Kir6.2 with Kir6.1 in SU R 2B - 
containing channels influences the residues in the Walker m otifs that are involved in 
the cata lytic  A T Pase cycle (M atsuo, Kimura et al. 2005). A preliminary experim ent 
was conducted in which the sam e W a  lysine was m utated to arginine (K 1349R ), and 
threonine 1345 in the W a  phosphate-binding loop in the N B D 2 head was m utated to 
asparagine, and sim ilarly K ir6.1/SU R 2B functionality was unaffected (Figure 6.7). 
Since m utation  o f lysine at position 1349 to either arginine or m ethionine (i.e. a 
positively  charged or non-polar am ino acid) does not affect channel functionality, this 
m ay be further indication that A T P does not bind here. M utation of Arginine 816, 
residing three positions after the signature linker sequence in the N B D l tail, to either 
lysine or glutam ine (R 816K  or R816Q) did not affect channel functionality  either 
(Figure 6.7). The m utations screened in Figure 6 .7  were engineered because recent 
work dem onstrated by Vergani and colleagues would indicate that the equivalent 
residues are involved in dynam ic N B D  dim erization in the CFTR (Vergani, Lockless et 
al. 2005). H owever, this would not necessarily appear to be the case for SU R 2B .
216
Differences in sensitiv ity  between SU R 1, SU R 2A  and SU R 2B  in the interaction with  
adenine nucleotides have been reported to exist. The affinities o f N B D l o f SUR1 for 
A T P and A D P  (especially ATP) are significantly higher than those o f SU R 2A  and 
SU R 2B . The affin ity o f N B D 2 for A T P is significantly higher than that o f SU R 2A , 
and the affinities o f N B D 2 o f SU R 2B  for A T P and A D P  are significantly higher than  
those o f SU R 2A . It is possible that these differences in nucleotide binding affinities o f  
SU R  subunits are possibly related to differential regulation o f K a t p  channels. 
Structural m odeling has revealed that seven residues at the central portion o f the C- 
terminal 42 am ino acids localize near the W a m otif o f N B D 2 (M atsushita, Kinoshita et 
al. 2002). The polar and charged residues in the segm ent are located within a distance  
that allows their electrostatic interaction w ith  A rgl344 on the Walker-A loop o f N B D 2. 
It is thought th at the C-terminal region m ay alter the sensitivity o f K a t p  channels to  
adenine nucleotides by affecting the affin ity and/or ATP hydrolysis o f N B D s o f the  
sulphonylurea receptor (Babenko, Gonzalez et al. 1999). It is possible, that as well as 
affecting the strength o f  nucleotide interaction with the residues in the W alker m otifs, 
these key residues in the C-terminal 42 am ino acids influence the exact residues that are 
involved via slight sterical differences that may be induced between sulphonylurea  
receptor subtypes. It was recently shown that syn tax in -lA  was shown to inhibit K a t p  
channel by in teraction  w ith N B D l o f SU R 1. It is possible that other cellular system s  
or ligands m odify the nucleotide binding and/or A TP hydrolysis o f each SU R  subtype  
in a different w ay (Pasyk, Kang et al. 2004).
7 .4  P ossib le  extension o f  these studies
There are a num ber o f issues in continuation of the work presented here that could be 
addressed in the future. Photoaffin ity labelling and scanning with sulfhydryl group 
reagents accomplished via m utagenesis identified that both N-and C-termini o f the 
pore-forming subunit contribute to recognition o f ATP (Trapp, Haider et al. 2003). The 
m ost recently developed model im plicates two Kir6.2 subunits in the coordination o f  
one A TP molecule. W hile K185 and R201 in the C-terminus o f one subunit and R50 in 
the N-term inus o f another Kir6.2 have been directly im plicated in the interaction o f the
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y- and (3-phosphate o f ATP, respectively, the adenine ring interacts w ith E179 and 
R301 of the second subunit (A lekseev, H odgson et al. 2005). It would o f interest to  
m utate the corresponding residues o f Kir6.1 to understand the m echanism  o f A TP  
inhibition o f  the pore in K ir6.1/SU R 2B  channel com plexes, and in turn m etabolic  
regulation. It would also be o f interest to make chimeras between Kir6.1 and Kir6.2 
containing deletion m utants that remove that R K R  m otif (Kir6.1-A48 and Kir6.2-A36). 
Splicing by overlap extension could be applied to swap the N-term ini, whole C-terminus 
and distal C-term inus between Kir6.1 and Kir6.2. Other investigators have found that 
a num ber o f these are functional in the presence o f the coexpressed sulphonylurea  
receptor (K ondo, R epunte et al. 1998; Takano, X ie et al. 1998). The use o f a Kir6.1 
chimera has also proved to be a useful technique in the determ ination of PN U -37883A  
sensitiv ity  (K ovalev , Q uayle et al. 2004). It would be interesting to swap residues o f  
Kir6.2 that confer A T P sensitiv ity  w ith those o f Kir6.1 to determine if  sensitiv ity  
would be abolished, and to identify if  there are residues or structural determ inants 
outside the region exchanged that also m ake a contribution.
The introduction o f  m utations into  the W b m otif would also prove useful. M utation of  
the invariant W b aspartate o f either N B D  at either S853 or D1505 o f SUR1 has been 
shown to abolish channel activation  by M gADP (Gribble, Tucker et al. 1997; Shyng, 
Ferrigni et al. 1997), and m utations in N B D l abolish A TP binding (Ueda, Inagaki et al. 
1997). These results are therefore similar to those reported for the W a  lysine. The  
model proposed by Campbell and colleagues suggests that the W b aspartate is 6A away  
from the A T P molecule; therefore its exact role is not clear. It m ay be that the  
structural effects o f these m utations disrupt the electrostatic coordination o f the A T P  
molecule, and it would be interesting to see if  the same holds true for SU R 2B .
I have already begun to subclone SU R 2B  into two fragments (containing N B D l and 
N B D 2) into the vectors p E Y F P  and pECFP (which encode enhanced versions o f the  
green fluorescent protein (G FP) and an enhanced cyan fluorescent protein respectively) 
and pcD N A 3.1. This will enable future Fluorescence Resonance Energy Transfer
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(FR E T ) experim ents to be conducted in the future to determine if  the two fragm ents 
co-localise when expressed with K ir6.1-G FP or K ir6.2-G FP, and to identify which  
SU R 2B  fragm ent interacts w ith the pore-forming subunit via observation o f any 
conform ational change.
It Chapter 3, Figure 3 .13 , it was dem onstrated that AM PK  may play an indirect 
response o f the channel to m etabolic inhibition. It would be o f interest to investigate  
the role o f A M PK  in native tissue, since the result obtained would obviously be more 
representative o f  how AM PK  regulates the K a t p  channel in a physiological setting.
U ltim ately , 3 D  m odels and crystallography studies o f K a tp  channel subunits have been 
dem onstrated to reveal an abundance o f inform ation w ith respect to the function o f the  
channel and the residues involved in nucleotide interaction (Campbell, Sansom  et al. 
2003; Ashcroft 2005; M ikhailov, Campbell et al. 2005; Ashcroft 2006). Such studies 
have so far focussed on Kir6.2 and SU R 1, and the application of the m odelling 
programs applied to SU R 2B  will identify any key structural differences, and hopefully  
enhance our understanding o f the m etabolic regulation o f K ir6.1/SU R 2B and clarify the  
key observations that I have discussed.
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